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Described herein are the total syntheses of the antibiotic polyketides baulamycin A and 
baulamycin B. A synthesis giving rise to much of the baulamycins’ initially-proposed structures 
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This work is divided into five parts. The first of these parts, Chapter 1, provides a very brief 
chronological introduction to the intersection of antimicrobial compounds with human health, 
followed by a detailed introduction to the principle subject of this work: the baulamycin natural 
products, their proposed and revised stereochemical assignments, and our initial retrosynthetic 
analysis of their proposed structure. The second part of this work, Chapter 2, describes our 
subsequent efforts towards the synthesis of the proposed structures of the baulamycins. 
Part three of this work provides an overview of how the originally-proposed stereochemical 
assignment was discovered to be incorrect, how we addressed this revelation and set about 
attempting to deduce the correct structure of the natural products, and how the correct structures 
of the baulamycins ultimately came to be revealed through total synthesis. Chapter 4 details our 
retrosynthetic analysis of the newly-revealed revised structure, followed by our efforts toward and 
eventual total synthesis of the baulamycins. 
The fifth and final part of this work gives detailed accounts of all experimental procedures 
employed in our work on the baulamycins, including analytical data for all newly-described 
compounds. Copies of NMR spectra for such compounds may be found in Appendix I.  
1.2 A Brief History of Antimicrobial Chemotherapy 
 
The attempted use of natural and artificial agents to eliminate disease while sparing the 
host dates to ancient times. While reports of purely empirical remedies for infectious disease – the 
use of emetine in the form of ipecac for dysentery or quinine in the form of cinchona extracts for 
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fever, for example – have a long and complex history, antimicrobial chemotherapy as we know it, 
founded on the principles of germ theory, dates only to the dawn of the 20th century1. 
Sometime between 1889 and 1901, Paul Ehrlich, building on the foundational theories of 
Louis Pasteur and others, and drawing on his own earlier work in immunology for which he would 
later win the Nobel Prize, first formulated the idea of a "magic bullet"2. This magic bullet was to 
be a substance which, taken internally, would harm only pathogenic microorganisms while leaving 
the patient unscathed. This dream began to come to fruition in 1909, when the antisyphilitic 
properties of arsphenamine, an organoarsenical, became established in Ehrlich's laboratories2. The 
subsequent marketing of arsphenamine as Salvarsan in 1910 marked the beginning of a new era in 
Western medicine: the era of effective antimicrobial chemotherapy. 
Although widespread adoption of synthetic antimicrobials was not immediate, and was at 
times hampered by opposing theories concerning the most effective strategies for the treatment of 
infectious disease, Salvarsan opened the door to an entirely new world of treatment for human 
disease. This path of discovery was extended by Gerhard Domagk, whose 1935 discovery of 
Prontosil marked the first of many successful sulfonamide antibiotics which would go on to be 
therapeutically valuable3. However, it was Alexander Fleming’s discovery of penicillin in 1928, 
made therapeutically practical in the 1940’s by Howard Florey and others, which truly ushered in 
the modern era of antibiotic discovery4-5. 
The discovery of penicillin, unlike that of Salvarsan, Prontosil, or other sulfa drugs, marked 
a sea change in the ongoing quest to discover new and more effective agents for the treatment of 
infectious disease. For the first time since the general acceptance of germ theory, a natural product 
had been harnessed as a therapeutic weapon against infectious disease. Penicillin inaugurated the 
new era of antibiotics, or naturally-occurring antibacterial compounds. In this new paradigm, 
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Earth’s vast diversity of natural products would be tirelessly mined for agents capable of killing 
pathogens, and the substances thus identified developed into the scores of marketed drugs which 
form the modern armamentarium of antimicrobial chemotherapy. This period extends to the 
present day, with the list of available antibiotics continuing to grow, albeit perhaps more slowly 
now than in decades past1.  
Despite the impressive advances of the past century, many have imagined a future where 
bacterial evolution outpaces our ability to respond with new and more effective antimicrobial 
agents6-9.  The so-called “post-antibiotic era”10-11  – a time when pandemic resistance to both first-
line agents and drugs of last resort leads to skyrocketing mortality from common pathogens – has 
not yet arrived. Such a development has been feared and foretold since the earliest days of 
antibiotic use: Fleming himself, in 1945, during the very Nobel lecture given upon receipt of his 
shared prize for the discovery of penicillin, warned that “it is not difficult to make microbes 
resistant to penicillin in the laboratory… and the same thing has occasionally happened in the 
body.”12  He then narrated a pointed anecdote in which improper use of antibiotics by one patient 
leads to the death of another from a resistant infection. Clearly, the idea of antibiotic resistance as 
a serious threat to public health is not new; rather, this danger has been foreseen from the 
beginning. Yet despite these early warnings, the glut of discovery over the two decades subsequent 
to the discovery of penicillin quieted fears somewhat, until it seemed that there would always be 
an adequate supply of new antibiotics to replace the ones which had succumbed to resistance8. 
The ongoing quest for the discovery of new and more efficacious antibiotics is rooted in 
this century-long history of warfare against humanity’s oldest scourge. Resistance – a phenomenon 
present since before the beginning of antimicrobial chemotherapy – drives this search, as bacteria 
and our weapons against them co-evolve in a never-ending arms race of natural selection. Thus, it 
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was with great excitement that the Williams group received Sherman and co-workers’ 2014 report 
of novel broad-spectrum antibiotic activity in what appeared to be a new, structurally-distinct class 
of antibiotics: the baulamycins13. 
1.3 The Baulamycins: History, and Proposed and Revised Structures 
 Baulamycins A and B (Figure 1) were first described in 2014, when Sherman reported 
their isolation from cultures of Streptomyces tempesquensis, an actinomycete identified in soil 
sediment taken from Playa Grande, Costa Rica, near Las Baulas National Marine Park13.  
Figure 1. Baulamycins A and B.  
The baulamycins were notable for their broad-spectrum antibiotic activity (i.e., activity 
against both Gram-positive and Gram-negative species), as well as for their unusual structure, 
apparently unrelated to other known classes of antibiotics. The baulamycins also appeared unusual 
in the nature of their suspected mechanism of action. At the time of their isolation, it was believed 
that the baulamycins exerted their biological effects by inhibiting the biosynthesis of siderophores. 
Siderophores, small-molecule chelators of iron, are produced and excreted by many bacteria, 
facilitating access to iron, particularly in environments where iron is scarce or tightly controlled14. 
Production of siderophores has been linked to virulence in a number of human pathogens, and 
siderophore production has been repeatedly validated as a promising drug target15-18. The 
baulamycins were identified as part of a high-throughput screening campaign for inhibitors of 





Figure 2. High-throughput screening identification of the baulamycin antibiotics. 
Sherman and coworkers found that the baulamycins inhibited both SbnE and AsbA, 
enzymes involved in siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis, 
respectively. Additionally, the baulamycins were found to inhibit the growth of Gram-positive (S. 
aureus, including methicillin-resistant S. aureus (MRSA), and B. anthracis) and Gram-negative 
(Shigella flexneri and Escherichia coli) species in culture; however, for most species, the effect 
appeared independent of medium iron availability, raising the idea that the mechanism of action 
might not be fully dependent on inhibition of siderophore biosynthesis13. 
The biological findings detailed in Sherman’s initial report were fascinating; however, 
further study of the baulamycins was severely hampered by the low yield of the baulamycins from 
their natural source: 39 L of bacterial culture were laboriously extracted and purified to obtain a 
mere 3.6 mg of baulamycin A, along with 2.1 mg of baulamycin B. This predicament, along with 
a desire to study unnatural and otherwise inaccessible derivatives of the natural products, led us to 
envision a total synthesis of the baulamycins. 
These interests were not unique to the Williams group, and the baulamycin story became 
only more interesting when, in February of 2017, Guchhait et al published a total synthesis of the 
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originally proposed structure of baulamycin A, demonstrating that this structure was not in fact 
the structure of the natural product19. In fact, when Sherman and coworkers first assigned the 
stereochemical configuration of the baulamycins, their initial assignment (Figure 3) differed 
substantially from that which would later be shown to be correct (Figure 1). 
Figure 3. Proposed structures of baulamycins A and B, later invalidated by total synthesis. 
 Indeed, mere months after Guchhait et al published their work falsifying the original 
structural assignment, Aggarwal and coworkers published their seminal work on the baulamycins, 
revising the structure, identifying the absolute stereochemistry, and reporting the first total 
syntheses of baulamycins A and B20, an achievement paralleled and closely followed by Sengupta 
et al’s synthesis of the antipode of baulamycin A21. Although we, along with these others, initially 
targeted the structures shown in Figure 3 in our retrosynthetic analysis, we were fortunate in that 
our chosen strategy allowed us freedom with respect to alterations to the stereochemical 
configuration of the baulamycins. This fundamental flexibility of approach paved the way for our 
rapid pivot toward the revised structures of baulamycins A and B, ultimately culminating in our 
synthesis of the natural products.  
In the course of our studies toward the revised structure of the baulamycin scaffold, we 
were all the more intrigued by the work at hand when a report from Wuest and co-workers 
suggested the possibility of an alternate or additional mechanism of action for the baulamycins in 
the form of possible interference with bacterial membranes22.  
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1.4 Retrosynthetic Analysis of the Proposed Structures 
 
 Conceptually, the baulamycin scaffold lends itself to disconnection into left- and right-
hand sides (LHS and RHS, respectively; Figure 4). Retrosynthetically, we imagined the 
baulamycin scaffold dissected between C11 and C12, giving rise to synthons 4 and 5 (Figure 4). 
 
Figure 4. Key retrosynthetic disconnection of baulamycin scaffold in to LHS and RHS. 
 
We imagined 4 arising from a stereoselective aldol reaction between synthon 6, derived from 3,5-
dihydroxybenzaledehyde, and a nucleophilic coupling partner in the form of 7 (Figure 5). 
 
Figure 5. Retrosynthetic analysis showing 4 arising from a stereoselective aldol reaction. 
 
 While the approach to the LHS immediately suggested several well-known strategies for 
the stereoselective synthesis of aldol products, further analysis of tactics to synthesize 5 seemed 
warranted. While the LHS retains the polyketide’s natural oxidation state, inspiring a (presumably) 
biomimetic approach involving aldol couplings, the fully-reduced RHS portion of the baulamycin 
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scaffold poses a more interesting synthetic challenge, with the lack of functional handles limiting 
options towards the C4, C6 and C8 methyl-bearing stereocenters. 
 The synthesis of reduced polyketides, or deoxypolypropionates, is not a new problem, and 
a number of synthetic approaches have been developed and reviewed23-24. A handful of non-
iterative approaches to deoxypropionates have been reported; however, thus far these methods 
have remained relatively underdeveloped compared to the plethora of stepwise approaches25-26. 
Rovis’ formal synthesis of ionomycin beginning with the desymmetrization of methyl-substituted 
anhydrides showcases the potential of these approaches in select cases, and undoubtedly these 
tactics will continue to be an area of active research27. 
 Of the iterative approaches to the polydeoxypropionates, a handful of methods stood out 
as maximizing efficiency while keeping functional group manipulations to a minimum. These 
methods were Burgess’ asymmetric hydrogenations of trisubstituted olefins28-29, Breit’s zinc-
catalyzed coupling of alkylmagnesium chlorides with chiral triflates derived from D- and L-lactic 
acid30-31, Feringa’s copper-catalyzed asymmetric conjugate addition of Grignard reagents to 
unsaturated thioesters32 and Negishi’s one pot zirconium-catalyzed asymmetric carboalumination 
(ZACA) and palladium-catalyzed vinylation.  
1.4.1 Previous Work: Burgess’ Asymmetric Hydrogenations 
Burgess’ approach to the deoxypropionates relies on the use of chiral analogues of 
Crabtree’s catalyst (Figure 6) capable of catalyzing the asymmetric hydrogenation of trisubstituted 
allylic alcohols or α,β-unsaturated carbonyls. The work has been applied in total synthesis by 
Burgess and coworkers (Figure 7), and appears to allow general access to all deoxypropionates 





Figure 6. Chiral catalysts developed by Burgess and coworkers. 
 
 
Figure 7. Application of Burgess’ hydrogenation to the synthesis of (S,R,R,S,R,S)-4,6,8,10,16,18-
hexamethyldocosane28, 33. 
 
 Initially, we noted several limitations to Burgess’ approach. First, the methodology 
requires the synthesis of both enantiomers of the chiral iridium catalyst, each synthesis requiring 
seven steps from commercially available materials – a high cost of investment to test the method’s 
suitability on our substrates35. Second, Burgess notes that although the reactions are nominally 
under catalyst control, substrate configuration does appreciably influence stereochemical outcome, 
sometimes requiring “optimization” of substrate to achieve acceptable levels of diastereocontrol. 
Finally, while not fundamentally limiting, the requirement that all hydrogenations be run at 50 atm 
after freeze-pump-thaw degassing of the reaction mixture was deemed inconvenient. With these 
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considerations in mind, Burgess’ method did not seem a good initial starting point for our work on 
the right-hand side of the baulamycins. 
1.4.2 Previous Work: Breit’s Zinc-Catalyzed Cross-Coupling 
 A second option for the synthesis of deoxypolypropionates is found in Breit’s zinc-
catalyzed cross-coupling of alkylmagnesium halides and lactate-derived triflates (Figure 8a). In 
this method, methyl-bearing stereocenters are derived stoichiometrically from the chiral pool by 
way of 17 and ent-17. These triflates are coupled to alkylmagnesium halides, a transformation 
which, under Breit’s conditions, proceeds with complete inversion of configuration. The resulting 
ester products may then be reduced, halogenated and re-subjected to the coupling conditions as 
Grignard reagents (Figure 8b). 
 While Breit and coworkers have applied these conditions in total synthesis, in these cases 
the cross-coupling strategy played an isolated role in the construction of the relevant natural 
products: it was not the foundation of the larger strategy, nor were multiple iterations employed36-
37.  Nonetheless, the strategy had been used to produce intermediates with the desired anti/anti-




Figure 8. (A) Synthesis of (R)- and (S)-lactic acid triflate esters in four steps from lactic acid. (B) 
Application of 17 and ent-17 in the synthesis of deoxypropionates31. 
 
towards structures like 5, Breit’s method suffers from the severe drawback that all stereocenters 
are derived from either (D)- or (L)-lactic acid in 37% yield across four steps. Considering the 
expense of D-lactate (>$7000/mol), and in light of the fact that the absolute configuration of the 
baulamycins was hitherto unknown, the possibility that two stereocenters might be derived from 
D-lactic acid was deemed an economically prohibitive barrier to implementing Breit’s chemistry. 
Nonetheless, extensive work by Breit and coworkers on the synthesis and characterization of 




1.4.3 Previous Work: Feringa’s Asymmetric Conjugate Addition 
 Feringa and coworkers have shown that the copper-catalyzed conjugate addition of 
Grignard reagents to thioesters proceeds with high enantioselectivity in the presence of catalytic 
amounts of Josiphos ligand (Figure 9)32. The asymmetric conjugate addition of organometallic 
reagents to unsaturated systems is well-known, and has been reviewed38-39; however, the work by 
Feringa and coworkers is notable for overcoming several practical limitations to these methods.  
 
Figure 9. Asymmetric conjugate addition of Grignard reagents to unsaturated thioesters32. 
 
Historically the 1,4-addition of relatively unreactive methylmagnesium bromide to 
conjugated systems containing a carbonyl carbon in the acid oxidation state (e.g., esters, amides) 
has proved particularly challenging when compared to conjugate addition on more electron 
deficient systems such as enones40-41. Feringa’s work solves this problem by employing thioesters, 
which are more susceptible to conjugate addition while still remaining capable of undergoing many 
of the same functional group transformations as their oxo-analogues. On these substrates, the 
reaction with methylmagnesium bromide proceeds to high conversion (>90%) on reasonable 
timescales (12 -16 hrs)32.  
Another area in which Feringa’s methodology improves on previous methods is the high 
stereoselectivity of the transformation.  The use of CuBr-DMS and Josiphos gives consistently 
high enantio- and diastereoselectivity with methylmagnesium bromide and other Grignard 
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reagents, with the reaction apparently taking place under almost complete catalyst control even at 
low catalyst loadings. Combined with the fact that all of the necessary reagents, catalysts, and 
ligands are commercially available and relatively cheap, these attributes make Feringa’s strategy 
towards the polydeoxypropionates particularly appealing. Moreover, Feringa’s method has been 
repeatedly applied in total synthesis32, 42-43.   
1.4.4 Previous Work: Negishi’s Zirconium-Catalyzed Carboalumination 
 Negishi has reported that that polydeoxypropionate motifs may be rapidly constructed by 
a combined approach utilizing a zirconium-catalyzed asymmetric carboalumination (ZACA) 
reaction in sequence with a nominally-in situ Negishi cross-coupling (Figure 10)44.  Negishi’s 
Figure 10. Zirconium-catalyzed carboalumination and homologation of alkenes to give 
polydeoxypropionates under Negishi’s conditions. 
 
approach achieves chiral induction through the use of Erker’s catalysts45 (-)-bis(1-
neomenthylindenyl)zirconium dichloride and (+)-bis(1-neomenthylindenyl)zirconium 
dichloride (henceforth (-)-(NMI)2ZrCl2 and (+)-(NMI)2ZrCl2). These catalysts are available from 
(-)- and (+)-menthol in three steps, respectively; at the time of our retrosynthetic analysis, they 
were also available commercially on a very limited basis. 
The promising nature of this strategy with respect to the synthesis of the baulamycin is 
immediately apparent, as each methyl-bearing stereocenter nominally requires only a single pot 
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for installation. The development of the ZACA/cross-coupling approach was reported following 
extensive research46-49 by Negishi and coworkers into zirconium catalyzed carboalumination, and 
these protocols were thus well-represented in the literature, albeit primarily in reports by Negishi 
et al. An important insight was contributed to the field by Wipf and coworkers when they reported 
that addition of stoichiometric water to the ZACA reaction results in a dramatic rate acceleration 
without any apparent loss of enantioselectivity; this observation would later become instrumental 
in the practical application of the ZACA methodology50. The ZACA/homologation strategy toward 
polydeoxypropionates has been applied in total synthesis, again mostly51-56, although not 
exclusively57, by Negishi and coworkers. 
1.4.5 Summary of Previous Approaches to Deoxypropionates 
Of the several strategies toward the synthesis of polydeoxypropionate motifs considered, 
each had respective advantages and disadvantages. Burgess’ method offered the advantage of 
operational simplicity in the form of hydrogenation as the stereodetermining step; at the same time, 
the appeal of such an approach was mitigated by the lengthy syntheses required to obtain the 
necessary catalysts. Similarly, while the operational simplicity of Breit’s ZnCl2-catalyzed cross-
coupling, with its cheap and air stable catalyst and well-understood coupling partners (i.e., a 
Grignard reagent and a triflate) was appealing, the extreme expense of D-lactic acid as a 
stoichiometric starting material proved prohibitive to pursuing this strategy. 
On the other hand, Feringa’s conjugate addition had much to recommend it. All of the 
reagents and catalysts were commercially available, cheap, and relatively simple to manipulate; 
moreover, the methodology appeared to give good enantio- and diastereoselectivity on a variety 
of substrates and the yields were reported to be excellent. Likewise, Negishi’s protocol had a 
number of apparent advantages, the most obvious and compelling being the enticing prospect of a 
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“one pot, one stereocenter” approach. In addition, the ZACA reaction had seen numerous 
applications in total synthesis, albeit largely by Negishi and coworkers. 
 In the event, the incredible step economy of Negishi’s ZACA/cross-coupling approach was 
simply too attractive to pass up. Despite the necessity of preparing Erker’s catalysts on scale if the 
method were to be viable, Negishi’s ZACA/homologation protocol initially seemed to constitute 
an ideal initial starting point for our burgeoning attack on the baulamycin scaffold. Thus, without 




Chapter 2 – Partial Synthesis of the Proposed Structures of 




2.1 Overview of Synthetic Strategy 
Considering Negishi’s ZACA protocol as our most promising avenue towards the 
deoxygenated portion of the baulamycins, we imagined a straightforward synthesis of the RHS 
beginning with styrene as shown below (Figure 11). 
 
Figure 11. Proposed synthesis of RHS synthon and aldol coupling electrophile 38. 
 Simultaneously, we imagined the synthesis of the LHS coupling partner by way of a 
diastereoselective Evans-style aldol reaction58 (Figure 12). Transamidation of the chiral auxiliary 
to give the Weinreb ketone, followed by protection and Weinreb ketone synthesis would give LHS 




Figure 12. Proposed synthesis of LHS synthon and aldol coupling nucleophile 43. PG = protecting 
group, Si = “super silyl”, e.g., tris(triethylsilyl)silyl. 
 
 We initially hoped to couple the LHS and RHS using a 1,4-syn selective aldol reaction 
under Yamamato’s conditions59, exploiting the directing effects of an extremely bulky silyl 
protecting group on the C1’-hydroxyl. The resulting aldol product would then be subjected to 
stereoselective reduction, again directed by steric bulk pendant to C1’, to give syn-diol 45. Weinreb 





Figure 13. Proposed coupling of LHS and RHS followed by completion of the total synthesis of 
the baulamycins. 
 
2.2 Synthesis of the Right-Hand Side 
 Negishi’s methodology for the synthesis of polydeoxypropionates relies on the use of 
Erker’s chiral catalysts, (-)-(NMI)2ZrCl2 and (+)-(NMI)2ZrCl2. Although both enantiomers of this 
catalyst were available in limited quantities from commercial suppliers at the time of our initial 
synthetic studies, the cost of using these sources on scale was prohibitive. In order to be assured 
of our supply of these materials, we elected to begin our attack on the RHS with the synthesis of 
(-)-(NMI) 2ZrCl2 from (-)-menthol as described by Erker and coworkers45 (Figure 14). 
 
Figure 14. Preparation of (-)-(NMI)2ZrCl2 according to Erker’s method. 
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 Tosylation of (-)-menthol proceeded in high yield under standard conditions as expected, 
giving menthyl tosylate 46 as a white crystalline solid. Displacement of the tosylate with indenyl 
lithium was sluggish; however, after 3 days at reflux in THF neomenthyl indene 47 was obtained 
as a colorless, waxy solid in poor yield, as reported. Deprotonation of 47 with methyl lithium and 
addition to zirconium(IV) chloride-THF in toluene did indeed give 32 as a yellow solid 
contaminated with minor amounts of diastereomeric products as described by Erker and 
coworkers. However, further purification of this material proved challenging. 
 Erker reports trituration of crude 32 with pentane, followed by extraction and filtration with 
DCM in order to remove residual lithium chloride, yielding a DCM solution of 32 as the filtrate. 
This solution is then partially concentrated, and subsequent repeated recrystallizations at -28 °C 
give the product in an overall 61% yield. In our hands, we found that while organic impurities 
could indeed be removed by trituration with pentane, and while a white insoluble material indeed 
appearing to be lithium chloride (hygroscopic; magenta flame test) could be removed by filtration 
from DCM, further recovery of the dissolved product in crystalline form proved intractable. Aging 
of the air-sensitive yellow filtrates at -25 °C overnight did indeed induce the formation of solids; 
however, despite repeated attempts, these appeared to be solely precipitants of a non-crystalline 
nature (or at least, they were never crystalline in their entirety). A range of solution concentrations, 
handling methods and recrystallization temperatures were employed without success; ultimately, 
the product was always obtained as a free-flowing yellow powder with evidence of residual 
impurities by 1H and 13C NMR. Possibly, some failure to precisely replicate the conditions of 
Erker’s synthesis introduced contaminants which preferentially precipitated from solution before 
recrystallization could take place. Alternatively, such unknown contaminants might have induced 
product decomposition over the relatively long timescales necessary for recrystallization. At any 
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rate, the isolation of air-sensitive substances from solution by recrystallization at low temperature 
and subsequent low-temperature filtration without exposure to oxygen is an endeavor fraught with 
challenge from the outset. 
 Whatever the reason for our failure to obtain rigorously-pure (-)-(NMI)2ZrCl2, we 
nonetheless remained undeterred in our resolution to implement the ZACA reaction in the pursuit 
of the baulamycins. Hoping to work out the purification of 32 at a later date, we decided to attempt 
the zirconium-catalyzed carboalumination of styrene with semi-pure catalyst, in the hopes of 
demonstrating the viability of the route while the latent purification issues were being resolved 
(Figure 15). 
 
Figure 15. Attempted application of Negishi’s ZACA protocol to styrene. 
 Our initial attempts at the carboalumination and in situ homologation of styrene met with 
failure. The mechanism of the ZACA reaction is believe to involve an initial transmetalation 
between Me3Al and the zirconocene dichloride precatalyst, giving rise to a catalytically-active 
species containing a methyl-zirconium bond (Figure 16) 46. Association of this active catalyst 
(perhaps in cationic form as part of a “tight ion pair” with Cl2AlMe2-) to the alkene π-bond leads 
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to stereospecific migratory insertion, and subsequent transmetalation with aluminum gives the 
dimethylalkylaluminum product while regenerating the zirconocene dichloride precatalyst. 
 
Figure 16. Proposed mechanism of zirconium-catalyzed methylalumination. 
 Previous work47 has shown that the efficiency of the carbozirconation and subsequent 
transmetalation is heavily solvent-dependent, with polar solvents, in particular methylene chloride, 
proving optimal. Accordingly, in our initial studies we employed anhydrous dichloromethane as 
the solvent for the carboalumination; trimethylaluminum was introduced as a solution in toluene. 
When the combined ZACA-homologation protocol failed to give 47 as expected, we attempted to 
intercept the carboalumination product by oxidation (Figure 17). Unfortunately, none of the 
expected (R)-2-phenylpropanol (48) could be isolated. At this juncture, exhaustive attempts to 




Figure 17. Attempted carboalumination-oxidation of styrene. 
 
Ultimately, we realized that the major products of our endeavors were in fact a series of 
isomeric bistolylmethanes formed from the Friedel-Crafts alkylation of methylene chloride with 
two equivalents of toluene derived from our commercial solution of trimethylaluminum. A single 
account60 of the Friedel-Crafts reaction between toluene and methylene chloride is known, and 
reports of Friedel-Crafts alkylations61 and acylations62 catalyzed by trimethylaluminum are not 
unheard of; however, a Friedel-Crafts alkylation of toluene with methylene chloride under 
trimethylaluminum catalysis has not been reported.  Pleasingly, treatment of our semi-pure 32 with 
neat trimethylaluminum followed by carboalumination and oxidation gave the desired 
2-phenylpropanol, albeit in low yield (Figure 18). 
 
Figure 18. Successful zirconium-catalyzed carboalumination with neat trimethylaluminum. 
 At this stage, despite our success in converting styrene to 48 with our semi-pure catalyst, 
we were concerned that the as-yet-unresolvable impurities in 32 might be impacting the yield of 
the carboalumination step. Consequently, we obtained a small supply of commercial ent-32 (TCI 
America, Inc.) in order to continue our studies on the ZACA-homologation sequence. In the event, 
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commercial ent-32 gave methylated olefin 49 in 24 – 54% yield (Figure 19), showing little 
improvement over our catalyst. Preliminary investigations of enantioenrichment by polarimetry 
revealed the correct sign of optical rotation, but a disappointing enantiomeric excess of only 38%.  
 Despite the lackluster enantioselectivity, the modest yield of desired product seemed 
encouraging, and a number of attempts were made to install the second methyl group by way of a 
further round of zirconium-catalyzed carboalumination (Figure 19). 
 
Figure 19. ZACA-homologation of styrene and attempted ZACA-homologation of 49. (a) i. 5 
mol % ent-32, DCM, -78 °C,  then1.5 eq Me3Al, then 1.0 eq water; ii. 1 eq styrene, 0 °C, 26 h; 
iii. solvent removal; iv. 1 eq Zn(OTf)2, DMF, 70 °C, 2h; v. from a separate flask: 3 mol % 
Cl2Pd(DPEPhos), 6 mol % DIBAL-H, THF or THF/hexanes; vi. 3 eq vinyl bromide, r.t., 20 h (b) 
) i. 5 mol % 32, DCM, -78 °C,  then1.5 eq Me3Al, then 1.0 eq water; ii. 1 eq styrene, 0 °C, 26 h; 
iii. solvent removal; iv. 1 eq Zn(OTf)2, DMF, 70 °C, 2h; v. from a separate flask: 3 mol % 
Cl2Pd(DPEPhos), 6 mol % DIBAL-H, THF or THF/hexanes; vi. 3 eq vinyl bromide, r.t., 20 h. 
 
Frustratingly, conditions identical to those used successfully on styrene failed 
unequivocally on 49. Meanwhile, acylation of 48 obtained using the ZACA-oxidation protocol 
with our semi-pure 32 gave known compound 51, which, when subjected to chiral-phase HPLC 
analysis was shown to be essentially racemic (Figure 20). Simultaneously, all our considerable 
efforts to obtain useful quantities of crystalline 32 continued to be met with failure. 
 
Figure 20. Synthesis of  (R)-2-phenylpropyl acetate. (a) i. 5 mol % 32, then 1.5 eq Me3Al, then 
1.0 eq water; ii. styrene, 17 h; iii. O2, 3 h. (b) 5 mol % DMAP, 1.5 eq. pyridine, 1 eq. acetyl 
chloride. 
 
 In light of these ongoing issues, and with extensive efforts to effect the second methylation 
on 49 proving fruitless, we chose to abandon further development of the ZACA/homologation 
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route. While initially promising, the modest-to-poor yields, poor enantioselectivities, intractable 
catalyst purification, long reaction times, tedious manipulations of material under both air- and 
moisture-free conditions and the necessity of using stoichiometric quantities of highly pyrophoric 
neat trimethylaluminum ultimately sounded the death knell for this route.  
We next considered that Feringa’s asymmetric conjugate addition approach might provide 
a tractable alternative to the ZACA strategy (Figure 21). We imagined that addition of 
methylmagnesium bromide to unsaturated thioester 53 (derived from hydrocinnamaldehyde) 
would allow the installation of the first stereocenter. Reduction and Wittig-based homologation 
would give unsaturated thioester 56, which would undergo a second conjugate addition to install 
the second methyl-bearing stereocenter. Homologation of 57 followed by oxidation to the alcohol, 
protection, and oxidation of the phenyl group to reveal carboxylic acid 60 would set the stage for 
the installation of the third stereocenter by auxiliary-directed alkylation. Methylation, auxiliary 
removal, deprotection and oxidation of alcohol to aldehyde would then give key intermediate 38. 
While both Wittig43 and Horner-Wadsworth-Emmons63 homologations of thioesters are 
known, we elected a Wittig-based synthesis of the requisite unsaturated starting materials for two 
reasons. First, phosphonium ylide 26 was reported to be an air-stable, crystalline solid available in 
three steps from cheap bromoacetic acid64. Large scale production of this reagent in line with the 
quantities necessary for use throughout the synthesis thus seemed feasible. Second, in contrast to 
the conditions required for the Horner-Wadsworth-Emmons reaction, the use of preformed ylide 
26 obviates the need for an exogenous base in the olefination, leading to supreme operational 
simplicity in these reactions. 
25 
 
Figure 21. Proposed synthesis of RHS according by asymmetric conjugate additions. 
With these considerations in mind, we began our renewed attack on the RHS with the 
synthesis of phosphonium ylide 26. Steglich-type thioesterification cleanly gave 64; excess 
dicyclohexylurea byproducts were readily removed by filtration through Celite. Reaction of crude 
64 with triphenylphosphine gave phosphonium bromide 65 as colorless crystals; subsequent 
deprotonation with sodium carbonate afforded 26 as a crystalline solid in 82% yield over three 




Figure 22. Synthesis of phosphonium ylide 26 from bromoacetic acid. 
With access to a plentiful supply of 26 secured, we turned our attention to the synthesis of 
the first thioester substrate for conjugate addition. Cheap ($60/kg) and readily available 
hydrocinnamaldehyde provided an ideal starting material, giving 53 in 86% yield and 17:3 d.r. 
after Wittig olefination (Figure 23). E- and Z-isomers were readily separated by a single round of 
flash chromatography, a necessary evil since the cis-thioesters were known65 to react giving the 
opposite sense of enantioselectivity relative to the corresponding cis-isomers. 
 
Figure 23. Synthesis of thioester and first asymmetric conjugate addition; synthesis of alcohol 
derivatives for HPLC analysis. 
  
To our great delight, slow addition of 53 to 1.2 equivalents of methylmagnesium bromide, 
1.5 mol % (R,S)-Josiphos and 1.25 mol % CuBr-DMS over two hours at low temperature, followed 
by stirring overnight gave methylated product 54 in 83% yield and 93% ee. Enantiomeric excess 
was determined by reduction to known (R)-3-methyl-5-phenylpentanol 66 with LAH; comparison 
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with racemic 66 generated in two steps from 53 showed an e.r. of 96.5 : 3.5 by chiral-phase HPLC 
analysis under known conditions66. 
With an effective approach to the first stereocenter in hand, we attempted the homologation 
of 54 in preparation for a second round of asymmetric conjugate addition. Reduction of 54 with 
DIBAL-H initially proved challenging, not due to a tendency to overreduction as might be 
expected by analogy to the reduction of esters, but rather due to the opposite problem: a complete 
lack of reactivity (Figure 24). When DIBAL-H in THF was employed, the reaction failed to go to 
completion even when excess reagent and long reaction times were employed. 
 
Figure 24. Attempted reduction of thioester 54. 
  
Table 1. Conditions attempted for the reduction of 54; N.R. = no reaction. 
Reagents Solvent Temperature Time Result 
DIBAL-H, 1.05 eq THF -65 °C 5 h N.R. 
DIBAL-H, 1.05 eq THF -78 °C to -10 °C 60 h N.R. 
DIBAL-H, 3.00 eq THF -78 °C to r.t. 12 h N.R. 
DIBAL-H, 1.05 eq DCM -65 °C 40 min >99% of 55 
 
Eventually, a renewed survey of the literature revealed that these reactions have only been 
reported in non-coordinating solvents, with DCM and toluene being predominant67. Gratifyingly, 
when the reaction was repeated with 1.05 equivalents of DIBAL-H in DCM, aldehyde 55 was 
obtained in near-quantitative yield in less than one hour.  
With reliable access to 55 in hand, we next attempted conversion to 56 by Wittig 
olefination. This transformation also proved challenging, with conditions successfully employed 
previously on hydrocinnamaldehyde giving rise to unacceptably-long reaction times for 55 
(Figure 25). While the reason for this behavior remains unclear, it is possible that the added steric 





Figure 25. Attempted olefination of 55. 
Table 2. Conditions for attempted olefination of 55. 
Amount of 26 Solvent Concentration (55) Temperature Time Yield 
1.3 eq DCM 0.3 M r.t. 36 h 66% 
1.3 eq DCM 0.3 M reflux 108 h 79% 
2.0 eq DCM 0.1 M reflux 26 h 67% 
2.0 eq DCM 0.4 M reflux 26 h 87% 
2.0 eq CHCl3 0.1 M reflux 2 h 87% 
 
In practice, while temperature, concentration, and the number of equivalents of ylide all 
influenced the reaction kinetics in predictable ways, it was ultimately found that conversion to 56 
was best effected with two equivalents of ylide at reflux in chloroform. Under these conditions, 56 
could be isolated in 87% yield after only two hours (Table 2). Presumably, the reaction could be 
further accelerated by increasing the reaction concentration; however, this line of investigation 
was not pursued further. The diastereoselectivity of the reaction was measured to be 17:1 by 1H 
NMR analysis of the crude material; once again, a single iteration of flash chromatography was 
sufficient to readily separate E- and Z-isomers. 
Second methylation and confirmation of stereochemistry 
With homologated thioester 56 in hand, the stage was set for the second asymmetric 
conjugate addition and installation of the second methyl-bearing stereocenter. Treatment of 56 
with methylmagnesium bromide, CuBr-DMS and (S,R)-Josiphos under Feringa’s conditions gave 
dimethyl thioester 57 in excellent yield and appreciable diastereoselectivity. Subsequent reduction 
gave aldehyde 67 in excellent yield, and a final Wittig homologation with Ph3P=CH2 proceeded 
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accordingly to give terminal olefin 68, thus installing the final carbon in the nine-carbon backbone 
of the RHS (Figure 27). 
 
Figure 27. Second methylation and synthesis of terminal olefin 68. 
 With the installation of the second methyl-bearing stereocenter, it became necessary once 
again to determine whether we had succeeded in accessing the correct stereoisomer of our desired 
intermediates. While the sense of the first asymmetric conjugate addition was efficiently confirmed 
by conversion to a known compound in a single step, such a strategy seemed less appealing for 
more advanced intermediate 57. In fact, according to a literature search done at the time, the known 
structure most closely related to 57 was 69 (Figure 28), synthesized by Breit and coworkers in the 
course of their own efforts toward polydeoxypropionates31. While conversion of 57 to 69 was 
deemed possible (Figure 28), it would certainly have constituted an inconvenient detour, one 
which we were reluctant to take if it was unnecessary. Accordingly, we sought a more general 
means of investigating the stereochemistry of our growing polydeoxypropionate scaffold.  
Breit and coworkers, in addition to their own synthetic work on such substrates, noted an 
interesting phenomenon in the 1H NMR spectra of the polydeoxypropionates68-69. Breit’s work 




Figure 28. Imagined conversion of 57 into known compound 69. 
deoxypropionates is primarily dependent on the relative configuration of those stereocenters. The 
result of this is a set of empirical rules that can provide strong evidence for the configuration of 
deoxypropionates moieties based on the difference in chemical shift between the diastereotopic 
protons on the intervening methylene in deoxygenated stereodiads (Figure 29).  
 
Figure 29. Symmetry observations allowing the development of Breit’s empirical rules. 
 
Breit has shown that, for a series of over 70 compounds containing 1,3-dimethyl 
stereodiads, the compounds were always syn when the difference in chemical shift between the 
diastereotopic protons on the intervening methylene was greater than 0.40 ppm, and the 
compounds were always anti when the difference was less than 0.15 ppm69. While not providing 
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strict “proof” of stereochemistry without the synthesis of both the syn and anti diastereomers, in 
conjunction with the presumption of stereochemical outcome provided by Feringa’s work, Breit’s 
rules could give strong evidence that we had in fact obtained 57 rather than its syn-epimer.  
In the event, assignment of the signals in the 1H NMR spectrum of 57 by HSQC analysis 
showed that the diastereotopic protons on the methylene intervening between the methyl-bearing 
stereocenters differed in chemical shift by a mere 0.10 ppm (Figure 30), thus conclusively falling 
within the trends established by Breit’s rule for anti-methyl stereodiads. With our confidence in 
the stereochemical assignment of 57 thus re-affirmed, we turned our attention to other synthetic 
problems. 
 
Figure 30. Application of Breit’s rule to 57, showing diastereotopic protons less than 0.10 ppm 
apart. 
   
When aldehyde 67 first became available from thioester 57, an interim of several days 
passed before the subsequent olefination could be effected. In this way it became apparent that 67 
was rather unstable, even when rigorously pure and stored under inert atmosphere in the cold. 
While we at first imagined that 67 was perhaps suffering autooxidation or self-condensation, the 
former hypothesis did not match the chromatographic characteristics of the single impurity we 
observed: the contaminant eluted faster than 67 under normal-phase conditions, seemingly 
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inconsistent with oxygen incorporation. Moreover, the IR spectrum of the unknown material was 
devoid of any sign of a carbonyl resonance, and the material itself was inert to reduction with 
borane in THF. At the same time, the 1H NMR spectrum of the isolated impurity was inconsistent 
with self-condensation, and was indeed strikingly similar to the spectrum of 67 itself, with the 
exception of the loss of the aldehyde signal and the appearance of a new signal integrating to 1H 
at 4.94 ppm in CDCl3.  
After much thought, it was considered that the NMR spectra and chromatographic behavior 
of this decomposed material were consistent with structure 73, formed from the spontaneous 
trimerization of 67 to give a substituted 1,3,5-trioxane (Figure 31). The spontaneous trimerization 
of aldehydes is well-known70-71 and has been identified as a mechanism of undesired spontaneous 
decomposition even in long-chain aldehydes72. Our suspicions were confirmed when refluxing the 
unknown contaminant in 1:1 THF / 6 N HCl overnight regenerated monomeric aldehyde 67, albeit 
with concomitant partial decomposition. 
 
Figure 31. Spontaneous decomposition of aldehyde 67 by trimerization. 
Armed with the knowledge that 67 was subject to a thermodynamically-favored 
decomposition on relatively short timescales, we elected to eschew storing this material, instead 
generally converting it to 68 in its entirety immediately after synthesis. This knowledge would 
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inform our ideas about the storage of other key aldehydes in the baulamycin synthesis, as will be 
seen later. 
With an adequate supply of olefin 68, we turned our attention to the necessary installation 
of the first terminal oxygen in the RHS scaffold. Hydroboration-oxidation appeared to be the 
obvious choice, and our efforts commenced with 9-BBN as the borylating reagent (Figure 32).  
 
Figure 32. Attempted hydroboration-oxidation of olefin 68. 
Table 3. Conditions surveyed in attempted hydroboration-oxidation of 68. 
Conditions Result (% yield) 
9-BBN, THF, r.t., 
then NaOH 
inconclusive: product not fully separated 
from 1,5-octanediol after chromatography 
BH3-THF, THF, r.t., then NaOH 58 (56%), 74 (32%) 
disiamyl borane,  58 (83%) 
 
Hydroboration with 9-BBN appeared to give 58 with good regioselectivity by 1H NMR 
analysis of the crude product; however, chromatographic purification gave material still 
contaminated with what appeared to be residual 1,5-cyclooctandiol (this diol has been reported to 
be soluble in water73, but see74). Rather than optimize purification conditions, we chose to test 
other borylating agents in the hopes of avoiding the issue entirely. Borane in THF, despite 
exhibiting a surprising degree of regioselectivity (only a single regioisomer could be isolated), 
proved unsuitable due to the formation of substantial amounts of alkane 74, an outcome we could 
only assume to be the result of competing protodeboronation during the oxidation step. Finally, it 
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was determined that disiamylborane, generated in situ from BH3-THF and 2-methyl-2-butene, 
provided optimal results, giving 58 in 83% yield as a single regioisomer. 
With 58 in hand, we turned our attention to the next synthetic hurdle: the unmasking of the 
latent carboxylic acid represented by the phenyl moiety of 58. Our plan had been to avail ourselves 
of Sharpless’ well-known conditions75 for the RuO4-catalyzed oxidation of arenes; however, 
before we could attempt this transformation, we needed to find a suitable protecting group for the 
primary alcohol of 58. 
Secondary TBS ethers are well known76-79 to survive the RuO4-catalyzed oxidation of 
unactivated phenyl moieties to carboxylic acids, and Schreiber notes good stability of a primary 
TBS ether during the RuO4 oxidation of an alcohol80. Thus, considering the many advantages of 
silyl protecting groups in general, we first attempted protection of 58 as the TBS ether (Figure 33). 
Silylation proceeded as expected, giving TBS-ether 75 in 75% unoptimized yield; however, 
ruthenium(VIII) oxide oxidation under Sharpless’ conditions failed to give any of protected acid 
76. 
 
Figure 33. Attempted protection of alcohol 58 as tert-butyldimethylsilyl ether 75. 
Since ruthenium tetroxide oxidations have been reported to be relatively sensitive to steric 
factors, we next toyed with the idea of employing a more sterically demanding silyl protecting 
group76. With this in mind, we considered the use of a tert-butyldiphenylsilyl ether. Although the 
TBDPS group itself contains unsaturated moieties, it has been known81-82 to survive the ruthenium 
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tetroxide oxidation of other arenes (albeit only that of electron-rich arenes), and it was hoped that 
its extensive bulk would provide additional protection for the masked alcohol. In retrospect, it 
seems clear that this line of thinking probably ascribes too great a significance to the role that 
sterics play in determining the outcome of complex ruthenium tetroxide oxidations. In any event, 
silylation with TBDPSCl proceeded uneventfully, but subjection of the resulting silyl ether to 
oxidation gave none of the desired acid (Figure 34). 
 
Figure 34. Attempted oxidation of TBDPS-protected 58. 
With several attempts at oxidation of our advanced substrate having met with failure, the 
decision was made to continue our studies on more readily-accessible model systems rather than 
continue to deplete our stock of 58. Accordingly, several test substrates were prepared in order to 
investigate different aspects of the problem at hand. 
TBS-protected 4-phenylbutanol 80 was prepared under standard conditions and subjected 
to ruthenium tetroxide oxidation (Figure 35). It was hoped that careful analysis of the products 
obtained might shed light on the mechanism of failure in our previous silyl-protected oxidations. 
In particular, we speculated that failure to this point might have been caused by overoxidation, 
specifically oxidation of the “protected” alcohol moiety. Indeed, when 80 was subjected to 
ruthenium-tetroxide catalyzed oxidation, we obtained glutaric acid (82) as the sole product, 





Figure 35. Attempted oxidation of tert-butyldimethyl(4-phenylbutoxy)silane. 
With strong evidence that our difficulties did indeed stem from adventitious oxidation of 
the silyl ether (rather than, say, incomplete oxidation of the phenyl moiety or oxidation at a methine 
position – another known76 reaction of ruthenium tetroxide systems), a possible mechanism for 
this process suggested itself.  
The RuO4-catalyzed oxidation of ethers to esters is well-known83, and proceeds 
preferentially to the oxidation of unactivated aromatics75, 84. In light of the neutral conditions of 
our oxidation, it seems plausible that, rather than undergoing solvolysis, primary silyl ethers 
instead suffer oxidation to the corresponding silyl esters in the presence of ruthenium tetroxide 
(Figure 36). These presumably-unstable85-86 silyl esters might then suffer spontaneous 
hydrolysis87 under the conditions of the reaction, giving the corresponding diacid. 
 
Figure 36. Proposed mechanism for the oxidative decomposition of primary silyl ethers by RuO4. 
Conversely – and oddly – it has been reported that simple sodium periodate alone, in 
THF/water88 or heterogeneously in THF89-90, is capable of rapidly deprotecting a variety of silyl 
ethers (including secondary TBS ethers) in excellent yields at room temperature. How this 
observation can co-exist with the well-established stability of secondary TBS ethers to Sharpless’ 
conditions remains a mystery. The idea that perhaps sodium periodate, soluble in water, remains 
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largely sequestered from the organic substrate in Sharpless’ biphasic CCl4/ACN/H2O solvent 
system comes to mind as one of few possible explanations. Given that Sharpless notes Oxone as a 
viable, although less active, alternative to NaIO4 in catalytic RuO4 oxidations, one cannot help but 
wonder whether such a system might give better results for silylated substrates. 
Regardless of the mechanism of overoxidation, it seemed clear that further optimization of 
a silyl-protection strategy was unlikely to see success. Several alternate avenues presented 
themselves. One the one hand, we considered pursuing an early oxidation of the alcohol followed 
by protection as the acetal (Figure 37).  
Figure 37. Imagined oxidation and protection of 58 as the cyclic acetal 84. 
Accordingly, acetal-protected hydrocinnamaldehyde was subjected to ruthenium tetroxide 
oxidation conditions (Figure 38). Desired acid 87 could not be isolated; however, overoxidation 
product succinic acid (88) was obtained in 48% yield. 
 
Figure 38. Attempted oxidation of acetal 86 with ruthenium tetroxide. 
38 
 
 Previous work44, 75 has shown that esters fare well as protecting groups for primary alcohols 
during the oxidation of phenyl moieties. Initially, we had been reluctant to employ an ester as 
protection for 58 since we believed that most esters would be incompatible with the strongly-basic 
conditions proposed for the installation of the third methyl stereocenter (Figure 21). On the other 
hand, we reasoned that a carbonate ester, without acidic protons, would be well-suited to survive 
both ruthenium tetroxide as well as strong, but non-nucleophilic, base. 
Methyl carbonates, a relatively underutilized protecting group, are nonetheless well-
documented in the literature85. With typical removal effected by catalytic base in protic solvent, 
we were concerned that removal of such a protecting group might prove intractable without 
concomitant epimerization of the third stereocenter, adjacent to what we hoped would be the 
Weinreb amide of 37. Nonetheless, with few other obvious options for protection of 58 remaining, 
we attempted an ester-based protection strategy. 
 Preparation of 4-phenylbutyl acetate 89 proceeded as expected under standard conditions 
(Figure 39). Pleasingly, when 89 was subjected to ruthenium tetroxide oxidation, the desired 
protected acid 81 was isolated as the sole product. Emboldened by the success of the acetate, we 
turned our attention to modeling our proposed methyl carbonate protection strategy. 
 
 
Figure 39. Synthesis and controlled oxidation of 4-phenylbutyl acetate with RuO4. 
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 Installation of the carbonate proceeded uneventfully (Figure 40) in good yield. To our 
delight, upon subjection of 79 to Sharpless’ conditions, we obtained protected carboxylic acid 92 
as the sole product of the reaction. 
 
Figure 40. Synthesis and controlled oxidation of methyl (4-phenylbutyl)carbonate 91. 
Trial deprotection with potassium carbonate in methanol also proceeded efficiently as previously 
reported91, thus cementing methyl carbonate as the promising option for protection of 58. 
 Setting about to implement our previous findings, we commenced with the carbonate 
protection of 58. In the event, conditions which had been successful on 79 proved sluggish when 
applied to 58; however, a brief screen for suitable conditions soon yielded success and the 
carbonate was successfully installed in good yield (Figure 41). 
 




Table 4. Conditions attempted for protection of 58. N.R.= no reaction; temp. = temperature. 
Reagents Solvent Temp. Time Result (% yield) 
t-BuOK, 0.20 eq; dimethyl dicarbonate, 5.0 eq THF r.t. 24 h N.R. 
t-BuOK, 0.20 eq; dimethyl dicarbonate, 5.0 eq THF reflux 12 h N.R. 
methyl chloroformate, 2.95 eq DCM r.t. 10 h N.R. 
pyridine, 43 eq; methyl chloroformate, 45 eq DCM r.t. 12 h 93 (71%) 
methyl chloroformate, 1.3 eq; 
DMAP, 2 mol %; pyridine, 1.3 eq 
DCM r.t. 4 h 93 (87%) 
 
 Gratifyingly, when methyl carbonate 93 was subjected to ruthenium tetroxide oxidation 
under Sharpless’ conditions, desired acid product 94 was obtained in acceptable 52% yield, or 61% 
based on recovered starting material (Figure 42). Benzyl ketone 95 was also isolated in 9.2% yield 
as a minor byproduct from benzylic oxidation. 
 
Figure 42. Oxidation of methyl carbonate 93 with ruthenium tetroxide.  
With a suitable strategy for the oxidation of 58 finally in place, we turned our attention to 
the installation of an appropriate chiral auxiliary to direct the installation of the final methyl-
bearing stereocenter. While several92-94 strategies for auxiliary-controlled alkylations are known, 
we settled on an Evans-style oxazolidinone primarily for its supreme ease of installation and 
removal, coupled with its satisfactory diastereoselectivity. Pleasingly, amide coupling of 94 with 
commercially-available (R)-4-phenyloxazolidinone oxazolidinone under standard conditions95 
gave N-acyl oxazolidinone 97 in good yield (Figure 43). Alkylation of the sodium enolate of 97 
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at low temperature with methyl iodide gave 98 as a single detectable diastereomer, and removal of 
the chiral auxiliary was effected under Evans’ conditions96. 
 
Figure 43. Installation of the chiral auxiliary, methylation and auxiliary removal. 
 Assignment of the signals in the 1H NMR spectrum of 98 by HSQC showed that the 
diastereotopic protons on the methylene β to the exocyclic carbonyl exhibit a chemical shift 
difference of 0.29 ppm (Figure 44). This value is inconclusive for the general formulation of 
Breit’s rule in the sense that, according to Breit’s most general formulation, a syn-configuration 
could not be ruled out. However, Breit has also identified a rule specific to stereodiads in which 
one methyl is adjacent to carbonyl functionality69. 
 
Figure 44. Chemical shifts for diastereotopic protons at the β-position of N-acyloxazolidinone 98. 
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Using this more restricted subset of the large database from which the general rule is drawn, 
we see that such compounds are always syn when the chemical shift difference for the 
diastereotopic protons on the intervening methylene is larger than 0.5 ppm, and always anti-when 
the chemical shift difference is less than 0.45 ppm. While again not providing absolute proof of 
stereochemistry, this variant of Breit’s rule, combined with the known, highly reliable 
stereochemical outcome of the Evans alkylation, provided strong evidence that the methylation 
had proceeded with the desired sense of stereoinduction to give 98 rather than its anti/syn-epimer. 
 With the third methyl-bearing stereocenter in place, and an effective strategy for the 
removal of the Evans-type chiral auxiliary in play, completion of the remainder of the RHS 
synthesis proceeded smoothly. PyBOP-mediated coupling of 99 with N,O-dimethylhydroxylamine 
hydrochloride provided Weinreb amide 100, and removal of the methyl carbonate proceeded 
uneventfully under basic conditions in methanol to give 101 (Figure 45). Finally, oxidation under 
Swern’s conditions gave ultimate RHS intermediate 38 in 60% unoptimized yield on a small scale. 
 
Figure 45. Completion of the synthesis of RHS aldehyde 38. 
While 38 was isolable and appropriate analytical data for it could indeed be obtained, 38, 
like aldehyde 67 before it, proved generally unstable. Unlike 67, 38 did not (at least in our 
observation) seem particularly susceptible to trimerization. Instead, 38 appeared to exhibit an 
exquisite sensitivity to oxidation, giving polar decomposition products even on short timescales. 
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This decomposition pathway appeared particularly rapid in solution, necessitating short reaction 
times and expeditious workups to obtain good yields. However, 38 was also resistant to storage, 
and appeared to suffer oxidation even when stored cold in seemingly oxygen-free environments. 
Thus, while the small-scale (~10 mg) oxidation of 101 provided an important benchmark, 
demonstrating that 38 was indeed accessible by our newly-developed route, we elected to store the 
remainder of our material as 101 rather than attempt to identify conditions for the storage of 38. 
The successful oxidation of 101 thus marked the conclusion of our synthesis of the RHS of the 
proposed structure, with 38 obtained in 3% overall yield from hydrocinnamaldehyde. While 
prepared to pursue further optimization of this route should the need arise, at this point we turned 
our attentions to the completion of the LHS. 
2.3 Synthesis of the Left-Hand Side 
 While development on the right-hand side progressed, work on the left-hand side of the 
baulamycin scaffold was in full swing as well. With our aldol-based proposed strategy (Figure 12) 
in mind, the first task in hand was to decide on a protecting group strategy for the LHS phenols. 
Judicious choice of these protecting groups was particularly important, given that they would be 
required to survive from the first step of the synthesis to the final global deprotection giving rise 
to the natural products. Accordingly, we hoped for protecting groups that would be (1) stable to a 
wide variety of conditions, while also (2) being relatively easy to remove. Finally, we hoped to 
maintain orthogonality to the silyl ethers, as it was imagined that at least one of the alcohols on 
the LHS might be protected by silylation and that differential deprotection might be required. 
Methyl ethers, although consummately stable, were ruled unsuitable according to criterion 2, as 
conditions for the cleavage of phenoxymethyl ethers remain relatively harsh. Similarly, silyl ethers 
were viewed as a suboptimal solution, since stability during the removal of other silyl protecting 
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groups later in the synthesis might have required extensive optimization. Benzylation, while 
otherwise attractive, appeared a risky choice in light of the native benzylic alcohol at C-1’; we 
feared that debenzylation might proceed with concomitant reduction at C-1’. Protecting groups 
susceptible to hydride reduction or nucleophilic attack were unsuitable due to the proposed late 
stage reduction of a carbonyl at C-13 as well as the late-stage installation of the C-3 ketone by 
Weinreb ketone synthesis, ruling out carbonates, esters, and similar moieties. Allyl ethers were 
considered; however, our desire to effect a global deprotection in the final step of the synthesis 
using uniform, simple conditions led us to look elsewhere, as we believed that removal of allyl 
ethers would probably require a catalytic isomerization best effected as a separate step. 
Ultimately, given our desire to reserve silyl ethers for elsewhere on the baulamycin 
scaffold, a mixed acetal such as a methoxymethyl ether seemed like the most attractive candidate 
for protection of the LHS phenols. Methoxymethyl ethers, stable to base, nucleophilic attack, 
hydrogenation and many sources of fluoride ion, are ideal in that they nonetheless succumb to 
protic acids under mild conditions. They thus appeared to perfectly suit our goal of a simple, global 
deprotection, while hopefully maintaining adequate stability through the rest of the route. 
 Accordingly, we begin our synthesis of the left-hand side of the baulamycins with a screen 
of routes towards MOM-protected 3,5-dihydroxybenzaldehyde 104 (Figure 46). 
 
Figure 46. MOM-protection of 3,5-dihydroxybenzoic acid and subsequent reduction with DIBAL. 
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Table 5. Conditions employed for the MOM-protection of 3,5-dihydroxybenzoic acid. 
Electrophile Base Solvent Time Result 
MOMCl, 3.00 eq DIPEA, 3.0 eq  DCM 16 h 23% 
MOMCl, 3.00 eq NaH, 3.0 eq THF 1 h 30% 
MOMCl, 3.00 eq DIPEA, 6.0 eq DCM 1 h 46% 
MOMCl, 3.05 eq NaH, 3.65 eq THF/Et2O 5 h 74% 
MOMCl, 4.00 eq DIPEA, 6.00 eq DCM 12 h 80% 
MOMCl, 4.50 eq DIPEA, 6.00 eq DCM 24 h 90% 
 
 An extensive screen of conditions for the MOM-protection of 3,4-dihydroxybenzoic acid 
with methoxymethyl halides revealed that alkylation with 4.5 eq methoxymethyl chloride in the 
presence of 6.00 eq Hünig’s base gave the exhaustively protected ester 102 in >90% yield. A 
simple base wash effectively removed all partially-protected contaminants, allowing isolation of 
pure 102 without chromatographic purification. All attempts to effect the direct reduction of 102 
to aldehyde 104 with DIBAL-H were unsuccessful, giving exclusively alcohol 103 in quantitative 
yields in as little as 5 minutes at -78 °C. Lower temperature reductions were not pursued.  
With 103 in hand, a simple screen of oxidation conditions revealed the optimal route to 
104 (Figure 47). Despite the marginally-higher yield of the Parikh-Doering oxidation, oxidation 
with activated manganese dioxide became the obvious choice for its supreme operational 
simplicity: the reaction is run at room temperature, is insensitive to oxygen, and the product can 
be isolated in relatively pure form by simple filtration through Celite followed by solvent removal. 
 
Figure 47. Oxidation of benzylic alcohol 103 to aldehyde 104. 
 
Table 6. Conditions for the oxidation of benzylic alcohol 103 to aldehyde 104. 
Conditions Yield of 104 
SO3•pyridine, 2.00 eq; DIPEA, 3.50 eq; DCM/DMSO (10:1) 83% 
MnO2, 20 eq; DCM 81% 
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 Despite our development of this efficient route to aldehyde 104, we nevertheless hoped 
that we might identify a strategy that would avoid the use of nearly five equivalents of expensive 
and highly carcinogenic methoxymethyl chloride. We first considered conditions reported97 to give 
the methoxymethyl ethers of phenols from 2,2-dimethoxymethane (Figure 48); unfortunately, 
these conditions, which relied on the use of a Soxhlet extractor and molecular sieves to remove 
methanol from the reaction, did not go to completion on 3,5-dihydroxybenzoic acid. Believing that 
the low solubility of the bisphenol acid in DCM might be a contributing factor, we prepared methyl 
3,5-dihydroxybenzoate (105) and subjected it to similar conditions, with the addition of 
acetonitrile as an additional solubilizing factor; however, these conditions also failed to afford 
appreciable yields of the protected product. 
 
Figure 48. Attempted protection of 3,5-dihydroxybenzoic acid with 2,2-dimethoxymethane. 
 Undeterred, we considered the possibility that perhaps an alternate order of operations 
might allow us to access more soluble material, or at least forgo one or more equivalents of 
methoxymethyl halide. Thus, we envisioned that borane reduction of 3,5-dihydroxybenzoic acid 





Figure 49. Attempted construction of aldehyde 104 via triol 107. 
The bisphenol could then be protected either (1) with fewer equivalents of methoxymethyl 
halide, or, ideally, (2) with 2,2-dimethoxymethane under acid-catalyzed conditions. While 
reduction of 3,5-dihydroxybenoic acid proceeded smoothly, giving triol 107 as a colorless 
crystalline solid, attempted oxidation of 107 to 108 with MnO2 gave only extensive decomposition. 
We later learned that activated manganese dioxide is known to promote the oxidative 
polymerization of unprotected phenols, most likely via a radical mechanism, suggesting a possible 
reason for the failure of these conditions98. In light of the success of the extant route to 104, other 
oxidative conditions were not investigated, and further attempts to optimize the synthesis of 104 
were abandoned. 
With access to a steady supply of benzaldehyde 104, we turned our attention to 
accomplishing the diastereoselective aldol reaction of 104 with some analogue of 4-methylvaleric 
acid. While a vast number of approaches to the syn-aldol reaction have been reported, and have 
been extensively reviewed99, Evan’s N-acyl oxazolidinone-based strategy seemed most appealing, 
not only for the exquisitely high levels of diastereocontrol afforded (for so-called “Evans syn” 
aldol reactions of boron enolates, often as high as 200:1 d.r.), but also for the remarkably-well 
documented, mild and varied known methods for auxiliary removal58. 
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 Pleasingly, enolization of known100 oxazolidinone 109 – prepared in good yield from 
commercial material in one step – with dibutylboron triflate in the presence of triethylamine 
followed by reaction with aldehyde 104 gave syn-aldol 110 in excellent yield as a single detectable 
diastereomer (Figure 50). Crucial to the success of this reaction was the use of freshly-prepared 
(n-Bu)2BOTf, which was prepared according to Evans’ modification101 of Mukaiyama’s 
procedure102 in good yield from tributylborane and triflic acid. Dibutylboron triflate obtained in 
this way could be carefully stored in a Schlenk tube for future use; however, no rigorous studies 
correlating the age of the reagent with its activity were undertaken, and the material was generally 
used shortly after preparation. 
 
Figure 50. Boron-mediated syn-selective aldol reaction between aldehyde 104 and N-acyl 
oxazolidinone 109. 
 
 We next undertook to verify the relative stereochemistry of 110. Hydrolysis of the aldol 
with lithium hydroperoxide under Evans’ conditions96 gave hydroxy acid 111 in excellent yield 
(Figure 51). Reduction with borane in THF gave diol 112, which provided acetonide 113 as the 





Figure 51. Removal of chiral auxiliary, reduction, and acetalization of 110 for determination of 
stereochemistry. 
 
 Careful examination of the 1H NMR spectrum of acetonide 113 reveals strong evidence 
that the stereochemistry of aldol 110 is in fact syn as expected. The coupling constant for the 
benzylic methine proton reveals a gauche relationship between that proton and the neighboring 
proton on C-14 (Figure 52). Ignoring the presumably-negligible conformer in which both the 
aromatic ring and the isobutyl group are in the axial position, the anti-product should demonstrate 
an antiperiplanar relationship between the protons on C-1’ and C-14, giving rise to a coupling 
constant greater than 10 Hz103. Conversely, both populated conformers of the syn-product should 
exhibit coupling constants less than 5.5 Hz, corresponding to the gauche relationship between the 
neighboring protons. In fact, the coupling constant for the methine proton at C-1’ was measured 




Figure 52. Confirmation of stereochemistry in LHS acetonide 113. 
 
With the relative stereochemistry of 110 assured, we set about attempting to effect the 
installation of the Weinreb amide. It was Weinreb himself who first noted that esters could be 
efficiently converted to the corresponding amides by the action of aluminum amides generated 
from the reaction of trimethylaluminum with primary or secondary amines104 or (as Weinreb later 
demonstrated) their hydrochloride salts105. Evans subsequently noted the applicability of these 
conditions to the direct conversion of N-acyl oxazolidinones to amides in the course of his work 
on the polyether antibiotic X-206 106. Significantly, as Evans pointed out later, an unprotected 
alcohol at the β-position of such N-acyl oxazolidinones (such as that present in the products of 
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oxazolidinone-directed aldol reactions, for example) plays a crucial role in directing the attack of 
the aluminum amide to the exocyclic carbonyl107. 
With this precedent in mind, we first attempted chiral auxiliary removal by 
trimethylaluminum-mediated transamidation of 110 (Figure 53). Unfortunately, despite a number 
of attempts, Weinreb’s conditions led only led to decomposition. In some cases, retro-aldol 
products were significant components of the crude. Evans has noted poor results for the direct 
transamidation of N-acyloxazolidinones with substantial steric hindrance96, and later work on our 
part demonstrated that 110 and related compounds are prone to decomposition by way of base-
catalyzed retro-aldol reactions. 
 
Figure 53. Attempted direct transamidation of 110 to Weinreb amide 114. 
 Despite the failure of the direct route to 114, we were nonetheless keen to remove the 
oxazolidinone moiety without first protecting the C-14 hydroxyl. Our motivation lay in our firm 
intent to implement Yamamoto’s “supersilyl”-directed 1,4-syn selective aldol reaction in the 
coupling of the right- and left-hand sides. Given the extreme steric hindrance engendered by 
Yamamoto’s tris(trialkylsilyl)silyl ethers, we desired to avoid installing these massive protecting 
groups until as late as possible in the synthesis of the LHS. We reasoned that such large moieties 
might well interfere with other synthetic transformations, including the synthesis of the requisite 
methyl ketone or even the removal of the chiral auxiliary itself. With Weinreb’s direct 
transamidation approach effectively dead in the water, our next move was to attempt a standard 
hydrolysis of 110, with the hope that traditional amide coupling conditions would be effective for 
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the installation of the Weinreb amide even without prior protection of the C-14 hydroxyl. A 
“protecting group swap” strategy was considered, but was deemed unpalatable on principle.  
Accordingly, we subjected 110 to lithium hydroperoxide-mediated hydrolysis as 
previously described, obtaining 111 in excellent yield on scale (Figure 54). 
 
Figure 54. Hydrolysis and attempted amidation of aldol 110.  
 
Table 6. Conditions for amide formation with hydroxy acid 111. 
Conditions Yield 
EDCI, 1 eq 
N-methylmorpholine, 3.5 eq 
N,O-dimethylhydroxylamine HCl, 1.5 eq 
31% 
EDCI, 3 eq 
N-methylmorpholine, 15 eq 
N,O-dimethylhydroxylamine HCl, 10 eq 
82% 
N-methylmorpholine, 4.10 eq 
N,O-dimethylhydroxylamine HCl, 3.00 eq 
2-chloro-4,6-dimethoxy-1,3,5-triazine, 1.10 eq 
58% 
N-methylmorpholine, 5.10 eq 
4-(dimethylamino)pyridine, 0.20 eq 
N,O-dimethylhydroxylamine HCl, 2.00 eq 
2-chloro-4,6-dimethoxy-1,3,5-triazine, 1.10 eq 
95% 
 
Our attempts at the amidation of 111 began with the use of EDCI; however, despite initial 
optimization attempts, results with this reagent were inconsistent, with some reactions failing to 
go to completion after up to one week, and others giving good yields after approximately 36 hours. 
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Consequently, we sought more reliable conditions. 2-Chloro-4,6-dimethoxy-1,3,5-triazine 
(CDMT) seemed like an attractive choice, as it has been known to allow the formation of amides 
from β-hydroxy acids without prior protection of the alcohol108. After some optimization, 1.10 eq 
of CDMT with catalytic DMAP and excess N-methylmorpholine were found to give ideal results, 
affording 95% of relatively pure 114 after 12 hours.  
With access to Weinreb amide 114 thus secured, we next chose to investigate whether the 
methyl ketone could be installed without prior protection of the C-1’ hydroxyl (Figure 55). 
 
Figure 55. Attempted installation of methyl ketone without C-1’ hydroxy protection. 
Table 7. Conditions attempted for the conversion of 114 to 115. N.R. = no significant reaction, 
decomp. = unidentified decomposition products, retro-aldol = retro-aldol reaction products. 
Reagents Temp. Time Result (% yield) 
MeMgBr, 4.50 eq 0 °C to r.t. 36 h 115 (23%) 
MeLi, 3.00 eq 0 °C to r.t. 2 h retro-aldol 
MeLi, 5.00 eq -78 °C 1 h N.R. 
MeLi, 1.2 eq; TMSCl, 1.1 eq; then MeMgBr, 3 eq -78 °C 6 h N.R. 
MeMgBr, 4.10 eq -65 to -25 °C 60 h N.R. 
CeCl3, 3.00 eq; MeMgBr, 3.00 eq; then 114 0 °C to r.t. 55 h N.R. 
CeCl3, 1 eq; MeMgBr, 3.00 eq 0 °C to r.t. 12 h retro-aldol 
Ph3P=CH2, 2.1 eq -78 °C 28 h decomp. 
 
 Our first attempt at the formation of 115 met with limited success – 4.5 equivalents of 
methylmagnesium bromide gave 115 in low but appreciable yield over 36 hours. Heartened, we 
set about trying variations of these conditions, with the hope of improving the yield of the reaction. 
Methyllithium between 0 °C and room temperature gave only the products of the corresponding 
retro-aldol reaction, readily identifiable by the presence of aldehyde 104 as a major product. Even 
larger quantities of methyllithium at cryogenic temperatures gave primarily starting material. 
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Attempts at transient protection as the TMS ether were likewise unsuccessful. Organocerium 
reagents – which may be generated by the action of organolithium or Grignard reagents on 
anhydrous ceriu(III) chloride, among other methods – have proved superior as carbon nucleophiles 
in cases where addition into carbonyl compounds otherwise unstable to basic conditions is 
desired109-110. Among other advantageous qualities, organocerium species are known to avoid 
adventitious retro-aldol-type reactivity during addition to sensitive unprotected β-hydroxy 
ketones111. Disappointingly, the use of a pre-formed organocerium reagent gave no reaction at 
room temperature, even after prolonged reaction times. The use of a 1:3 ratio of CeCl3 to 
methylmagnesium bromide gave retro-aldol products, suggesting that the organocerium species 
was indeed formed but was simply not reactive enough to alkylate 114. Reaction with 
phosphonium ylide Ph3P=CH2, reported to react with Weinreb amides to give methyl ketones, gave 
only unidentified decomposition products112.  
 With development of the Weinreb ketone synthesis on 114 thus stalled at an unacceptably 
low yield of 23%, we turned our attention to other approaches. Isolated attempts (Figure 56) to 
directly convert 110 to the methyl ketone were unsuccessful. Treatment of 110 with MeLi gave 
endocyclic cleavage product 117 as the sole product in 61% yield, without any evidence of the 
formation of 116. Likewise, treatment of 110 with 5 equivalents of Ph3P=CH2 gave only aldehyde 





Figure 56. Failed attempt at methyl ketone formation from 110 using methyllithium. 
 
 We next considered the possibility of eliminating the Weinreb amide from the synthesis 
altogether, forming 116 directly from unprotected hydroxy acid 111. A number113-117 of methods 
for the direct conversion of acids to ketones are known, and the topic has been briefly reviewed118. 
We elected to start with the reaction of organic acids with organocuprates116. Despite the successful 
and quantitative conversion of hydrocinnamic acid to methyl ketone 119 in a test reaction, 
subjection of 111 to identical and similar conditions gave only starting material (Figure 57).  
 





Table 8. Conditions attempted for the conversion of 111 to 116. N.R. = no reaction. 
Conditions Result 
MeLi, 4.00 eq; then TMSCl, 10.0 eq decomposition 
MeLi, 5.00 eq; CuCN, 5.00 eq N.R. 
MeLi, 10.0 eq; CuCN, 5.00 eq N.R. 
 
Likewise, treatment of 111 with methyllithium followed by quenching with excess 
TMSCl119 led only to extensive decomposition, presumably mediated by the basicity of 
methyllithium under the reaction conditions. 
 In light of this slew of failures to access 116 by any method, we abandoned the idea of 
proceeding with the C-1’ hydroxyl unprotected. At this point, we elected to proceed with the 
installation of the desired “supersilyl” protecting group. Thus, we first attempted the reaction of 
tris(triethylsilyl)silyl triflate (generated in situ from tris(triethylsilyl)silane and triflic acid) with β-
hydroxy amide 114; however, neither the use of 2.2 equivalents (TES)3SiOTf  (Yamamoto 
reports120 the use of 1.05 eq of the analogous tris(trimethylsilyl)silyl triflate in a similar reaction) 
nor the use of very large excesses of this reagent (up to 24 equivalents) ever produced isolable 
product (Figure 58). A similar attempt on 115 gave only starting material, even after one week at 
room temperature. Hoping that the marginally less hindered tris(trimethylsilyl)silyl protecting 
group might prove more amenable to installation on our scaffold, we attempted the analogous 
reaction using 114 as our test substrate (Figure 59). Disappointingly, these attempts met the same 
fate as their earlier analogues with (TES)3SiOTf, giving either decomposition or no reaction. 
With all attempts to access “supersilyl”-protected structures thus stymied, we were forced 
to reconsider our approach to the stereoselective aldol reaction we proposed would couple the left- 
and right-hand sides. With no proof that the “supersilyl” strategy would prove fruitful, and with 
our long efforts in pursuit of any protected LHS methyl ketone thus far unproductive, it was 
57 
 
decided that a simple TBS ether would serve the purpose of protecting the alcohol at C-1’, at least 
until experimental evidence from attempted aldol reactions could inform us otherwise. 
 
Figure 58. Attempted installation of tris(triethylsilyl)silyl protecting group on 114 and 115. 
 
 
Figure 59. Attempted installation of the tris(trimethylsilyl)silyl protecting group on 114. 
 
Table 9. Conditions attempted for tris(trimethylsilyl)silylation of 114. N.R. = no reaction 
Conditions Result 
 (Me3Si)3SiCl, 25 eq; imidazole, 50 eq decomposition 




With a large amount of hydroxy acid 111 on hand at the time, we first attempted TBS-
protection of the acid, reasoning that upon treatment of 111 with silylating reagents, bis-silylation 
would ensue; the silyl ester moiety could then be removed by basic hydrolysis. In the event, 
however, despite apparent transient protection of 111 under a variety of conditions, basic 
hydrolysis always gave starting material back as the major product (Figure 60).  
 
Figure 60. Attempted TBS-protection of hydroxy acid 111. 
 
Table 10. Conditions attempted for the TBS-protection of 111. SM = starting material. 
Silylation Reagents Solvent Hydrolysis Conditions Result 
TBSCl, 2.10 eq 
imidazole, 3.50 eq 
DCM 10% aq. K2CO3 (w/w) SM recovered 
DMAP, 0.40 eq 
TBSCl, 2.10 eq 
imidazole, 3.50 eq 
DMF 
sat. sol’n of K2CO3 in 
H2O/MeOH 
SM recovered 
DMAP, 0.40 eq 
TBSCl, 2.44 eq 
imidazole, 5.90 eq 
CDCl3 1% aq. K2CO3 (w/w) SM recovered 
 
Based on TLC analysis of the reaction of 111 and TBSCl in DCM, as well as real-time 1H 
NMR analysis of the reaction conducted in CDCl3, it appears that silylation was indeed happening 
(as evidence by disappearance of starting material by both TLC and 1H NMR); however, basic 
hydrolysis invariably regenerated 111. Considering the available evidence, it seems most likely 
that silylation was happening preferentially at the less-sterically-encumbered acid moiety (Figure 
61), giving rise to silyl ester 124. The added bulk of the tert-butyldimethylsilyl moiety adjacent to 
the C-13 carbonyl might then have proved sufficient to prevent a second silylation reaction, 
preventing formation of 125 altogether. Under these circumstances, despite the initial consumption 




Figure 61. Possible explanation for silylation reaction outcomes. 
In light of our inability to successfully silylated hydroxy acid 111, we finally chose to 
employ the straightforward strategy of TBS-protecting Weinreb amide 114. While reaction 
between 114 and TBSCl in the presence of imidazole alone or imidazole and 0.20 or 0.40 eq 
DMAP proved sluggish (data not shown); we were gratified to find that treatment of 114 with 
TBSOTf and 2,6-lutidine gave TBS-ether 126 in good yield (Figure 62). Likewise, treatment of 
126 with methyllithium successfully gave protected LHS methyl ketone 127 in good yield, thus 
completing our first attempt at the synthesis of the left-hand side of the baulamycin scaffold, albeit 
with alternate protection for the C-1’ hydroxyl. 
 
 





2.4 Attempted Aldol Coupling of Left- and Right-Hand Sides 
 With the synthesis of both RHS aldehyde 38 and LHS ketone 127 in place, our next task 
was to develop conditions leading to the diastereoselective aldol coupling of 38 with 127. While 
aldehyde 38 was available, it remained precious to us in light of the sixteen steps required to 
prepare it from hydrocinnamaldehyde. Thus, we elected to begin our studies by investigating the 
couplings of methyl ketone 127 with commercially-available aliphatic aldehydes.  
 Our initial investigations were conducted with heptanal (Figure 63); however, several 
attempts at deprotonation of 127 with lithium hexamethyldisilazide followed by treatment with a 
slight excess of heptanal gave only recovered ketone, despite a separate experiment showing 
incorporation of one deuteron at C-12 after quenching of the (presumed) lithium enolate of 127 
with deuterium oxide (data not shown). 
 
Figure 63. Attempted aldol reaction between 127 and heptanal. 
 
 With evidence of enolization in hand, we turned our attention to heptanal as a potential 
source of our reactivity issues. Examination of our material immediately prior to use revealed the 
unfortunate explanation: even freshly distilled heptanal is highly unstable and prone to rapid 
trimerization. In the event, we observed up to 35% trimerization to 2,4,6-trihexyl-1,3,5-trioxane 
over a period of just 3 hrs at room temperature. Examination of an old bottle of heptanal by 1H 
NMR showed an approximately 8:1 ratio of trimer to monomer, suggesting that the monomer and 
trimer may be in a relatively fast equilibrium; however, with no desire to add this unexpected set 
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of variables to our already complex reaction manifold, we chose to investigate other aldehydes as 
models for the RHS. 
A single experiment in which 127 was deprotonated with lithium diisopropylamide and 
subsequently treated with freshly purified butanal gave recovered 127 as the only product after 
workup; butanal was not recovered (Figure 64). Meanwhile, we were pleased to discover that 
pentanal, after purification by distillation, remains stable at room temperature under argon for 
timescales approaching weeks rather than hours. Armed with the increased certainty afforded by 
this discovery, we undertook a screen of aldol conditions between freshly purified pentanal and 
ketone 127.  
 
Figure 64. Attempted reaction between the lithium enolate of 127 and butanal. 
 
A number of conditions were attempted (Figure 65); however, despite the use of fresh and 
purified reagents and starting materials, as well as favorable results from control reactions showing 
enolization under a variety of conditions, results were generally poor (Table 11). 
 
 





Table 11. Conditions employed in the conversion of 127 to 130. 
Entry Conditions Result 
1 Et3N, 1.10 eq; (Cy)2BCl, 1.05 eq no reaction 
2 Et3N, 2.00 eq; (Cy)2BCl, 2.00 eq; then D2O, excess deuteration at C-12 
3 Et3N, 5.00 eq; TMSOTf, 1.50 eq; then BF3•Et2O, 1.05 eq, r.t. decomposition 
4 (n-Bu)2BOTf, 1.10 eq, Et3N, 1.50 eq; DCM, 0 °C, 3 hr no reaction 
5 (n-Bu)2BOTf, 1.10 eq, Et3N, 1.50 eq; DCM, 0 °C, 60 hr decomposition 
7 (+)-DIP-Cl, 2.70 eq, Et3N, 3.0 eq; DCM, -78 °C no reaction 
8 L-proline, 0.50 eq; CHCl3 no reaction 
9 L-proline, 0.50 eq; THF/H2O (1:1) no reaction 
10 LiHMDS, 3.00 eq; Et3N, 15.0 eq; toluene, -60 °C decomposition  
11 LiHMDS, 3.00 eq; Et3N, 15.0 eq; DMF, -78 °C decomposition 
12 LiHMDS, 3.00 eq; Et3N, 15.0 eq; toluene, -78 °C 64%, dr = 1 : 1 
 
 The one exception to the generally poor results of various hard and soft enolization, as well 
as direct, approaches to the aldol reaction was the reaction of the lithium enolate of 127 generated 
by LiHMDS in the presence of a large excess of triethylamine in toluene at -78 °C, which gave a 
64% yield of 130, but no diastereoselectivity. Increasing the temperature led to decomposition 
products. With reasonable yields in hand, we decided that it was worth trying these conditions on 
actual RHS aldehyde 38; however, when the reaction was carried out, regenerated 127 was the 
sole product, and precious aldehyde 38 could not be recovered (Figure 66). 
 
Figure 66. Attempted aldol reaction between 127 and RHS aldehyde 38.  
 
 Recognizing that continued optimization of these conditions was required, but loathe to 
sacrifice more of 38, we resolved to develop a more pertinent model of 38. Accordingly, we 
proposed to synthesize the tris-des-methyl analogue of 38, N-methoxy-N-methyl-9-
oxononanamide 137, as a model for 38 to be used in future aldol reactions (Figure 67). 
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Figure 67. Synthesis of model RHS aldehyde 137 from 1,9-nonanediol. 
 
Synthesis began with the monoprotection of 1,9-nonanediol as its TBS-ether 133. Under 
conditions121 which have been employed on other α,ω-diols, we received no better than a statistical 
yield of the diol; however, the ease of separating the various products and the extreme cheapness 
of the starting materials mitigated the issue, allowing us to proceed with little difficulty. Oxidation 
with TEMPO, bleach and sodium chlorite122 afforded acid 134 in excellent yield in a single 
operation. Subsequent Weinreb amide installation and deprotection with TBAF gave amide 
alcohol 136 in good yield over two steps; oxidation under Swern’s conditions then gave aldehyde 
137 quantitatively. We were thus able to rapidly access 137 in 32% overall yield from commercial 
material, providing a straightforward source of model aldehyde for future investigations of our key 
aldol reaction. 
It should be noted that, like a number of other aldehydes previously employed, 137 proved 
to be relatively unstable to prolonged storage. Storage in an apparently air-free environment at 
room temperature led to ~35% decomposition (byproducts unknown) after 20 days; storage in the 
cold profoundly worsened the issue, giving complete decomposition in mere days. Like so many 
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other aldehydes employed thus far, we elected not to prepare large quantities of 137, but rather to 
prepare it from 136 immediately prior to use. 
With model aldehyde 137, we immediately set about testing conditions for its coupling 
with LHS ketone 127. Subjection of 127 to soft enolization conditions followed by exposure to 
137 gave no product (Figure 68), a result consistent with that observed when pentanal was used 
as the electrophile. Conversely, hard enolization conditions similar to those which had been 
successful on pentanal (Figure 69) were successful, giving aldol product 138 in 27% yield as a 
1:1 mixture of diastereomers. 
 
Figure 68. Attempted soft-enolization aldol reaction of 127 with model RHS aldehyde 137. 
 
 
Figure 69. Aldol reaction between the lithium enolate of 127 and model RHS aldehyde 137. 
 At this point, with unequivocally poor yields and non-existent diastereoselectivity, we 
considered the idea of employing a chiral directing group in order to influence the outcome of 
aldol reaction. Ellman has shown that sulfinimines derived from the condensation of (R)- or (S)-2-
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methylpropane-2-sulfinamide with ketones can be deprotonated to give nucleophiles that perform 
stereoselective additions to aldehydes123. The resulting β-hydroxy sulfinimines can then be 
converted under mild conditions to β-hydroxy ketones. Thus, we envisioned a route to aldol 138 
in which 127 would undergo condensation with (R)-2-methylpropane-2-sulfinamide to give 
sulfinimine 139 (Figure 70). This latent nucleophile would then suffer deprotonation, reacting 
with 137 to give β-hydroxy sulfinimine 140, which, following acidic hydrolysis was imagined to 
give aldol 138 with good specificity for the desired C-11 stereochemistry. 
 We began our attack with the synthesis of 139; reflux of 127 in THF with 4 equivalents of 
titanium(IV) ethoxide did indeed give 139, albeit in mediocre yield (Figure 71). However, all 





Figure 70. Proposed approach to 138 based on Ellman’s chiral sulfinamide auxiliaries.  
 
 




 With Ellman’s chemistry out of the question, we considered other, less-straightforward 
approaches. β-Hydroxy diketoesters are known to be reduced stereoselectively to the syn triols by 
sodium borohydride in the presence of titanium(IV) isopropoxide124; we hoped that a similar 
pattern of reactivity might be operative on β-hydroxy diketones. Accordingly, we oxidized a 1:1 
mixture of 138 stereoisomers to diketone 141 in good yield under Parikh-Doering conditions 
(Figure 72); however, a several attempts to effect the deprotection of diketone 141 were 
unsuccessful. 
 
Figure 72. Oxidation of aldol 138 to diketone 141; attempted deprotection and reduction of 141. 
 
Table 12. Conditions attempted for deprotection of 141. 
Conditions Result 
TBAF, 1.20 eq; THF decomposition 
TBAF, 1.00 eq; NH4F, 1.00 eq; THF decomposition 
 
In retrospect, it seems likely that the basic nature of the fluoride sources employed proved 
a poor match to the relatively acidic diketone. When deprotection failed, reduction was attempted 
68 
 
on TBS-ether 141 directly; however, this reaction gave an intractable mixture of unknown 
products.  
2.5 Revised Retrosynthetic Analysis 
 
 With all attempts to effect an aldol-type coupling of the LHS and RHS having been thus 
far unsuccessful at producing any reasonable amount of diastereoselectivity, we considered that it 
was time to re-tool our core retrosynthetic strategy towards the baulamycins. Taking our cues from 
the structures of the advanced intermediates accessible from our previous synthetic work, we 
imagined that a Horner-Wadsworth-Emmons or Wittig-type reaction between a left-hand side 
nucleophile and a right-hand side electrophile would give rise to an enone containing the complete 
carbon skeleton of the baulamycins (Figure 73). This enone might then undergo a formal 
diastereoselective hydration by any number of methods in order to give rise to aldol 131. Syn-
selective diastereoselective reduction, Weinreb ketone synthesis and global deprotection would 
then give the baulamycins as formerly planned. 
 Our inintial inclination was the incorporation of a stabilized phosphonium ylide into the 
left-hand side synthon; we reasoned that since the high E-selectivity of resonance-stabilized Wittig 
reagents is well-known, we would stand a good chance of accessing a single diastereomer of the 
desired product. Moreover, we knew that the required phosphorane could be generated under mild 
conditions, avoiding the liabilities associated with the use of strong base. 
 With the above Wittig-based strategy in mind, we set about the synthesis of the 
α-bromoketone from 127 (Figure 74). Deprotonation of 127 with lithium diisopropylamide 
followed by treatment with stoichiometric bromine at -78 °C gave a mixture of starting material 
and an unknown product, which we hoped was α-bromoketone 148. Unfortunately, treatment with 








Figure 74. Attempted formation of phosphonium bromide salt 148 from LHS ketone 127. 
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but instead yielded an unidentified, phosphorous-containing (31P NMR) white solid which was 
unstable to oxygen, decomposing to give a greenish-black substance. Deprotonation of 127 with 
LiHMDS under the same conditions yielded identical results. All attempts to identify either the 
product of bromination or the subsequently-formed adduct with triphenylphosphine were 
unsuccessful. We considered the possibility that bromination was taking place at the aromatic ring 
rather than at the carbonyl α-position; however, no convincing evidence for this was ever obtained, 
and the route was eventually abandoned.  
 Unsuccessful in our attempts to prepare a Wittig-style nucleophile from 127, we turned our 
attention to the construction of the analogous Horner-Wadsworth-Emmons reagent, β-
ketophosphonate 149 (Figure 75). 
 
Figure 75. Synthesis of β-ketophosphonate 149 from Weinreb amide 114. 
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Table 13. Conditions employed for the conversion 114 directly to 149. N.R. = no reaction. 
Reagents Temperature and Time Results 
MeP=O(OMe)2, 3.05 eq; n-BuLi, 3.00 eq, THF -78 °C, 0.5 h; then -20 °C, 12 h N.R. 
MeP=O(OMe)2, 3.05 eq; n-BuLi, 3.00 eq, THF -78 °C, 2 h; then r.t., 12 h N.R. 
MeP=O(OMe)2, 3.05 eq; KHMDS, 3.00 eq, THF -78 °C, 2 h; then r.t.,12 h N.R. 
 
 We first attempted the conversion of Weinreb amide 114 directly to desired β-
ketophosphonate; however, 114 proved remarkably inert to attack with a variety of anions of 
methyl dimethylphosphonate, perhaps due to the severe steric constraints imposed by the isobutyl 
substitution at the α-position. With this in mind, we hypothesized that perhaps a less-bulky 
carbonyl might be more susceptible to nucleophilic attack by lithiated methyl 
dimethylphosphonate. Accordingly, we prepared aldehyde 150, which was available in good yield 
by reduction of 114 with two equivalents of DIBAL-H. Pleasingly, when 150 was subjected to the 
same conditions which had proved ineffective Weinreb amide 114, β-hydroxy phosphonate 151 
was obtained smoothly in excellent yield. Oxidation with Dess-Martin periodinane rapidly gave 
desired β-ketophosponate 149 in good yield. Efforts to effect the same transformation with cheaper 
activated-DMSO-type conditions were unsuccessful; no reaction was observed even after 29 hours 
under Parikh-Doering conditions. 
 With an effective route to β-ketophosphonate 149 thus securely in hand, we moved to effect 
the coupling of 149 with model RHS aldehyde 137 as a surrogate for our proposed coupling of 
149 with 38. In the event, Paterson’s mild olefination conditions125, catalyzed by a suspension of 
activated barium hydroxide in THF/water (40:1), provided enone 152 with perfect E-selectivity in 
69% (unoptimized) yield from β-ketophosphonate 149 and aldehyde 137 (Figure 76). At this 
point, having successfully coupled a key analogue of the baulamycin RHS to our LHS synthon, 





Figure 76. Successful Horner-Wadsworth-Emmons olefination of 137 with 149 under Paterson’s 
conditions. 
 
 The enantio- and diastereoselective formal hydration of various Michael acceptors is a 
topic of general interest and has been reviewed126. One well-known strategy for the 
enantioselective formal addition of water to enones is the cinchona-alkaloid-catalyzed addition of 
peroxides followed by facile reduction of the resulting β-peroxyketones to aldols. Variations on 
this protocol have been independently described by List and coworkers127 as well as Deng et al128; 
a similar addition of oximes to enones has also been independently described129. Although only 
moderate yields were reported for substrates other than methyl ketones, the relatively-mild 
conditions and the fact that List’s protocol reportedly facilitates the preparation of the aldol 
products from their enone precursors in one pot made these approaches attractive first strategies. 
Accordingly, catalyst 9-amino-9-deoxy-epi-quinine was synthesized from quinine in one step as 
reported130, and enone 152 was subjected to List’s conditions (Figure 77).  




Table 14. Conditions attempted for the diastereoselective formal hydration of enone 152. N.R. = 
no reaction. Decomp. = decomposition. 
Conditions Result 
9-amino-9-deoxy-epi-quinine, 0.1 eq; Cl3COOH, 0.2 eq; H2O2, 3 eq; 50 h N.R. 
9-amino-9-deoxy-epi-quinine, 1 eq; Cl3COOH, 2 eq; H2O2, 30 eq; 7 days N.R. 
NaOH, 0.375 M in THF/H2O (1:1), 36 h N.R. 
(S,S)-5-isopropyl-2-methylcyclohex-2-enol, 1.5 eq; n-BuLi, 1.45 eq; THF, 12 h N.R. 
D-phenylalanine, 1.60 eq; allyl alcohol; 6 days N.R. 
p-TsOH, 2.5 eq; allyl alcohol; 24 h decomp. 
 
Disappointingly, even after prolonged reaction times in the presence of either catalytic or 
stoichiometric amounts of cinchona-alkaloid catalyst, no reaction was observed under List’s 
conditions and 152 was recovered unchanged. 
In light of this failure, and hypothesizing that perhaps the steric bulk of the catalytic species 
might have played a role, we considered that perhaps the direct addition of various oxygen 
nucleophiles to unactivated 152 should be investigated before proceeding with more complex 
routes. Accordingly, 152 was treated with a variety of oxygen-centered nucleophiles, beginning 
with hydroxide itself; however, all of these conditions led simply to the recovery of unchanged 
starting material, with the exception of 2.5 equivalents para-toluenesulfonic acid in allyl alcohol, 
which led to the loss of both MOM groups as well as the silyl ether with no evidence of Michael 
addition. 
At this point, although many other strategies for effecting the formal hydration on enone 
152 could have been investigated, other developments concerning the revision of the proposed 
stereochemistry of the baulamycins had become too pressing to ignore. Specifically, it was around 
this time in our efforts that Guchhait et al published their independent synthesis of the proposed 
structure of baulamycin A and several diastereomers, conclusively demonstrating that structure 3 








 In their foundational synthesis of the proposed structure of the baulamycins, Guchhait et 
al synthesized not only 3, the proposed structure of baulamycin A, but also several additional 
diastereomers of 3 (Figure 78). However, despite their best efforts, Guchhait et al were unable to 
identify the correct structures of the baulamycins. 
 
Figure 78. Compounds prepared by Guchhait et al. 
 
Guchhait et al reported the synthesis of the proposed structure in February of 2017; in July 
of the same year, Aggarwal and coworkers unveiled their seminal work encompassing the total 
synthesis of the proposed structures of the baulamycins, as well as the synthesis of a number of 
diastereomers, and culminating in the identification and total synthesis of the structures of natural 
baulamycins A and B. Direct comparison of the spectral data for synthetic baulamycins A and B 
with that reported by Sherman and coworkers convincingly confirmed their revised structures for 
the natural products, and good agreement with the optical rotation of isolated baulamycin A 
allowed the assignment of the absolute stereochemistry of the natural products as well. 
 Between February and July of 2017, little additional information prevailed concerning 
possibilities for the true structure of the baulamycin scaffold. Paladugu et al reported131 their 
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synthesis of the complete carbon framework of proposed structure 3, in which the most advanced 
intermediate differed from 3 only by the presence of various protecting groups and an olefin 
between C-9 and C-10; however, apart from this isolated report, which did little to add to that of 
Guchhait et al, we had scant data to inform our understanding of the structures of the natural 
products we were ostensibly preparing. 
 Clearly, in light of these developments, serious reconsideration our strategy was required. 
Rather than continue in the Sisyphean endeavor of performing the total synthesis of an invalidated 
structure, we resolved to deduce the correct structure of the baulamycins based on all data available 
at the time, if at all possible. In this endeavor we were encouraged and inspired by R. B. 
Woodward’s elegant and landmark work elucidating the structure of oxytetracycline, a highlight 
of inspiration for any natural product chemist132-133. Meanwhile, we continued in our attempts to 
identify tractable conditions for diastereoselective formal hydration on 152, a system we now 
considered a “model of a model”. 
 One aspect of the baulamycins’ structural assignment which had proved puzzling from the 
outset was the apparent violation of Breit’s rule (see Chapter 2) by the right-hand side 
polydeoxypropionate motif. Sherman reports that the diastereotopic methylene protons at C-5 and 
C-7 exhibit chemical shift differences of 0.75 ppm and 0.27 ppm, respectively (Figure 79). While 
the chemical shift difference observed for C-7 would not violate (in the sense of “provide the only 
known exception to”) Breit’s most general formulation of his empirical rule (which observes that 
the relative stereochemistry of 1,3-dimethyl stereodiads exhibiting chemical shift differences over 




Figure 79. Chemical shift differences for diastereotopic methylene protons reported by Sherman 
in baulamycin A.  
 
the 0.27 ppm chemical shift difference at C-7 would violate Breit’s narrower observation that, for 
all known cases, when the moieties adjacent to such a stereodiad are entirely aliphatic and the 
stereodiad is anti, the chemical shift differences observed for the intervening methylene protons 
are always less than 0.10 ppm. 
 The chemical shift difference observed for the diastereotopic protons at C-5 is another 
matter entirely. Besides being fundamentally intriguing in its own right, the fact that one of these 
protons is reported to appear at 0.98 ppm while the other is found at 1.73 ppm in the 1H NMR 
spectrum of baulamycin A renders this segment of the baulamycin scaffold in flagrant violation 
of Breit’s rule. Specifically, Breit records no cases of an anti-configuration in which a chemical 
shift difference greater than 0.40 ppm has been observed. While it is clear that exceptions to 
empirical guidelines such as Breit’s rule can indeed be found, the demonstration of a 0.75 ppm 
chemical shift difference at C-5 of structure 3 would provide such a remarkable deviation from 
Breit’s rule as to render the rule as a whole useless, since there would be essentially no known 
threshold above which a chemical shift difference could empirically be taken to imply an anti-
configuration (the highest chemical shift difference Breit has noted for any case is in fact 0.76 ppm, 
roughly equivalent to that observed at C-5 of the baulamycins). Thus, it seemed clear that either, 
on the one hand, Breit’s rule was completely without basis, or, alternatively, the C-4 and C-6 
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stereocenters should be assigned a relative configuration of syn (Figure 80). In a word, either Breit 
was wrong, or Sherman. 
 
Figure 80. Revised proposal for RHS stereochemistry based on Breit’s rule. 
 In addition to the relative stereochemistry of the C-4 and C-6 stereocenters, Breit’s rule 
provided a strong argument for the relative configuration of the C-6 and C-8 stereocenters as well. 
As noted above, at least according to the more narrow formulation of Breit’s rule specific to alkane 
motifs, one should be able to conclude that the relative configuration of C-6 and C-8 is also syn. 
While less data supports this particular set of empirical guidelines, other observations give us aid 
in making the necessary assignment. 
 Hanessian23 and others134 have noted that Nature rarely deviates from an all-syn 
configuration in preparing polydeoxypropionate natural products. In fact, so axiomatic is this 
preference that only three exceptions to the general rule are known:  ionomycin135, and two closely- 
related cuticular hydrocarbons from the cane beetle, 4,6,8,10,16-pentamethyldocosane and 
4,6,8,10,16,18-hexamethyldocosane136. This well-documented natural bias, combined with the 
evidence provided by Breit’s rule, left us confident that the relative stereochemistry of the 
baulamycins’ right-hand side was indeed all-syn (Figure 81). 
 





On the other side of the baulamycin scaffold, we were particularly intrigued by the large 
discrepancy between the coupling constant reported by Guchhait et al for the C-1’ methine of 3 (J 
= 3.7 Hz) and that reported by Sherman and coworkers for isolated baulamycin A (J = 7.0 Hz). On 
the surface, the significance of such a coupling constant in an acyclic system such as 3 might have 
seemed insignificant; however, we noted that for at least one pair of homologous series resembling 
the baulamycin LHS, a strong pattern was discernible in which the analogous methine showed the 
largest coupling to its neighbor when the configuration of the system was anti/anti (Figure 82)137. 
 
Moreover, the coupling constants observed in these cases, and particularly in the anti/anti cases, 
resembled that reported by Sherman and coworkers for the C-1’ methine (J = 7.0 Hz). We 
rationalized these observations using a mnemonic that envisioned a pseudo-chair-like 
conformation containing an intramolecular hydrogen bond between the C-1’ hydroxyl and its 
neighbor at C-13 (Figure 83). According to this mnemonic, the anti/anti-configuration of the 
baulamycin LHS should experience the strongest bias towards the (imaginary) conformation in 




Figure 83. Mnemonic for one contribution to the baulamycin C-1’-C-14 1H-1H coupling constant 





conformations in which intramolecular hydrogen bonding is present. While the above description 
is clearly an oversimplification of the baulamycins in some ways (for example, by leaving out the 
possible effects of the C-11 hydroxyl), we noted that further perturbation of the proposed structure 
reported by Guchhait et al in which other stereocenters were inverted (including a stereocenter on 
the LHS in 155) without disturbing the syn-relationship between the C-1’ and C-13 stereocenters 
always led to small (< 4Hz) coupling constants. Based on the above observations, we thus 
tentatively assigned the relative configuration of the baulamycin C-1’, C-14, and C-13 
stereocenters as anti/anti (Figure 84) by analogy to structures like 161 and 162. 
 
Figure 84. Proposed relative configuration of the LHS stereocenters with the exception of C-11. 
 
The next logical part of the puzzle appeared to be the relative relationship of the C-13 and 
C-11 stereocenters. In tackling this problem, we imagined that some insights might be gained by 
examining the NMR spectra of compounds 154 and 155, reported by Guchhait et al. These 
compounds, diastereomers of 3, differ from each other in the relative configurations of only two 
pairs of stereocenters: C-13 and C-11 on the LHS, and C-4 and C-6 on the RHS. Significantly, 154 
exhibits a syn-relationship between C-13 and C-11, while 155 exhibits an anti-relationship 
between the two stereocenters. 
Before we could begin to tease out the apparent effects of inverting the relative relationship 
between the C-13 and C-11 stereocenters, it was necessary to convince ourselves that the inversion 
of the stereocenter at C-4 would have little to no effect on the relevant portions of the 1H and 13C 
NMR spectra for 154 and 155 (i.e., the portions of those spectra which corresponded to the LHS 
stereocenters). Fortunately, the problem of deciphering the relationship between the proton and 
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carbon NMR spectra of polyketide natural products and their respective stereochemical 
configurations has been approached many times, and significant developments have been made. 
In particular, Kishi and coworkers have attempted to exhaustively characterize these relationships 
for a number of common polyketide motifs138-139. While perhaps Kishi’s best known work 
correlating structure to spectrum has been his work on contiguous polyols140, Kishi has also made 
a number of other, more general observations about such relationships. In particular, in one such 
guideline (which we will henceforth refer to as Kishi’s postulate), Kishi argues that: 
“…the spectroscopic profiles of the stereoclusters present in [certain] natural products are 
inherent to the specific stereochemical arrangement of the small substituents on the carbon 
backbone... and interactions between stereoclusters connected with a two- or more-
methylene bridge are negligible” (italics added)140. 
 
This observation, borne out by Kishi’s extensive work on a variety of polypropionate-
containing natural products, suggests that the portion of the proton and carbon spectra for 154 and 
155 corresponding to the stereocenters on the LHS should be relatively insensitive to any variation 
in the stereochemistry on the RHS, by virtue of the fact that the two stereoclusters are separated 
by two contiguous methylene units as illustrated in Figure 85.  
 
Figure 85. Structure of baulamycin A showing two contiguous methylenes separating LHS and 
RHS. 
 
Thus, if Kishi’s postulate holds true for the baulamycin scaffold, we would expect that the 
inversion of the C-4 stereocenter in 155 relative to 154 should have little to no impact on the 
portion of the proton and carbon NMR spectra that are derived from the LHS stereocluster. In fact, 
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excellent evidence that Kishi’s postulate does indeed hold true for the baulamycins was provided, 
ironically, by no other than Guchhait et al themselves. After analysis of 3 showed that it was clearly 
distinct from isolated baulamycin A, their next move was to synthesize diastereomer 154, which 
differs from 3 only in the relative configuration of the left- and right-hand sides; all other 
stereochemical relationships are identical. In fact, the proton and carbon spectra of these two 
compounds precisely follow Kishi’s predictions: they are indeed nearly indistinguishable, with the 
13C NMR spectra in particular showing exquisite similarity (Table 15). 
Table 15. Chemical shifts of 1H and 13C NMR signals for compounds 3 and 154 in ppm. 
1H NMR 13C NMR 
Atom Number 3 154 3 154 
1 2.52 2.52 8.1 8.1 
2 1.00 1.04 35.1 35.1 
3 - - 218.4 218.4 
4 2.70 2.69 45.0 44.8 
5 1.20, 1.46 1.20, 1.46 42.4 42.4 
6 1.50 1.49 29.2 29.3 
7 1.09 1.09 46.2 45.8 
8 1.48 1.48 31.4 31.4 
9 1.28 1.40, 1.16 34.4 34.5 
10 1.44 1.49, 1.40 35.9 36.0 
11 3.69 3.69 72.3 72.4 
12 1.63, 1.67 1.65 42.4 42.3 
13 3.96 3.98 75.1 75.1 
14 1.67 1.68 49.3 49.3 
15 1.38, 1.23 1.39, 1.23 33.4 33.4 
16 1.23 1.23 28.3 28.3 
17 0.78 0.77 23.4 23.4 
18 0.64 0.63 22.9 23.0 
19 1.03 1.03 17.0 17.0 
20 0.83 0.83 19.8 19.8 
21 0.84 0.84 19.8 20.0 
1’ 4.82 4.83 76.8 76.8 
2’ - - 148.6 148.6 
3’ 6.32 6.33 105.7 105.7 
4’ - - 159.3 159.3 
5’ 6.12 6.12 102.0 102.0 
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Based on the above data, we were confident that the inversion of the C-4 stereocenter in 
155 relative to 154 would have essentially no effect on our comparison of the LHS components of 
both 1H and 13C NMR spectra of these compounds. Accordingly, we performed a systematic 
comparison of the 1H NMR signals for the relevant portions of 154 and 155 with the corresponding 
signals in the 1H NMR spectrum of isolated baulamycin A (Chart 1). We then performed the same 
comparison for the 13C NMR spectra of these compounds (Chart 2). As can be seen, there is little-
to-no difference in the degree of deviation from isolated baulamycin A for the non-backbone 
signals (i.e., C-15, C-16, C-17 and C-18) in the LHS of either 154 or 155. On the other hand, clear 
differences between 154 and 155 can be seen in the agreement of each compound’s spectra with 
natural baulamycin A for signals produced by C-1’, C-14, C-13, C-12 and C-11, corresponding to 
the LHS backbone. 
 
Chart 1. Magnitude of deviation in chemical shift from isolated baulamycin A for key 1H NMR 









































Magnitude of 1H NMR Deviations from Isolated Baulamcyin A




Chart 2. Magnitude of deviation in chemical shift from isolated baulamycin A for key 13C NMR 
signals in 154 and 155. 
 
 These differences can be summed up in two key observations based on the above data. 
First, agreement of the spectra collected with that of natural baulamycin differ sharply when it 
comes to C-11. In both the proton and carbon spectra of 154, the signals produced by C-11 and its 
corresponding methine proton are in nearly exact agreement with the spectrum of natural 
baulamycin. Conversely, there is a relatively sharp disagreement between the natural signals and 
the signals for C-11 in the 1H and 13C spectra of 155, with the 13C signal deviating by almost 3 ppm 
and the proton signal deviating by nearly 0.10 ppm. Thus, at least when it comes to C-11, it is clear 
that 154, with a syn-relationship between the C-13 and C-11 stereocenters is in closest agreement 
with the natural product itself. Second, by aggregating the data above, we can come up with values 
for the “total discrepancy” in both 1H and 13C spectra for compounds 154 and 155. These values 








































Magnitude of 13C NMR Deviations from Isolated Baulamcyin A
Magnitude of Difference for 154 Magnitude of Difference for 155
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Table 16. Total deviation from natural baulamycin A for 154 and 155 in both 1H and 13C spectra. 
Compound 1H NMR 13C NMR 
154 1.38 ppm 10.9 ppm 
155 1.40 ppm 13.9 ppm 
 
 Clearly, both 154 and 155 are in relatively close agreement with the spectra of natural 
baulamycin A. However, between the two and overall, it is again compound 154 which finds itself 
in closest agreement with the spectra of natural baulamycin A. In particular, we note that there is 
almost an additional 3 ppm of discrepancy in the agreement of the 13C NMR spectrum of 155 with 
that of natural baulamycin as compared to that of compound 154. Ultimately, considering the 
overall superior agreement of 154 with the spectra of natural baulamycin, and taking into particular 
consideration the better agreement of the signals for C-11, the stereocenter in question, we felt 
confident in concluding that there must exist a syn-relationship between the C-13 and C-11 
stereocenters in natural baulamycin A, mirroring that observed in compound 154 (Figure 86). 
 
Figure 86. Proposed relative stereochemistry of the LHS. 
 
 The last task in the establishment of the relative stereochemistry of the baulamycin scaffold 
was to assign the relative stereochemical relationship between the LHS as a whole and the RHS 
as a whole (i.e., between the stereocenter at C-11 and the stereocenter at C-8). In other words, we 
still needed a means to discriminate between structure 163 and structure 164 (Figure 87). 
Figure 87. Two possible configurations of the baulamycin scaffold, based on the available 




Of all the stereochemical relationships in the baulamycin scaffold, the relative relationship 
between C-11 and C-8, separated as they were by two contiguous methylene units, seemed to us 
to be by far the most obscure. We expected that the 1H and 13C NMR spectra of 163 and 164 should 
be near-identical in accordance with Kishi’s postulate, as had been so aptly demonstrated by 
Guchhait et al in the case of 154 and 155. Thus, the problem appeared at first glance intractable. 
 Nonetheless, wanting to stake our claim one way or another, we considered that perhaps a 
clue might be found in the original work performed by Sherman and coworkers in their initial 
assignment of the relative stereochemistry of the baulamycins. Specifically, Sherman’s group had 
employed what has become known as J-Based Configuration Analysis (JBCA), a method of 
assigning relative stereochemistry in acyclic systems based on the use of both 3JH,H and 2,3JC,H 
coupling constants to establish the relative relationships of sequential non-quaternary 
stereocenters141. JBCA, as used by Sherman and coworkers, relies on the assumption that the most-
populated conformations in acyclic systems like the baulamycins are all staggered, with little 
(i.e., < 10°) deviation from ideality. While this assumption appears to generally hold true for 
acyclic systems in which branching is confined to relatively small substituents, larger substituents 
may render this supposition invalid. Significantly, in their seminal paper establishing the principles 
of JBCA, Matsumori et al note that substituents bulkier than methyl and hydroxyl may perturb the 
conformation distribution of polyketide-like scaffolds such that the application of JBCA becomes 
impossible141. 
Among other possible issues, it appears likely that one of the pitfalls in Sherman’s application 
of JBCA to the baulamycin scaffold was interference from the isobutyl/phenyl substitutions on the 
LHS, and conformational perturbation engendered by the carbonyl adjacent to the methyl-bearing 
stereocenter at C-4. On the other hand, the core of the baulamycin scaffold, consisting of the 
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methyl-bearing stereocenter at C-11, the methyl-bearing stereocenter at C-8, and the two 
methylene units between them, provides a perfect example of the type of system JBCA is 
apparently well-suited to analyze. Barring errors in the data which form the basis of the analysis, 
there appeared to be absolutely no reason why the particular analysis employed by Sherman and 
coworkers should have failed for this particular portion of the baulamycin scaffold. Thus, it seemed 
reasonable to us to assume that, if any of the relative stereochemical relationships assigned by 
Sherman and coworkers were in fact correct, it might well be the relationship between C-11 and 
C-8. Thus, in the absence of data to the contrary, we tentatively proposed that the correct structure 
of baulamycin A was in fact 163, exhibiting a syn-relationship between the “innermost” 
stereocenters on the left- and right-hand sides. 
 Before we were able to find further ways to investigate our proposed stereochemical 
assignment for the baulamycin scaffold, we were gratified to learn of its validation by Aggarwal’s 
seminal report of the total synthesis of baulamycin A, in which the natural product was shown to 
exhibit the structure shown in 1, the optical antipode of structure 163. Thus, our tentative 
hypothesis concerning the syn-relationship between the stereocenters at C-11 and C-8 was in fact 
borne out, and the necessity for further investigations into the stereochemical configuration of the 
baulamycins was simultaneously eliminated. Accordingly, we turned our attention to the 








4.1 Overview of Synthetic Strategy 
With the stereochemical configuration of the baulamycin scaffold confirmed and the 
absolute stereochemistry assigned by Aggarwal’s total synthesis, our next task was to revise our 
plan of attack in order to target the corrected structures. The intentional flexibility of our initial 
approach now paid rich dividends, and we rapidly devised a new approach based on our previous 
work toward the both sides of the proposed structure (Figure 88 and Figure 89). 
 
Figure 88. Proposed approach to the revised RHS starting with known compound 56. PG = 





Figure 89. Retrosynthetic analysis of the revised LHS. 
 
4.2 Synthesis of the Right-Hand Side 
 Since the absolute configuration of the first stereocenter in our synthesis of the proposed 
RHS matched that of the corresponding stereocenter in the newly-revised structure, we were able 
to begin our synthesis of the revised RHS with known α,β-unsaturated-γ-methyl thioester 56 
(Figure 90).  
 
Figure 90. Installation of second stereocenter in the revised RHS synthesis and subsequent steps. 
 
 Pleasingly, installation of the critical second methyl-bearing stereocenter by asymmetric 
conjugate addition proceeded in good yield and excellent diastereoselectivity to afford β,γ-
dimethyl thioesters 165. Indeed, we found that the diastereoselectivity of this conjugate addition 
was actually improved relative to the analogous construction of anti-dimethylthioester 57 in the 
synthesis of the proposed RHS, perhaps indicating a slight substrate bias towards the syn-
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configuration. Feringa has reported slightly higher diastereoselectivity for syn-products; however, 
the effect was very slight, with a 24:1 d.r. for syn-addition and a 19:1 d.r. for anti-addition in the 
example given32. Since we had previously synthesized the corresponding anti-diastereomer (57), 
the relative stereochemistry of 165 could be unequivocally confirmed by the application of Breit’s 
rule (Figure 91), establishing conclusively that 165 did indeed exhibit a syn-configuration. 
 
    
Figure 91. Proof of stereochemistry for 165 showing (A) the chemical shift difference for the 
diastereotopic protons on the corresponding anti-diastereomer, which is smaller (B) the chemical 
shift difference for the analogous protons on 165, demonstrating a syn-configuration for 165. 
 
 Reduction of 165 with DIBAL-H afforded the corresponding aldehyde in near-quantitative 
yields, and subsequent Wittig olefination also proceeded in good yield to give terminal olefin 170 
in 89% yield over two steps. Hydroboration-oxidation using our optimized condition with our 
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optimized conditions using disiamylborane was quantitative, and subsequent protection proceeded 
as expected to afford carbonate 171 in 80% yield. 
 Having now arrived at the crucial task of oxidizing 171 to the acid, we considered ways in 
which we could optimize the as-yet moderate yields of this important oxidation. One 
transformation which had come to our attention since we had last required the conversion of R-Ph 
to R-COOH was a procedure which has been referred to as “dry ozonolysis”. 
 Dry ozonolysis, or the co-adsorption of a substrate and O3 to silica gel at cryogenic 
temperatures followed by warming, has been known for at least forty years; the propensity of 
ozone to adsorb to silica at low temperatures has been known for at least forty years before that142.  
Dry ozonolysis exhibits considerably enhanced oxidative power relative to “traditional” 
ozonolysis procedures, and has been shown to induce the oxidation of a wide variety of recalcitrant 
and non-traditional substrates, including unactivated tertiary hydrocarbons and aromatics. The 
transformation has been the subject of at least one Org. Syn. preparation143, has been partially 
reviewed144, and contains an entry in the Encyclopedia of Reagents for Organic Synthesis as the 
reagent “Ozone-Silica Gel” 145. Despite this extensive documentation, little recent application of 
dry ozonolysis has been noted, with essentially no reports of preparative use during the last twenty 
years142.  
 Far from being deterred by this neglect of an apparently-useful transformation, we viewed 
this as an opportunity to bring a safe, convenient, and highly economic transformation into the 
twenty-first century. We were of the opinion that O3-SiO2 had the potential to be uniquely suited 
to the task of oxidizing 171 to acid 172, as the use of dry ozonolysis to transform arenes to acids 
was already well-known146. In the event, we were delighted to find that this was indeed the case, 
with oxidation under dry ozonolysis conditions proceeding in near-quantitative yields on scales up 
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to 7 grams (Figure 92). Moreover, the simplicity of the procedure was itself a valuable asset, as 
workup consisted of simply eluting the product from silica with ethyl acetate. 
 
 
Figure 92. Successful application of dry ozonolysis in the oxidation of 171. 
 
 Having thus handily solved what we viewed as the major supply problem in our proposed 
route to RHS aldehyde 169, we turned our attention to the coupling of 172 with commercially-
available (S)-4-benzyloxazolidinone 173 (Figure 93). Lithiation of 173 under mild conditions 
followed by treatment with the mixed anhydride of 172 and pivalate smoothly gave 
N-acyloxazolidinone 174 as expected, and diastereoselective methylation of the sodium enolate of 
174 gave alkylated N-acyloxazolidinone 175 in good yield as a single detectable diastereomer. 
 




 Once again, Breit’s rule allowed confirmation of the stereochemistry of the newly-formed 
stereogenic center at C-4: we observed a remarkable 0.84 ppm difference in chemical shift between 
the two diastereotopic protons at C-5, thus confirming that the C-4 methyl group had indeed been 
installed in a syn-relationship with C-6 (Figure 94).  
 
Figure 94. HSQC spectrum of 175 showing a 0.85 ppm difference in chemical shift between the 
protons on the C-5 methylene, confirming the syn-relationship of the C-4 and C-6 stereocenters. 
 
 Removal of the oxazolidinone auxiliary with lithium hydroperoxide gave acid 176 in near-
quantitative yield, and subsequent treatment with N,O-dimethylhydroxylamine hydrochloride and 
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) smoothly gave 
Weinreb amide 177. Finally, deprotection was achieved by hydrolysis of the methyl carbonate 
ester under basic conditions in good yield. It is interesting to note that the methyl carbonate could 
also be removed by treatment with resin-bound lipase from Candida antarctica (sold as 
“Novozyme 435” by Sigma-Aldrich) and five equivalents of water in tert-butyl methyl ether at 
35 °C. Subjection of 177 to the latter conditions for eleven hours followed by evaporation of 





4.3 Synthesis of the Left-Hand Side 
While work on the right-hand side was underway, progress on the left-hand side of the 
revised structure was proceeding apace. In our retrosynthetic analysis, we envisioned that MOM-
protected 3,5-dihydroxybenzaldehyde 102 would undergo an enantio- and diastereoselective aldol 
reaction with some analogue of 4-methylvaleric acid to give the key anti-aldol motif of the revised 
RHS. One possibility that seemed particularly appealing was MacMillan’s report of a direct, 
enantioselective aldol reaction between non-equivalent (i.e., non-identical) aldehydes147, which, 
in addition to being fundamentally appealing for its simplicity and step- and atom-economy, has 
seen use in total synthesis148. The fact that one of our aldehydes (102) would be non-enolizable 
also seemed promising. Accordingly, volatile 4-methylpentanal was prepared in one step and 
modest (unoptimized) yield from 4-methylpentanol (Figure 95), and subjected to MacMillan’s 
conditions with 102. Unfortunately, despite prolonged reaction times and increases in temperature, 
starting material was the major component of this reaction even after one week. Given our 
uncertainty about the level of anti-selectivity in this reaction (MacMillan reports excellent 
enantioselectivity but a 3:1 d.r. for similar substrates), minor constituents were not separated and 
development of this reaction was abandoned. 
 




 With MacMillan’s chemistry out of the question, we next turned ourselves to more 
traditional approaches to the LHS aldol motif. Evans’ magnesium-halide catalyzed anti-selective 
aldol reactions of N-acylthiazolidinethiones with aryl aldehydes149 were an attractive choice for 
several reasons: the diastereoselectivities were reportedly >19:1 for similar substrates, and the 
thiazolidinethione auxiliaries could be easily removed to yield the aldehyde in a single step under 
known conditions150. 
 Accordingly, known149 N-acylthiazolidinethione 182 was synthesized as described151 from 
4-methylvaleric acid and (R)-4-benzylthiazolidine-2-thione (in turn prepared by reduction of D-
phenylalanine152 followed by condensation with carbon disulfide153). Reaction of 182 with 102 
under Evans’ conditions (Figure 96) proceeded smoothly, giving the TMS-aldol in excellent yield 
as a single diastereomer.  
 
Figure 96. Synthesis of LHS aldehyde 186 using Evans’ anti-selective aldol. 
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Desilylation with TFA in DCM spared the methoxymethyl ethers; subsequent re-protection 
as the TBS-ether gave 184 in near-quantitative yield over two steps. Half-reduction of 184 with 
two equivalents of DIBAL-H smoothly gave known21 aldehyde 185, thus confirming the anti-
relationship between C-1’ and C-14. Finally, treatment of 185 with the lithium anion of methyl 
dimethylphosphonate followed by oxidation of the resulting inconsequential mixture of β-
hydroxyphosphonate diastereomers easily gave β-ketophosphonate 186 in respectable yield over 
two steps.  
4.4 Coupling and Formal Hydration of Coupled Scaffold 
Having established a path to important RHS precursor 178 and an efficient route to LHS 
β-ketophosphonate 186, we now turned our attention to the oxidation of 178 to aldehyde 169. 
Unsurprisingly, identifying appropriate conditions for the isolation of pure 169 proved 
challenging. Like model RHS aldehyde 137 before it, 169 proved highly susceptible to 
autooxidation in solution and upon storage, and a number of conditions were screened (Figure 97). 
Eventually, it was found that oxidation by the Dess-Martin periodinane, which was rapid, followed 
by filtration through a plug of silica eluting with 1:1 hexanes ethyl acetate provided 169 in good 
yield and in sufficient purity for immediate use in the next step (immediate use was crucial to 
achieving good yields in the subsequent step).   
 










Table 17. Conditions for the oxidation and purification of 177. N.D. = not determined.  
Oxidation Conditions Purification Yield of 169 
(COCl)2, 3 eq; DMSO, 6 eq; Et3N, 9 eq (none) 9%* 
Dess-Martin periodinane, 1.5 eq partitioning btw. ether and water N.D. (impure) 
Dess-Martin periodinane, 1.5 eq 




Dess-Martin periodinane, 1.5 eq silica plug; immediate use 83 - 90% 
* yield of enone after subsequent coupling with 186 under Paterson’s conditions. 
 
 Horner-Wadsworth-Emmons olefination of freshly-prepared 169 with β-ketophosphonate 
186 proceeded in good yield and excellent E-selectivity to give fully-elaborated enone 187 
(Figure 98). The cis-isomer was never detected, even upon close examination of the crude 
1H NMR spectrum. Crucially, the reaction proceeded to completion even with equimolar amounts 
of 169 and 186, ensuring maximally-efficient use of these advanced and precious intermediates. 
Masamune’s conditions154 were also explored; however, in our hands the corresponding reaction 
was extremely sluggish, resulting in the consumption of 169 through autooxidation before the 
reaction could reach completion.  
 
Figure 98. Successful Horner-Wadsworth-Emmons olefination of 169 with 186 under Paterson’s 
conditions. 
 
Pleasingly, Paterson’s conditions performed well even on a gram scale, and we were thus 
able to isolate over 1 gram of 187 in pure form. With ample quantities of 187 in hand, we turned 
our attention to the critical task of developing condition for the diastereoselective formal hydration 
of 187 (Figure 99).   
 
Figure 99. Proposed diastereoselective formal hydration of 187 to give 188. 
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Having experienced little success with the direct addition of oxygen nucleophiles to 
unsaturated model systems (see Chapter 2), we considered the use of a two-step approach, in which 
conjugate addition of a nucleophile to the enone would give an intermediate which could then be 
oxidized to provide the desired β-hydroxyketone (Figure 100). Historically, this strategy has been 
generally accomplished by the use of boron and silicon nucleophiles, both of which give rise to 
products susceptible to oxidation; however, in light of our choice of a silicon-based protecting 
group for the C-1’ hydroxyl, we chose to eschew silicon nucleophiles for fear of an inability to 
selectively oxidize a β-silyl ketone to a β-hydroxyketone in the presence of a silyl ether. Thus, the 
addition of boron nucleophiles to enones appeared to be the best alternative to direct addition of 
oxygen-centered nucleophiles, and we began to investigate various conditions for β-borylation on 
model systems. While we primarily employed enone 152 in this capacity, we also investigated 
certain transformations on cheap, commercially-available trans-chalcone, which figured centrally 
in a variety of methodology reports concerning the formal addition of water to α,β-unsaturated 
systems. 
 
Figure 100. Employing a water surrogate in the form of an oxidizable nucleophile. 
 Beginning with our studies on chalcone, we first investigated conditions developed by 
Santos and coworkers (Figure 101)155. These conditions, run “on water”, appeared to effect β-
borylation with bis(pinacolato)diboron by copper(II) catalysis. The presence of an amine base 
was required, with 4-picoline having been shown to be optimal in Santos’ work. By employing 
THF as a cosolvent and slightly increasing the amounts of 4-picoline employed relative to those 
reported, we were able to achieve good yields of β-borylated product; however, we still needed 




Figure 101. Attempted β-borylation of chalcone. 
 
Table 19a. Conditions attempted for the β-borylation of chalcone. 
Conditions Yield of 190 
CuCl2, 1 mol %; 4-picoline, 2 mol %; B2(pin)2, 1.1 eq, THF/H2O, 22 h 40% 
CuSO4, 1 mol %; 4-picoline, 5 mol %; B2(pin)2, 1.1 eq, THF/H2O, 1 h 62% 
CuSO4, 1 mol %; 4-picoline, 5 mol %; B2(pin)2, 1.1 eq, THF/H2O, 3.5 h 79% 
 
 Since Santos and coworkers had not reported any attempts to exploit chiral ligands of any 
kind in their reaction, we hoped that the simple addition of a chiral base to the reaction might lead 
to at least some level of stereoinduction. Accordingly, we attempted the use of several chiral 
additives (Table 19b); however, these conditions, perhaps predictably, gave only racemic 190. 
Table 19a. Conditions attempted for the β-borylation of chalcone. ee = enantiomeric excess. 
Conditions Yield ee 
CuCl2, 1 mol %; strychnine, 2 mol %; B2(pin)2, 1.1 eq, THF/H2O, 22 h 31% 0% 
CuSO4, 1 mol %; strychnine, 5 mol %; B2(pin)2, 1.1 eq, THF/H2O, 22 h 38% 0% 
CuSO4, 1 mol %; 9-deoxy-9-amino-epiquinine, 5 mol %; B2(pin)2, 1.1 eq, 17 h 38% 0% 
CuSO4, 10 mol %; 9-deoxy-9-amino-epiquinine, 12 mol %; B2(pin)2, 1.2 eq, 12 h 67% 0% 
CuSO4, 1 mol %; L-proline, 5 mol %; B2(pin)2, 1.1 eq, 12 h 0% - 
 
Turning our attention to previously-reported strategies for chiral induction, we attempted 
Kobayashi’s Cu(OH)2-catalyzed borylation conditions156 employing chiral bipyridyl diol 191, 
reported to give good yields and excellent enantioselectivities on chalcone and other acyclic 
enones (Figure 102). Unfortunately, in our hands, these conditions failed to produce product with 




Figure 101. Attempted application of Kobayashi’s enantioselective β-borylation of enones. 
Table 20. Attempted borylation of chalcone using Kobayashi’s catalyst. N.R. = no reaction. 
Conditions Yield ee 
Cu(OH)2, 5 mol %, AcOH, 6 mol %, 191, 6 mol %, B2(pin)2, 1.2 eq 66% 0% 
Cu(OAc)2, 5 mol %, 191, 6 mol %, B2(pin)2, 1.2 eq 50% 0% 
Cu(OH)2, 25 mol %, AcOH, 30 mol %, 191, 30 mol %, B2(pin)2, 1.2 eq N.R. - 
 
Without having had success in the enantioselective borylation of chalcone, we considered 
that perhaps we would have more success achieving stereoselectivity via substrate control. Not yet 
having access to revised enone 187, we began our studies with model enone 152 (Figure 102). 
 
Figure 102. Attempted diastereoselective β-borylation of model enone 152. 
 
Table 21. Conditions employed for the diastereoselective β-borylation of 152. N.R. = no reaction. 
Conditions Yield dr 
CuSO4, 1 mol %, 4-picoline, 5 mol %, B2(pin)2, 1.2 eq, THF/H2O N.R. - 
CuSO4, 10 mol %, 4-picoline, 50 mol %, B2(pin)2, 2.4 eq, THF/H2O 82% 1.85 : 1 
CuCl, 10 mol %, KOAc, 10 mol %, B2(pin)2, 1.1 eq, DMF 84% 2.45 : 1 
Cu(OAc)2, 5 mol %, 191, 6 mol %, B2(pin)2, 1.2 eq, THF/H2O 87% 2.50 : 1 
 
 We first investigated Santos’ conditions, which had afforded good yields on chalcone; 
however, exposure of 152 to 1 mol % copper(II) sulfate, 5 mol % 4-picoline and 1.2 eq 
bis(pinacolato)diboron gave only starting material after 27 hours at room temperature. Undeterred, 
we increased the concentrations of both copper(II) and base; this gave good yields and a d.r. of 
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approximately 2:1. A movement in the correct direction, this level of diastereoselectivity was 
nonetheless too low for preparative use on the baulamycin scaffold. Accordingly, we continued 
our search for conditions which might provide additional selectivity. In their seminal report 
describing the first example of copper-catalyzed beta borylation of enones, Miyaura and coworkers 
accomplish the reaction with a system containing CuI and inorganic base157. When applied to 152, 
these conditions gave β-borylketone 192 in 84% yield with a diastereoselectivity of 2.45 to 1. 
Hoping to improve the diastereoselectivity still further, we applied Kobayashi’s conditions to 152; 
however, despite the use of chiral ligand 191, they offered little advantage over Miyaura’s 
protocol, giving 192 in 87% yield with a diastereoselectivity of 2.5 to 1. Meanwhile, we had 
perfected the oxidation of our β-borylated substrates, allowing easy access to the β-hydroxy 
ketones (Figure 103). 
 
Figure 103. Simple oxidation of β-borylketone 192 to aldol 193 with sodium perborate. 
 Around this time we completed our synthesis of revised-structure enone 187. With several 
sets of conditions providing appreciable, albeit low, diastereoselectivity on model substrate 152, 
we now turned our attention to the diastereoselective borylation of our true target (Figure 104). 
 




Table 22a. Conditions attempted for the β-borylation of 187. N.R. = no reaction. 
Conditions Yield dr 
CuCl, 0.55 eq, 1.12 eq AcOK, 1.1 eq B2(pin)2, DMF N.R. - 
CuSO4, 10 mol %, 4-picoline, 1.0 eq, B2(pin)2, 1.2 eq, THF/H2O 84% 1 : 1 
CuSO4, 10 mol %, NaOAc, 15 eq, B2(pin)2, 1.2 eq, THF/H2O 47% 2 : 1 
CuSO4, 10 mol %, NaOAc,15 eq, B2(pin)2, 1.2 eq, L-proline, 10 eq, THF/H2O N.R. - 
CuSO4, 10 mol %, L-proline, 10 mol %, B2(pin)2, 1.2 eq, THF/H2O N.R. - 
 
In our first attempt at the borylation of 187 we chose to investigate Miyaura’s conditions, 
since they had provided an equivalently-high d.r. to the more-complex Kobayashi conditions with 
less expensive reagents. Unfortunately, subjection of 187 to Miyaura’s conditions gave only 
starting material, even with high catalyst loadings. Undeterred, we next investigated Santos’ 
conditions. While an optimized version of the conditions employing stoichiometric 4-picoline as 
the base did indeed provide a good yield of 194, the reaction proceeded without any 
diastereoselectivity. Conversely, use of superstoichiometric sodium acetate gave a 2:1 
diastereomeric ratio, but the reaction failed to go to completion, giving 194 in a mere 47% yield. 
Attempts to introduce chiral bases once again met with failure, as addition of L-proline completely 
abolished reactivity in this system, presumably by trapping the available copper in an inactive 
form. 
 With Santos’ conditions out of the question, we attempted Kobayashi’s conditions (Table 
22b); however, no reaction was observed under these conditions except when stoichiometric cupric 
acetate and ligand were employed. In this case, the starting material was indeed consumed, but the 
unidentified product of the reaction was not 194.  
Table 22b. Attempted use of Kobayashi’s conditions for β-borylation of 187. N.R. = no reaction. 
Conditions Yield dr 
CuSO4, 10 mol %; 191, 12 mol %; B2(pin)2, 1.2 eq; THF/H2O N.R. - 
CuSO4, 9.0 mol %; 191, 35 mol %; B2(pin)2, 2.4 eq; THF/H2O N.R. - 





We next attempted a set of conditions first reported by Yun and coworkers (Table 22c)158. 
We elected to carry out our initial test reactions under stoichiometric conditions; gratifyingly, 
when 187 was treated with bis(pinacolato)diboron in the presence of stoichiometric CuCl, (R,S)-
Josiphos and NaOt-Bu, 11-epi-194 was obtained in 90% yield and > 15:1 d.r. Unfortunately, the 
analogous application of (S,R)-Josiphos under identical conditions failed to replicate this excellent 
diastereoselectivity, giving desired β-borylated ketone 194 with a diastereomeric ratio of only 3:1. 
Reductions in catalyst, ligand and base loadings were successfully implemented, ultimately giving 
194 in good yield under catalytic conditions, but the diastereomeric ratio remained low despite 
repeated attempts. Apparently, 187 exhibits an inherent bias towards conjugate addition with the 
undesired facial selectivity; comparisons of the results of β-borylation under Yun’s conditions with 
those performed earlier using achiral catalysts and reagents revealed that the major diastereomer 
produced under those non-asymmetric conditions was also 11-epi-194, rather than desired isomer 
194. Oxidation of both 194 and 11-epi-194 with sodium perborate proceeded as expected to give 
188 and 11-epi-188, respectively, in good yield. 
Table 22c. Yun’s conditions for β-borylation of 187. N.D. = not determined. 
Conditions Yield dr 
CuCl, 1 eq; (R,S)-Josiphos, 1 eq; NaOt-Bu, 1 eq; B2(pin)2, 1.1 eq, THF 90% * 15 : 1 
CuCl, 1 eq; (S,R)-Josiphos, 1 eq; NaOt-Bu, 1 eq; B2(pin)2, 1.1 eq, THF 36% 3 : 1 
CuCl, 10 mol %; (S,R)-Josiphos, 30 mol %; NaOt-Bu, 15 mol %; B2(pin)2, 
1.1 eq, THF 
78% 3 : 1 
* yield of 11-epi-194. 
 With consistently poor diastereoselectivity in the formation of 194, but consistently 
excellent diastereoselectivity under Yun’s conditions for the formation of the C-11 epimer of 194, 
we imagined that it might be possible to produce 11-epi-188 in good yield via 11-epi-194, then 
invert the C-11 stereocenter under Mitsunobu-type conditions with a suitable oxygen nucleophile. 
Hydrolysis at the C-11 oxygen would then afford β-hydroxyketone 188. Accordingly, 11-epi-194 
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was prepared from 187 using Yun’s conditions and oxidized to provide 11-epi-188 (Figure 105). 
We then screened a series of Mitsunobu reaction conditions to attempt to identify conditions that 
could provide inversion of the C-11 stereocenter. 
 
Figure 105. Preparation of 11-epi-194 from 187 and subsequent screen of Mitsunobu inversions. 
 
Table 23. Attempted Mitsunobu-type inversion of 11-epi-194. Decomp. = decomposition. 
Reagents R Solvent Results 
2-picolinic acid, 4 eq; Ph3P, 4 eq; DIAD, 4 eq 2-pyr THF decomp. 
2-picolinic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq 2-pyr THF decomp. 
2-picolinic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq 2-pyr CHCl3 no reaction 
2-picolinic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq 2-pyr Et2O no reaction 
2-picolinic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq 2-pyr DCM no reaction 
2-picolinic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq 2-pyr benzene no reaction 
2-picolinic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq 2-pyr toluene no reaction 
acetic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq Me benzene no reaction 
acetic acid, 8 eq; Ph3P, 4 eq; DIAD, 4 eq Me THF no reaction 
acetic acid, 8 eq; Ph3P, 8 eq; DIAD, 8 eq Me THF no reaction 
acetic acid, 8 eq; Me3P, 4 eq; TMAD, 4 eq Me THF no reaction 
chloroacetic acid, 3 eq; Ph3P, 3 eq; DIAD, 3 eq -CH2Cl THF no reaction 
 
 Our initial endeavors were performed with 2-picolinic acid as the nucleophile. It was 
believed that many esters would prove challenging to remove by basic hydrolysis due to competing 
elimination. Conveniently, 2-picolinate esters are known to be cleaved under exceptionally mild 
conditions by treatment with 1 – 5 equivalents of cupric acetate in methanol, a fact which has been 
exploited in the context of Mitsunobu inversion of base-sensitive alcohols159. Unfortunately, in our 
system, 2-picolinate proved to be an inadequate nucleophile, showing no conversion to the ester 
under a variety of conditions. We next explored the use of acetic acid as the Mitsunobu 
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nucleophile, hoping to perhaps remove the acetate ester by enzymatic hydrolysis under neutral 
conditions; however, again, we observed a complete lack of conversion under a number of 
conditions. Puzzlingly, chloroacetic acid also failed in our hands, leading us to abandon our 
attempts at the Mitsunobu reaction on this substrate. 
 Undeterred, we considered that perhaps strategies other than conjugate addition might be 
exploited to eventually provide desired aldol 188. We believed that a diastereoselective 
epoxidation of 187 could provide an intermediate amenable to conversion into 188 by reduction 
with samarium diiodide (Figure 106)160. 
 
Figure 106. Proposed epoxidation of 187. 
 
Table 24. Conditions attempted for the epoxidation of 187. N.R. = no reaction. N.D. = not 
determined. 
Conditions Yield d.r. 
(R,R)-N-methylpseudoephedrine, 2.4 eq; diethyl zinc, 1.1 eq; O2, 85 h N.R. - 
(S)-BINOL, 0.25 eq; Ph3AsO, 0.25 eq; 
La(iOPr)3, 0.25 eq; TBHP, 1.2 eq, 4 Å MS 
N.R. - 
tert-butyl hydroperoxide, 20 eq; n-butyllithium, 15 eq, THF N.D. 1 : 1 
 
 We began our investigations with Enders’ conditions, in which asymmetric epoxidation is 
effected by an alkyl zinc peroxide generated in situ from diethyl zinc and molecular oxygen in 
close association with chiral amino alcohol N-methylpseudoephedrine161-162. Disappointingly, 
when applied to 187, these conditions gave only recovered starting material, even after prolonged 
reaction times. Undeterred, we next considered Shibasaki’s asymmetric epoxidation conditions 
employing a chiral lanthanum-BINOL-triphenylarsine oxide complex which, in the presence of 
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tert-butyl hydroperoxide, yields an active oxidant capable of the asymmetric epoxidation of 
enones163-164. Unfortunately, when these conditions were applied to 187, no reaction took place. 
Fearing that our implementation of Shibasaki’s conditions was somehow flawed, we subjected 
chalcone to the same conditions, which smoothly gave the desired α,β-epoxyketone. We thus 
concluded that, for whatever reason, 187 appeared inert to these conditions despite their 
demonstrated activity on other substrates. Finally, having had no luck with the asymmetric 
methods described above, we reasoned that perhaps the sluggish reactivity of 187 under these 
epoxidation conditions might translate to some substrate-controlled diastereoselectivity under 
more aggressive oxidation conditions. Accordingly, we treated 187 with a large excess of lithium 
tert-butyl peroxide. To our delight, we did indeed observe formation of α,β-epoxyketone under 
these conditions; however, subsequent successful reduction of the epoxyketone to the aldol 
revealed that 188 had been formed as a 1:1 mixture of diastereomers. We thus chose to abandon 
the idea of pursuing an asymmetric epoxidation of 187 as a route to diastereomerically-pure 188. 
 At the same time, we were encouraged by the apparent susceptibility of 187 to oxidation 
under select conditions. Re-tooling our approach, we noted that acetonides of α,β-
dihydroxyketones have been reported to be reduced efficiently to the corresponding β-
hydroketones with samarium diiodide165. Additionally, we observed that the Sharpless asymmetric 
dihydroxylation166 has been employed successfully on enones, including in the context of total 
synthesis167. Thus, we envisioned an asymmetric dihydroxylation of 187 leading to α,β-
dihydroxyketone 196, which, after protection in the form of the acetonide, could be reduced with 






Figure 107. Proposed conversion of 187 to 188 by asymmetric dihydroxylation, protection and 
reduction. 
 
 Accordingly, we attempted the Sharpless asymmetric hydroxylation protocol on 187, with 
the modification that 1 mol % potassium osmate and 5 mol % (DHQ)2PHAL ligand were employed 
rather than the traditional 0.2 mol % osmate and 1 mol % ligand as a means of compensating for 
the rather electron-poor nature of the enone substrate. Three equivalents each of potassium 
ferricyanide and potassium carbonate were employed as usual, along with one equivalent of 
methanesulfonamide as described by Sharpless166. As expected, the reaction was in fact sluggish, 
failing to reach completion even after 60 hours; however, we were pleased to see that, despite the 
low conversion, dihydroxylation was in fact observed. Integration of the C-1’ protons in the crude 
1H NMR spectrum appeared to show a d.r. of 1.8:1. Unfortunately, when an aliquot of purified 
α,β-hydroxyketone was quantitatively protected as its acetonide and reduced with SmI2, an 
unknown product, not 188, was obtained, which appeared to be a corresponding mixture of 
diastereomers. Further increases in catalyst loading up to stoichiometric quantities failed to rectify 
the low yield and diastereoselectivity, and the unknown product of SmI2 reduction was never 
conclusively identified, leading us to abandon further development of the reaction. 
Finally, without many plausible alternatives, and considering that tert-butyl peroxide had 
proven an effective oxidant of 187 under select conditions, we considered an adaption of List’s 
asymmetric hydroperoxidation conditions which had earlier proven unsuccessful in standard form 
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against model substrate 152. Accordingly, we treated 187 with 20 mol % of 9-deoxy-9-amino-epi-
quinine and 1.5 eq tert-butyl hydroperoxide in the presence of 60 mol % trifluoroacetic acid; 
however, after 3 days, 187 was uncovered unchanged with no evidence of epoxidation or 
hydroperoxidation at C-11. 
 Ultimately, despite our extensive efforts to identify alternative strategies for the 
introduction of the C-11 hydroxyl in a stereoselective fashion, and notwithstanding our 
considerable efforts to identify ways of converting 11-epi-188 to 188, it now appeared that the 
CuI-catalyzed β-borylation of 187 in the presence of (S,R)-Josiphos was the most effective route 
to diastereomerically-pure 188 available to us, despite its modest-at-best 3:1 diastereoselectivity. 
Fortunately, the C-11 epimers of 188 are separable by flash chromatography, although the 
procedure itself is tedious, as multiple iterations of chromatography are required. 
Determined to proceed at all costs, we scaled up the β-borylation of 187, achieving a 23% 
yield of 188 over two steps after chromatographic purification, which nonetheless provided us with 
sufficient material to proceed. With pure 188 in hand, we turned our attention to what appeared to 
be the final synthetic challenge in the synthesis of the baulamycins, the diastereoselective syn-




4.5 Synthesis of Baulamycin A 
 
Figure 108. Diastereoselective syn-reduction of β-hydroxyketone 188. 
Table 25 Conditions for the syn-selective reduction of β-hydroxyketone 188. N.R. = no reaction. 
N.D. = not determined. 
Conditions Yield d.r. 
Et2BOMe, 1.1 eq; NaBH4, 1.1 eq; THF/MeOH, -78 °C, 4 h N.R. - 
Et2BOMe, 1.1 eq; LiBH4, 1.1 eq; THF/MeOH, -78 °C, 2 h decomp. - 
NaBH4, 2.5 eq; MeOH, 4 h, 0 °C 70% 2:1 
Zn(BH4)2, 3.0 eq; toluene, -25 °C to 4 °C, 21 h N.D. 1:1 
BH3•DMS, 2.2 eq; THF, r.t. 16 h 32% 3:1 
BH3•DMS, 4.0 eq; TiCl4, 1.20 eq; DCM, -78 °C, 20 h decomp. - 
BH3•DMS, 2.2 eq; THF, -20 °C, 14 h 96% 4:1 
BH3•DMS, 2.2 eq; THF, -78 °C, 20 h N.R. - 
 
 We began our investigations with the well-known Narasaka-Prasad reduction168-169, which 
frequently proceeds with exceptional syn-selectivity and was viewed as all-the-more attractive for 
its not-inconsiderable use in total synthesis170-171. Unfortunately, when applied to 188, standard 
Prasad conditions with sodium borohydride as the reductant gave only recovered starting material. 
Conversely, modified conditions employing lithium borohydride reported172 to be more active 
gave complex mixtures of products involving partial or complete deprotection of the 
methoxymethyl ethers with or without concomitant reduction.  
It is interesting to note that, in their synthesis of the proposed structure of baulamycin A, 
Guchhait et al also attempted a Narasaka-Prasad-type reduction of a β-hydroxyketone at C-13, and 
under standard conditions they too saw no reactivity. With this in mind, we considered the 
possibility that the generally-congested steric environment around C-13 might be hindering 
reactivity under mild conditions. If so, we reasoned that diastereoselective reduction under 
substrate-controlled conditions might thus be possible. Accordingly, we attempted the reduction 
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of 188 with sodium borohydride alone at 0 °C. Pleasingly, this did indeed lead to excellent yields 
of the 1,3-syn-diol; however, the diastereoselectivity was undesirably low (d.r. = 2:1). 
We next investigated the use of zinc borohydride, which has been reported173 to give 
excellent selectivity for syn-reduction under certain conditions, not the least of which being those 
employed for analogous reduction by Wuest and coworkers of none other than the baulamycin 
scaffold itself22. However, as has been noted174, achievement of excellent diastereoselectivity 
appears to be dependent on the presence of γ,δ-conjugation, and in our hands, freshly-prepared175 
zinc borohydride proved nonselective. 
Finally, it came to our attention that a highly-selective-selective syn-reduction of aldols 
with BH3-pyridine or BH3-DMS in the presence of TiCl4 has been reported176. While the use of 
these precise conditions led to decomposition of our substrate, we were gratified to find that 
reduction with BH3-DMS alone in THF at room temperature afforded 198 with 3:1 
diastereoselectivity. Further optimization of these conditions eventually led to the discovery that 
the use of BH3-DMS at -20 °C in THF gave syn-diol 198 in near-quantitative yields and 4:1 d.r. 
Further reduction in temperature abolished reactivity. While these results were promising, their 
effectiveness was enhanced tremendously by the recognition that 198 could be rendered 
diastereomerically pure by protection as the acetonide followed by treatment with p-TsOH in DCM 
at 0 °C. These conditions selectively deprotected the anti-epimer while leaving the syn-acetonide 
intact, allowing a rapid chromatographic purification to provide pure syn-acetonide in 67% yield 
over two steps (Figure 109)177-178. The initial acetonide protection required optimization, and 
initial attempts using 2,2-dimethoxypropane without a dehydrating agent did not proceed to 




Figure 109. Protection of syn-diol 198 as the acetonide and subsequent purification by selective 
hydrolysis of its C-11 epimer. 
 
 With pure 199 in hand, we first confirmed that the sense of reduction with BH3-DMS was 
indeed syn; Rychnovsky’s method179-180 rapidly assured us that this was indeed the case. With this 
last hurdle thus surpassed, we subjected acetonide 199 to Weinreb’s conditions using 
ethylmagnesium bromide, which smoothly gave ethyl ketone 200. Finally, treatment of 200 with 
2 N hydrochloric acid in THF/methanol conveniently effected the global deprotection of the 
baulamycin scaffold, providing 1 in good yield over two steps (Figure 110). 
 
Figure 110. Weinreb ketone synthesis and final deprotection to provide baulamycin A (1). 
 
 Gratifyingly, comparison of the 1H and 13C NMR spectra and optical rotation of synthetic 1 
showed it to be identical to natural baulamycin A in every way, marking a satisfying conclusion 






Figure 111. Overlay of 1H and 13C NMR spectra for synthetic and natural baulamycin A. 
 
4.6 Synthesis of Baulamycin B 
 Having established an effective route to baulamycin A, with the opportunity to divert the 
synthesis toward baulamycin B in the penultimate step, we of course set our sights on an attempt 
at baulamycin B, the less-potent, chain-shortened analogue of baulamycin A. Accordingly, we 
treated Weinreb amide 199 with methyllithium at -78 °C, giving methyl ketone 201 as a single 
diastereomer (i.e., without epimerization, based on a lack of split signals in the crude 1H NMR) in 




Figure 112. Synthesis of baulamycin B (2) as an inseparable mixture with its C-3 epimer. 
 
Deprotection under conditions analogous to those employed on baulamycin A did indeed 
afford 2 in 50% yield as confirmed by 1H and 13C NMR (Figure 113); however, to our chagrin, 3-
epi-2 was also present in equal amounts!  
 
 




Apparently, acid-catalyzed deprotection had also catalyzed the epimerization of the C-3 
stereocenter, presumably through keto-enol tautomerization, despite the complete lack of evidence 
for any such degradation pathway in the deprotection of baulamycin A. Unfortunately, despite 
extensive efforts, 3-epi-2 could not be separated from 2, and, with our supplies of readily-available 
199 exhausted, we abandoned further efforts to isolate baulamycin B in pure form. Ultimately, we 
viewed this as a minor blemish on our overall efforts towards the baulamycins in light of the 
superior biological activity of baulamycin A with respect to baulamycin B and their extreme 
structural similarity. Undoubtedly, should it become desirable in the future to obtain further access 
to baulamycin B in pure form, the problem of deprotecting 201 without epimerization at C-3 will 
be readily solved. For our part, with both baulamycin A and baulamycin B in hand (albeit in impure 
form in the case of baulamycin B), we viewed these experiments as the natural conclusion to our 










4.1 General Considerations 
The use of flame- or oven-dried glassware, inert atmosphere and specific elements of air-
free technique are explicitly noted and described in detail for each experimental procedure in which 
they were used. The use of dried glassware or inert atmosphere should not be assumed for reactions 
which do not explicitly describe their use.  
Where used below, the term high vacuum refers to the vacuum generated by a Welch 1399 
DuoSeal pump producing a vacuum typically measuring 0.10 – 0.05 mm Hg. The term purge is 
used to refer to the evacuation of an experimental apparatus by high vacuum and subsequent back-
filling with a specified inert gas at least three times. The term sparge indicates that a gas was 
vigorously bubbled through a solvent, typically from a stainless steel needle positioned with its tip 
at the lowest point of the vessel. The term oven-dried refers to an apparatus which has been kept 
at a temperature of 120 °C overnight; the term flame-dried refers to glassware placed under high 
vacuum and heated with a propane torch until frosting of glass components was no longer 
observed, then cooled under positive pressure of a dry inert gas. Freeze-pump-thaw degassed 
denotes that the material thus described has been placed in a Schlenk flask sealed with a fresh 
rubber septum, connected to high vacuum by a sidearm equipped with a closed stopcock, 
magnetically stirred at -196 °C until frozen, exposed to high vacuum by opening of the stopcock 
for at least 3 minutes, resealed by closing of the stopcock, thawed, and thus treated a total of three 
times.  
Reactions conducted in flame- or oven-dried glassware were conducted with anhydrous 
solvents and reagents. In these cases, toluene, THF, DMF, diethyl ether, dichloromethane, 
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acetonitrile, DMSO, pyridine, benzene, methanol, triethylamine and diisopropylamine were 
sparged with argon then dried by passage through a Glass Contour solvent purification system.  
Anhydrous n-pentane, hexanes and tert-butyl methyl ether were obtained by drying over 4 Å 
molecular sieves (20% w/w) for at least 12 hours prior to use. Acetone was dried over 3 Å 
molecular sieves (20 % w/w) overnight immediately prior to use (when drying acetone with 
molecular sieves, immediate use of the dried solvent is essential to prevent re-equilibration to a 
higher water content through self-condensation; even then, acetone dried in this manner should 
not be assumed to contain less than ~320 ppm water)181. Concentrations of acids, bases, and 
hydrogen peroxide refer to aqueous solutions except where otherwise noted. Unless otherwise 
noted, reactants and reagents were obtained commercially and used without further purification. 
The terms freshly distilled and freshly purified, when used without citing an alternative reference, 
refer to purification according to the procedures described in Purification of Laboratory 
Chemicals182, the Encyclopedia of Reagents for Organic Synthesis183, or references contained 
therein. 
Flash chromatography was performed on “Standard Grade” 60 Å porosity, 230-400 mesh 
silica gel from Sorbent Technologies. Analytical and preparative TLC were conducted on glass-
backed plates precoated (0.21 – 0.27 mm) with Merck Silica Gel 60 F254. Preparative TLC was 
conducted by loading 10 mgs or less of sample onto 20 cm x 20 cm plates. In the case of analytical 
TLC, unless otherwise noted, compounds were visualized by 254 nm UV light or by immersion in 
Seebach’s stain184 followed by heating in a stream of hot air until the plate evolved a uniform blue 
color. 
1H and 13C NMR spectra were acquired at various field strengths as indicated using Varian 
and Bruker spectrometers. 1H NMR spectra were referenced internally to residual undeuterated 
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solvents (CHCl3 σ = 7.26 ppm, CH3OH σ = 3.31 ppm, DMSO, σ = 2.50 ppm, CH3CN σ = 1.94 
ppm, H2O σ = 4.79 ppm, C6H6 σ = 2.50 ppm, acetone σ = 2.05 ppm). 13C NMR spectra were 
referenced internally to the solvent (CHCl3 σ = 77.0 ppm, CH3OH σ = 49.0 ppm). Splitting patterns 
are described using the following abbreviations: s = singlet, br. s = broad singlet, d = doublet, t = 
triplet, q = quartet, quin = quintet, sext = sextet, sept = septet, m = multiplet. More than one 
abbreviation may be used to describe more complex splitting patterns, with the form “ab” denoting 
that splitting pattern a modifies pattern b. Thus, for example, the compound abbreviation “dt” 
denotes a “doublet of triplets”. Melting points were taken on a Mel-Temp capillary melting point 
apparatus equipped with a partially-immersed partial immersion thermometer and thus did not 
require correction185. Infrared spectra were recorded on a Nicolet iS5 or Nicolet iS50 FT-IR 
spectrometer. Mass spectra were obtained by the Colorado State University Central Instrument 
Facility on various TOF or QTOF spectrometers. Optical rotations were obtained on Rudolf 
Research Autopol III polarimeter operating at 589 nm at room temperature (typically 25 °C). 




 To a 35-mL round bottom flask equipped with a magnetic stir bar and containing 
4-phenylbutanol (0.200 g, 1.30 mmol, 1.00 eq), imidazole (0.199 g, 2.9 mmol, 2.2 eq) and tert-
butyldimethylsilyl chloride (0.221 g, 1.5 mmol, 1.1 eq) was added anhydrous DCM (10 mL) to 
give a colorless mixture which was stirred 44 hrs, at which time TLC indicated complete 
consumption of starting material. The reaction mixture was quenched with saturated aqueous 
NH4Cl and the resulting biphasic mixture stirred until two clear phases were obtained. The layers 
were separated and the aqueous phase extracted with DCM (3 x 10 mL); the organics were then 
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combined, dried over Na2SO4, decanted and concentrated under reduced pressure onto silica. CC 
on silica gel (15 g) eluting with 9:1 pentane / ethyl acetate gave 80 (0.320 g, 93%) as a colorless 
oil. Analytical data were in complete agreement with those previously reported186. 1H NMR (300 
MHz, CDCl3): δ 7.31 – 7.24 (m, 2H), 7.22 – 7.15 (m, 3H), 3.63 (t, J = 6.2 Hz, 2H), 2.63 (t, J = 7.5 
Hz, 2H), 1.73 – 1.51 (m, 4H), 0.89 (s, 9H), 0.04 (s, 6H). 
S-ethyl (3S,5R)-3,5-dimethyl-7-phenylheptanethioate (57) 
 
 A flame-dried 1-L round bottom flask equipped with a magnetic stir bar was charged with 
(S,RP)-Josiphos ethanol adduct (12 mgs, 0.019 mmol, 1.7 mol %) and copper(I) bromide-dimethyl 
sulfide complex (3.2 mgs, 0.016 mmol, 1.4 mol %), sealed with a rubber septum and purged with 
argon. tert-Butyl methyl ether (7.5 mL) was added and the resulting solution stirred 30 min at 
room temperature. The reaction solution was then cooled to -78 °C and methyl magnesium 
bromide (0.5 mL of a 3.0 M solution in Et2O, 1.5 mmol, 1.3 eq) was added. 56 (0.300 g, 1.14 
mmol, 1.00 eq) was then added as a solution in tert-butyl methyl ether (2 mL) via syringe pump 
over 1.5 hrs, and the resulting solution stirred 13 hrs, at which time TLC showed complete 
consumption of starting material. MeOH was added at -78 °C and the resulting solution allowed 
to warm slowly to r.t. Saturated aqueous NH4Cl was then added and the resulting biphasic mixture 
stirred an additional 30 min. The resulting layers were separated and the aqueous phase extracted 
three times with diethyl ether. The combined organics were dried over MgSO4, filtered, and 
concentrated under reduced pressure to reveal 0.280 g of yellow oil. Flash chromatography on 
silica gel (15 g) gave 57 (0.300 g, 94%) as an inseparable mixture with trace amounts of syn-isomer 
165 as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.31 – 7.23 (m, 2H), 7.22 – 7.13 (m, 3H), 
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2.88 (q, J = 7.4 Hz, 2H), 2.70 – 2.54 (m, 2H), 2.52 – 2.29 (m, 2H), 2.21 – 2.05 (m, 1H), 1.67 – 
1.39 (m, 4H), 1.25 (t, J = 7.4 Hz, 3H), 1.21 – 1.13 (m, 1H), 0.92 (d, J = 6.4 Hz, 3H), 0.90 (d, J = 
6.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 199.2, 142.9, 128.3, 128.3, 52.1, 44.0, 39.5, 33.4, 
29.7, 28.6, 23.3, 19.3, 19.2, 14.8. 13C NMR signals from minor syn-isomer 165: 51.3, 44.3, 38.4, 
33.2, 20.1, 20.0.  [α]25D = -17.4° (c 0.43, CHCl3). IR (neat): 2927, 1689, 1455, 1001, 699 cm-1. 
HRMS (ESI): calc’d for C17H27OS [M + H]+ 279.1777, found 279.1780. 
(3S,5R)-3,5-dimethyl-7-phenylheptanal (67)  
 
 A flame-dried 500-mL round bottom flask equipped with a magnetic stir bar and charged 
with 57 (4.57 g, 16 mmol, 1.00 eq) was sealed with a rubber septum and purged with argon. DCM 
(160 mL) was added and the resulting solution was cooled to -65 °C; DIBAL-H (17.2 mL of a 1.0 
M solution in hexanes, 17 mmol, 1.05 eq) was then added slowly against the wall of the reaction 
flask. After addition of DIBAL-H was complete, the reaction solution was stirred 15 min, at which 
time TLC showed complete consumption of starting material. MeOH (9 mL) was added and the 
resulting mixture was stirred an additional 5 min, then warmed to 0 °C. Saturated aqueous 
Rochelle’s salt was added; the biphasic mixture was then allowed to warm to r.t. and stirred 
overnight (note: workup after 3 hrs gave similar yields). The resulting layers were separated and 
the aqueous phase extracted twice with DCM. The combined organics were dried over Na2SO4, 
decanted, and concentrated under reduced pressure to reveal 67 (3.49 g, 97%) as a colorless oil 
which was used immediately in the next step without further purification. 1H NMR (300 MHz, 
CDCl3) δ 9.74 (t, J = 2.2 Hz, 1H), 7.32 – 7.24 (m, 2H), 7.21 – 7.13 (m, 3H), 2.74 – 2.50 (m, 2H), 
2.41 – 2.10 (m, 3H), 1.67 – 1.41 (m, 3H), 1.33 – 1.20 (m, 1H), 1.20 – 1.07 (m, 1H), 0.98 – 0.87 
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(m, 6H). 13C NMR (101 MHz, CDCl3) δ 202.9, 142.8, 128.3, 128.3, 125.6, 51.7, 44.4, 39.4, 33.3, 
29.7, 25.5, 19.6, 19.3. 13C NMR signals from minor syn-isomer: 203.0, 50.9, 44.6, 38.5, 33.2, 25.6, 
20.5, 19.9. [α]25D = -8.2° (c 0.18, CHCl3). IR (neat): 2955, 1726, 1455, 1704, 746, 699 cm-1. 
HRMS (ESI): calc’d for C15H26NO [M + NH4]+ 236.2009, found 236.2006. 
 ((3R,5R)-3,5-dimethyloct-7-en-1-yl)benzene (68) 
 
A flame-dried 500 mL round bottom flask was charged with methyltriphenyl-phosphonium 
bromide (6.45 g, 18.1 mmol, 1.13 eq), sealed with a rubber septum and purged with argon. THF 
(130 mL) was added, giving a colorless suspension, which was cooled to 0 °C. n-Butyl lithium 
(11.3 mL of a 1.6 M solution in hexanes, 18.1 mmol, 1.13 eq) was added slowly and an orange 
color evolved, lightening to yellow over 1 hr. 67 (3.49 g, 16.0 mmol, 1.00 eq) was then added 
portionwise as a solution in THF (50 mL over an additional 1 hr. The cooling bath was then 
removed and the orange reaction mixture stirred 12 hrs at room temperature, at which time TLC 
showed complete consumption of starting material. Saturated aqueous ammonium chloride and 
Et2O were added and the resulting biphasic mixture stirred until colorless; the layers were then 
separated and the aqueous phase extracted with diethyl ether. The organics were combined, dried 
over MgSO4, filtered and concentrated under reduced pressure onto silica. Flash chromatography 
on silica gel eluting with pentane gave 68 (3.10 g, 89%) as a colorless oil. 1H NMR (400 MHz, 
CDCl3): δ 7.32 – 7.23 (m, 2H), 7.22 – 7.14 (m, 3H), 5.89 – 5.64 (m, 1H), 5.03 – 4.98 (m, 1H), 4.98 
– 4.95 (m 1H), 2.62 (m, 2H), 2.02 (m, 1H), 1.95 – 1.79 (m, 1H), 1.70 – 1.51 (m, 3H), 1.50 – 1.37 
(m, 1H), 1.15 (dd, J = 6.9 Hz, 2H), 0.90 (d, J = 6.4 Hz, 3H), 0.84 (dd, J = 6.6, 3.0 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): δ 143.1, 137.7, 128.3, 128.2, 125.5, 115.5, 44.1, 42.2, 39.7, 33.5, 30.1, 
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29.9, 19.43, 19.24. 13C NMR signals from minor syn-isomer 170:  137.5, 115.6, 44.3, 41.2, 38.7, 
33.3, 30.0, 29.8, 20.2, 20.0. [α]25D = -10.3° (c 1.03, CHCl3). IR (neat): 2910 (C-H stretch), 1640 
(C=C), 1454, 910 (vinyl C-H) cm-1.  
(4R,6R)-4,6-dimethyl-8-phenyloctan-1-ol (58) 
 
 An oven-dried 50-mL round bottom flask containing a magnetic stir bar was capped with 
a rubber septum, purged with argon and charged with BH3 • THF (18.3 mL of a 1.0 M solution in 
THF, 18.3 mmol, 1.10 eq). The reaction vessel was cooled to -40 °C and 2-methyl-2-butene (4.26 
mL, 40.3 mmol, 2.42 eq) was added rapidly with stirring. The colorless solution was brought to 0 
°C and stirred for 2.75 hrs, at which time the entire solution was transferred via cannula to a 25-
mL pressure-equalized dropping funnel attached to a 2-neck, 100-mL round bottom flask. The 
flask was equipped with a magnetic stir bar and sealed at the other neck with a rubber septum. The 
reaction vessel was then purged with argon and charged with a solution of 68 (3.60 g, 16.6 mmol, 
1.00 eq) in THF (7 mL), then cooled to 0 °C. The freshly-prepared solution of disiamylborane was 
added dropwise over 30 min via dropping funnel; the resulting colorless solution was then stirred 
an additional 30 min at 0 °C before being allowed to come to r.t. and stirring for a further 18 hrs. 
The reaction solution was then cooled to -10 °C and quenched with ethanol (0.3 mL); sodium 
hydroxide (6.3 mL of a 3 M aqueous solution, 18.9 mmol, 1.14 eq) was then added, followed by a 
slow addition of 30% (w/w) aqueous hydrogen peroxide (6.3 mL) with concomitant exotherm and 
evolution of gas. Once the exotherm had ceased, the cloudy mixture was brought to r.t. and stirred 
3 hrs, at which time a heavy white precipitant had formed. Liquids were decanted and the layers 
separated. The precipitant was washed with ether (2 x 50 mL) and the washings used to extract the 
122 
 
aqueous layer (2 x 50 mL). After a third ether extraction of the aqueous layer (1 x 50 mL), the 
organics were combined, rinsed with brine, dried over MgSO4, filtered and concentrated under 
reduced pressure to reveal a colorless oil. Flash chromatography on silica gel (200 g) eluting w/ 
pentane followed by 2:1 pentane/ether gave 58 (3.24 g, 83%) as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 7.39 – 7.30 (m, 2H), 7.29 – 7.19 (m, 3H), 3.68 (t, J = 6.7 Hz, 2H), 2.80 – 2.55 (m, 
2H), 1.82 – 1.12 (m, 10H), 0.99 (d, J = 7.3 Hz, 3H), 0.92 (d, J = 7.6 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 143.1, 128.3, 128.2, 125.5, 63.4, 44.6, 39.7, 33.7, 33.4, 30.3, 29.9, 29.8, 19.5. 13C NMR 
signals from minor syn-isomer: 44.8, 38.7, 33.3, 32.7, 30.1, 29.9, 20.2, 20.1. [α]25D = +8.0° (c 0.20, 
CH2Cl2). IR (neat): 3319 (br, O-H), 2912 (C-H), 1453, 1055 (C-O) cm-1. HRMS (ESI): calc’d for 
C16H26NaO [M + Na]+ 257.1876, found 257.1876. 
(4R,6R)-4,6-dimethyl-8-phenyloctyl methyl carbonate (93) 
 
 To a flame-dried, argon-purged 500-mL round bottom flask containing 58 (3.26 g, 13.9 
mmol, 1.00 eq) and equipped with a magnetic stir bar was added DCM (28 mL) to give a colorless 
solution. Pyridine (1.46 mL, 18.1 mmol, 1.30 eq) and 4-(dimethylamino)pyridine (0.034 g, 0.278 
mmol, 2 mol %) were then added, and the resulting clear solution cooled to 0 °C. Methyl 
chloroformate (1.40 mL, 18.1 mmol, 1.30 eq) was added slowly, and the reaction mixture stirred 
4 hrs as the ice bath expired naturally, at which time TLC showed complete consumption of 
starting material. Saturated aqueous NH4Cl was added and the resulting biphasic mixture stirred; 
layers were then separated and the aqueous phase extracted with diethyl ether (3 x 75 mL). The 
organics were combined, rinsed with brine and saturated aqueous NaHCO3, dried over MgSO4, 
filtered and concentrated under reduced pressure to reveal a colorless oil. Purification by flash 
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chromatography on silica gel (200 g) eluting with 95:5 hexanes / ethyl acetate followed by 9:1 
hexanes / ethyl acetate gave 93 (3.76 g, 93%) as a colorless oil. 1H NMR (300 MHz, CDCl3) δ 
7.33 – 7.22 (m, 2H), 7.21 – 7.14 (m, 3H), 4.12 (t, J = 6.8 Hz, 2H), 3.78 (s, 3H), 2.73 – 2.46 (m, 
2H), 1.78 – 1.07 (m, 10H), 0.89 (d, J = 6.3 3H), 0.84 (d, J = 6.5, 3H). 13C NMR (101 MHz, CDCl3) 
δ 155.9, 143.0, 128.3, 128.2, 125.5, 68.5, 54.6, 44.4, 39.7, 33.6, 33.4, 29.8, 29.8, 26.2, 19.4, 19.3. 
13C NMR signals from minor syn-isomer 171: 44.8, 38.6, 33.3, 32.6, 29.7, 26.1, 20.2, 20.0. [α]25D 
= -5.7° (c 0.82, CHCl3). IR (neat): 2957 (C-H stretch), 1752 (carbonate C=O stretch), 1443, 1277 
(carbonate asymmetric stretch) cm-1. HRMS (ESI): calc’d for C18H29O3 [M + H]+ 293.2111, found 
293.2112. 
(4R,6R)-9-((methoxycarbonyl)oxy)-4,6-dimethylnonanoic acid (94) 
 
 To a 3000-mL three-neck round bottom flask equipped with an enlarged (7.5 cm x 3 cm) 
ellipsoid magnetic stir bar was charged with sodium periodate (43.21 g, 202 mmol, 15.0 eq), 
ruthenium(III) chloride trihydrate (0.352 g, 1.35 mmol, 10 mol %) and water (270 mL) to give an 
amber solution. 93 (3.94 g, 13.5 mmol, 1.00 eq) was added as a solution in CCl4 (135 mL) and the 
walls of the reaction flask rinsed with acetonitrile (135 mL). One of the outer necks of the reaction 
flask was sealed with a glass stopper; the other neck was equipped with a thermometer adapter and 
thermometer placed below the surface of the reaction mixture. The center neck of the flask was 
fitted with an efficient condenser and the reaction mixture brought to reflux with a heating mantle 
while maintaining an internal temperature of 60 – 65 °C. The reaction was refluxed with vigorous 
stirring for 2.5 hrs, at which time an off-white or tan color had evolved. The reaction mixture was 
then filtered through Celite twice; layers were separated and the aqueous phase extracted several 
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times with DCM. The organics were then combined, dried over Na2SO4, decanted and 
concentrated under reduced pressure to reveal 3.3 g black residue. Flash chromatography on silica 
gel (175 g) eluting with 9:1 pentane/ether, followed by 4:1 pentane ether, followed by 3:2 
pentane/ether + 0.76 % (v/v) acetic acid gave 0.550 g recovered starting material and product (1.84 
g, 52%, 61% b.r.s.m.) as colorless oils. Residual acetic acid from chromatography was 
azeotropically removed from the final product with toluene (1x) and heptane (2x). 1H NMR (400 
MHz, CDCl3) δ 4.12 (t, J = 6.7 Hz, 2H), 3.78 (s, 3H), 2.44 – 2.28 (m, 2H), 1.76 – 1.07 (m, 10H), 
0.91 – 0.81 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 179.7, 155.9, 128.5, 128.0, 68.5, 54.6, 44.1, 
33.5, 32.3, 31.7, 29.7, 29.6, 26.2, 19.2, 19.0. 13C NMR signals from minor syn-isomer 176: 44.5, 
32.6, 31.5, 31.2, 29.5, 26.04, 19.9, 19.8. [α]25D = -8.9° (c 0.99, CHCl3). IR (neat): 2957 (C-H 
stretch), 1747 (carbonate C=O stretch), 1706 (acid C=O stretch) cm-1. HRMS (ESI): calc’d for 
C13H23O5 [M - H]- 259.1551, found 259.1574. 
(4R,6R)-4,6-dimethyl-9-oxo-9-((R)-2-oxo-4-phenyloxazolidin-3-yl)nonyl methyl carbonate (97) 
 
 To a 100-mL round bottom flask containing a magnetically-stirred solution of 94 (1.79 g, 
6.88 mmol, 1.00 eq) in THF (10 mL) was added triethylamine (2.40 mL, 17.2 mmol, 2.5 eq) 
followed by pivaloyl chloride (0.85 mL, 6.88 mmol, 1.00 eq) at 0 °C. The resulting white slurry 
was stirred 1.5 hrs, at which point (R)-(-)-4-phenyl-2-oxazolidinone (1.12 g, 6.88 mmol, 1.00 eq) 
and lithium chloride (0.437 g, 10.3 mmol, 1.5 eq) were added and the reaction allowed to come to 
room temperature. After stirring 18 hrs, TLC showed complete consumption of starting material. 
The reaction mixture was diluted with Et2O and saturated aqueous NH4Cl, stirred, then further 
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diluted with water to give to clear phases. Layers were separated and the aqueous phase extracted 
with Et2O (3 x 50 mL); organics were combined, dried over MgSO4, filtered and concentrated 
under reduced pressure to reveal a yellow oil. Purification by flash chromatography eluting with 




 A flamed-dried 250 mL round bottom flask equipped with a magnetic stir bar was charged 
with 97 (2.47 g, 6.09 mmol, 1.00 eq), purged with argon, sealed with a rubber septum and charged 
with THF (30 mL) to give a stirred solution which was cooled to -78 °C. Sodium 
hexamethyldisilazide (1.34 g, 7.31 mmol, 1.20 eq) was added slowly as a solution in THF (20 mL, 
followed by 2 x 5 mL rinses). The resulting pale yellow solution was stirred 1 hr at -78 °C, at 
which time methyl iodide (0.95 mL, 15.2 mmol, 2.50 eq) was added slowly. The reaction solution 
was allowed to stir 1 hr, at which time TLC indicated complete consumption of starting material. 
The reaction solution was quickly warmed to near room temperature, then diluted with saturated 
aqueous NH4Cl and diethyl ether and stirred. Addition of a generous spatula-tip of Na2S2O3 
followed by vigorous shaking gave two colorless and distinct layers which were then separated. 
The aqueous phase was extracted with Et2O (2 x 125 mL) followed by DCM (1 x 125 mL); the 
organics were then combined, dried over MgSO4, filtered and concentrated under reduced 
pressure. Purification by flash chromatography on silica gel (125 g) eluting with 3:1 pentane / ethyl 
acetate gave 98 (1.59 g, 62%) as a white crystalline solid. 1H NMR (400 MHz, CDCl3) δ 7.41 – 
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7.25 (m, 5H), 5.43 (dd, J = 8.7, 3.6 Hz, 1H), 4.67 (t, J = 8.8 Hz, 1H), 4.25 (dd, J = 8.9, 3.7 Hz, 
1H), 4.11 (t, J = 6.7 Hz, 2H), 3.94 – 3.81 (m, 1H), 3.77 (s, 3H), 1.75 – 1.41 (m, 5H), 1.39 – 1.12 
(m, 3H), 1.12 – 1.03 (m, 5H), 0.87 – 0.79 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 176.9, 155.9, 
153.3, 139.3, 129.2, 128.6, 125.7, 69.7, 68.5, 57.8, 54.6, 44.7, 40.9, 35.4, 33.5, 29.8, 27.9, 26.2, 
19.2, 19.2, 17.2. [α]25D = -73.1° (c 1.49, CHCl3). IR (neat): 2965 (C-H stretch), 1783 (C=O), 1745 
(C=O), 1700 (C=O) cm-1. HRMS (ESI): calc’d for C23H34NO6 [M + H]+ 420.2386, found 
420.2374. 
(2R,4S,6R)-9-((methoxycarbonyl)oxy)-2,4,6-trimethylnonanoic acid (99) 
 
 To a 250-mL round bottom flask containing a magnetically-stirred solution of 98 (0.580 g, 
1.38 mmol, 1.00 eq) in THF (12 mL) was added a pre-mixed, clear solution of lithium hydroxide 
(1.73 mL of a 2 N aqueous solution, 3.46 mmol, 2.50 eq) and 30% (w/w) hydrogen peroxide (0.84 
mL, 8.28 mmol, 6.00 eq) at 0 °C. The reaction mixture was stirred 5.5 hrs, at which time TLC 
showed complete consumption of starting material. The reaction mixture was quenched with the 
addition of 0.1 M aqueous Na2S2O3 (3 mL), followed by Et2O and water. Addition of additional 
Na2S2O3 gave a clear biphasic mixture. The layers were separated and the aqueous phase acidified 
to pH 2.5 with 2 N HCl, then extracted with Et2O (3 x 50 mL). The organics were combined, 
washed with bring, dried over MgSO4, filtered and concentrated under reduced pressure to reveal 
a colorless solid.  Flash chromatography on silica gel eluting with 4:1 hexanes / ethyl acetate gave 
98 (0.260 g, 69%) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 4.12 (t, J = 6.7 Hz, 2H), 3.78 (s, 
3H), 2.63 – 2.46 (m, 1H), 1.78 – 1.43 (m, 5H), 1.41 – 1.20 (m, 3H), 1.16 (d, J = 7.0 Hz, 3H), 1.13 
– 1.03 (m, 2H), 0.89 – 0.79 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 182.8, 155.9, 68.5, 54.6, 44.4, 
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41.6, 29.7, 27.8, 26.2, 19.2, 16.9. [α]25D = -1.85° (CHCl3). IR (neat): 2958 (alkane C-H stretch), 
1749 (carbonate C=O stretch), 1705 (acid C=O stretch) cm-1. HRMS (ESI): calc’d for C14H27O5 
[M + H]+ 275.1853, found 275.1857. 
(4R,6S,8R)-9-(methoxy(methyl)amino)-4,6,8-trimethyl-9-oxononyl methyl carbonate (100) 
 
 To a 20-mL glass scintillation vial containing a magnetically-stirred solution of 99 
(0.260 g, 0.948 mmol, 1.00 eq) in DCM (3.5 mL) was added PyBOP (0.518 g, 0.995 mmol, 1.05 
eq) and diisopropylethylamine (0.40 mL, 2.32 mmol, 2.45 eq). The resulting pale yellow reaction 
solution was allowed to stir 5 min, then N,O-dimethylhydroxylamine hydrochloride (0.125 g, 1.28 
mmol, 1.35 eq). The reaction solution was allowed to stir 6 hrs, at which time TLC showed 
complete consumption of starting material. The reaction was diluted with DCM, washed with 1 N 
HCl (1 x 10 mL), water (1 x 10 mL) and saturated aqueous NaHCO3 (1 x 10 mL). The basic wash 
was then back-extracted with DCM (3 x 10 mL) and the organics combined, dried over Na2SO4 
and concentrated under reduced pressure to reveal a viscous, translucent, amorphous solid. Flash 
chromatography on silica gel eluting with 3:1 hexanes / ethyl acetate gave pure 100 (0.240 g, 80%) 
as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 4.12 (t, J = 6.7 Hz, 2H), 3.77 (s, 3H), 3.69 (s, 
3H), 3.18 (s, 3H), 3.06 – 2.90 (m, 1H), 1.77 – 1.57 (m, 2H), 1.57 – 1.43 (m, 3H), 1.41 – 1.13 (m, 
3H), 1.13 – 1.02 (m, 4H), 0.91 – 0.78 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 178.4 (weak), 
155.8, 68.5, 61.4, 54.6, 44.6, 41.8, 33.7, 32.6, 29.7, 27.9, 26.2, 19.3, 19.1, 17.4. [α]25D = XX° (c 
0.X, CHCl3). IR (neat): 2958 (alkane C-H stretch), 1747 (carbonate C=O stretch), 1633 (amide 




 (2R,4S,6R)-9-hydroxy-N-methoxy-N,2,4,6-tetramethylnonanamide (101) 
 
 A 25-mL round bottom flask equipped with a magnetic stir bar was charged with 100 
(0.095 g, 0.299 mmol, 1.00 eq) followed by MeOH (5 mL) to give a stirred solution. Potassium 
carbonate (5 mL of a 1% (w/v) solution in MeOH) was then added and the resulting mixture stirred 
19 hrs, at which time TLC indicated complete consumption of starting material. Solvent was 
evaporated to give a pale yellow residue, which was then partitioned between water and Et2O. The 
aqueous phased was extracted with Et2O (2 x 10 mL); the organics were then combined, dried over 
MgSO4, filtered and concentrated under reduced pressure to reveal 101 (0.062 g, 79%) as a 
colorless oil. 1H NMR (400 MHz, CDCl3) δ 3.68 (s, 3H), 3.61 (t, J = 6.7 Hz, 2H), 3.16 (s, 3H), 
3.06 – 2.89 (m, 1H), 1.64 – 1.43 (m, 5H), 1.35 – 1.22 (m, 2H), 1.21 – 1.12 (m, 1H), 1.12 – 1.03 
(m, 5H), 0.90 – 0.76 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 63.3, 61.4, 44.8, 41.7, 33.8, 32.6, 
30.2, 29.8, 27.9, 19.3, 17.3 (C=O not observed). [α]25D = -12.7° (c 0.33, CHCl3). IR (neat): 3430 
(O-H stretch), 2927 (alkane C-H stretch), 1642 (C=O) cm-1. HRMS (ESI): calc’d for C14H30NO3 
[M + H]+ 260.2220, found 260.2180. 
(2R,4S,6R)-N-methoxy-N,2,4,6-tetramethyl-9-oxononanamide (38) 
 
 To a 10-mL round bottom flask containing 101 (0.031 g, 0.120 mmol, 1.00 eq), equipped 
with a magnetic stir bar and purged with argon was added DCM (2 mL). To the resulting 
magnetically-stirred solution was added Dess-Martin periodinane (0.152 g, 0.36 mmol, 3.00 eq) 
and the reaction mixture stirred 4 hrs, at which time TLC appeared to indicate complete 
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consumption of starting material. Saturated aqueous NaHCO3 was added, followed by 0.1 M 
aqueous Na2S2O3 until the biphasic mixture clarified. Layers were separated and the aqueous phase 
extracted with DCM (3 x 10 mL). Organics were combined, dried over Na2SO4 and concentrated 
under reduced pressure to reveal 38 (0.014 g, 50%) as a colorless unstable oil. 1H NMR (300 
MHz,CDCl3) δ 9.77 (t, J = 2.0 Hz, 1H), 3.69 (s, 3H), 3.18 (s, 3H), 2.98 (s, 2H), 2.44 (m, 2H), 1.70 
– 1.15 (m, 7H), 1.10 (d, J = 6.8 Hz, 3H), 0.83 (d, J = 6.0 Hz, 6H). 
9-((tert-butyldimethylsilyl)oxy)nonan-1-ol (133) 
 
 To a flame-dried 3-neck 500-mL round bottom flask equipped with a reflux condenser and 
magnetic stir bar was added sodium hydride (2.50 g, 60% dispersion in mineral oil, 62.4 mmol, 
1.00 eq). The system was sealed with rubber septa and purged with argon; the sodium hydride 
dispersion was then rinsed (2x) with hexanes and suspended in THF (125 mL). 1,9-nonanediol 
(10.00 g, 62.4 mmol, 1.00 eq) was then added against a stream of argon through the right neck; 
the system was re-sealed with septa and the thick white suspension brought to 55 °C and stirred 
18 hrs. Evolution of gas was initially observed, and the mixture thickened over the first hour of 
stirring. At 18 hrs, the slurry had thinned considerably – the mixture was allowed to cool to r.t. 
and tert-butyldimethylsilyl chloride (9.40 g, 62.4 mmol, 1.00 eq) was added. The resulting mixture 
was stirred 24 hrs, then poured into an equal volume Et2O and rinsed with 10% (w/w) aqueous 
K2CO3 followed by brine. The organics were then dried over MgSO4, filtered and concentrated 
under reduced pressure to give a pale yellow oil which solidified into a white amorphous mass on 
exposure to high vacuum. Flash chromatography on silica gel eluting with 9:1 pentane/ethyl 
acetate followed by 3:1 pentane/ethyl acetate gave 133 (7.45 g, 43%) as a colorless oil. Analytical 
data were in accordance with those previously reported187. 1H NMR (300 MHz, CDCl3) δ 3.71 – 
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3.49 (m, 4H), 1.63 – 1.42 (m, 4H), 1.30 (s, 10H), 0.89 (s, 9H), 0.05 (s, 6H). 13C NMR (101 MHz, 
CDCl3) δ 63.3, 63.1, 32.9, 32.8, 29.6, 29.4, 26.0, 25.8, 25.7, 18.4, -5.3. 
9-((tert-butyldimethylsilyl)oxy)nonanoic acid (134) 
 
 To a 1000-ml round bottom flask containing a magnetically-stirred solution of alcohol 133 
(7.43 g, 27.1 mmol, 1.00 eq) in ACN / 0.67 M aqueous monobasic sodium phosphate (1:1, 275 
mL) was added TEMPO (0.423 g, 2.71 mmol, 10 mol %), giving a mild orange solution. Bleach 
(13.5 mL, 6% (w/w) aqueous sodium hypochlorite) was added, at which time a pale yellow color 
evolved. Addition of sodium chlorite (4.90 g, 54.1 mmol, 2.00 eq) was followed by the evolution 
of a dark brown color which eventually lightened to a dark yellow. Evolution of a green-yellow 
gas was observed and a mild exotherm was noted. The reaction mixture was stirred 16 hrs, at which 
time TLC indicated the absence of starting material. Saturated aqueous Na2S2O3 (100 mL) was 
added, instantly decolorizing the reaction solution. The mixture was allowed to stir briefly, then 
extracted with diethyl ether (3x). The organics were combined, washed with brine, dried over 
MgSO4, filtered and concentrated under reduced pressure to reveal 134 (7.45 g, 95%) as a colorless 
oil. Analytical data were in accordance with those previously reported188. 1H NMR (400 MHz, 
CDCl3) δ 3.59 (t, J = 6.6 Hz, 2H), 2.34 (t, J = 7.5 Hz, 2H), 1.69 – 1.58 (m, 2H), 1.53 – 1.44 (m, 
2H), 1.31 (m, 9H), 0.89 (s, 9H), 0.04 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 179.8, 63.3, 34.0, 
32.8, 29.2, 29.0, 26.0, 25.7, 24.7, 18.4, -5.3. IR (neat) 3250-3050 (very broad, acid O-H stretch), 





 To a 1000-mL round bottom flask containing a magnetically-stirred solution of 134 (7.43 g, 
25.8 mmol, 1.00 eq) in DCM (240 mL) was added N,O-dimethylhydroxylamine hydrochloride 
(3.76 g, 38.6 mmol, 1.50 eq) and triethylamine (9.3 mL, 67.0 mmol, 2.60 eq). After 15 minutes, 
EDCI•HCl (5.43 g, 28.3 mmol, 1.10 eq) and 4-(dimethylamino)pyridine (0.629 g, 5.15 mmol, 20 
mol %) were added and the colorless reaction solution stirred 4 hrs, at which time TLC indicated 
complete consumption of starting material. The reaction solution was rinsed three times with 
water, three times with 1 N HCl, twice with brine, then dried over MgSO4, filtered and 
concentrated under reduced pressure into a 1000-mL round bottom flask to reveal 8.75 g of yellow 
oil. A magnetic stir bar, THF (30 mL) and tetrabutlylammonium fluoride (31.0 mL of a 1.0 M 
solution in THF, 31.0 mmol, 1.20 eq) were added to the flask to give a yellow solution which was 
allowed to stir 14 hrs, then evaporated to reveal a yellow oil. Purification by flash chromatography 
on silica gel (500 g) eluting with 1:1 hexanes / ethyl acetate followed by neat ethyl acetate gave 
136 (4.38 g, 78%) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 3.67 (s, 3H), 3.62 (t, J = 6.6 Hz, 
2H), 3.16 (s, 3H), 2.39 (t, J = 7.6 Hz, 2H), 1.67 – 1.49 (m, 5H), 1.40 – 1.26 (m, 8H). 13C NMR 
(101 MHz, CDCl3) δ 62.9, 61.2, 32.7, 32.1, 31.8, 29.3, 29.3, 29.2, 25.6, 24.5 (C=O not 
observed189). IR (neat): 3049 (O-H stretch), 2928 (alkane C-H stretch), 1642 (amide C=O) cm-1. 
HRMS (ESI): calc’d for C11H24NO3 [M + H]+ 218.1751, found 218.1748.  
N-methoxy-N-methyl-9-oxononanamide (137) 
 
 A flame-dried, argon-purged 1000-mL round bottom flask containing a magnetically 
stirred solution of oxalyl chloride (5.09 mL, 60.2 mmol, 3.00 eq) in DCM (100 mL) was cooled to 
-78 °C. DMSO (8.52 mL, 120 mmol, 6.00 eq) was added dropwise over 1 hr as a solution in DCM 
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(10 mL). To the resulting clear solution was added alcohol 136 (4.36 g, 20.1 mmol, 1.00 eq) via 
cannula as a solution in DCM (30 mL + 50 mL washings). A white suspension formed and was 
stirred 30 min, at which time triethylamine (25.2 mL, 181 mmol, 9.00 eq) was added quickly, 
giving first a colorless solution, then a thick white suspension. This suspension was stirred 15 
minutes, then was allowed to come to r.t. overnight, during which time a dark yellow color 
evolved. Water was added; the organics were separated, washed with water (3 x 200 mL) and 1 N 
HCl (1 x 300 mL), followed by water and brine. The organics were then concentrated, re-diluted 
with ether, washed with water followed by brine, dried over MgSO4, filtered and concentrated to 
give a brown oil which was then passed through a plug of silica eluting with ethyl acetate to give 
137 (3.16 g, 73%) as a yellow oil.  
Note: aldehyde 137 is unstable and should be used soon after purification. At room 
temperature, 137 is observed to have a half-life of approximately 1 month under inert gas. Cooling 
dramatically accelerates the rate of decomposition, with complete degradation ensuing on a 
timescale of days at -30 °C. The identity of the degradation product (a white solid) remains 
unknown; however, the absence of acetal protons in the 1H NMR spectrum suggests that it is not 
simply a trimer or other oligomer of 137. Although cyclizations and polymerizations of aliphatic 
aldehydes are well-known, and although the apparent increase in reaction rate at low temperature 
suggests an entropically-disfavored process such as trimerization, other mechanisms cannot be 
ruled out. In particular, the IR and 1H NMR spectra of the degradation product are not inconsistent 
with oxidation of the aldehyde to the acid, with a broad increase in absorbance from 3600 - 3000 
cm-1 in the IR and a faint hint of signal around 10.5 ppm in the 1H NMR. As autooxidation of 
aldehydes proceeds stoichiometrically in oxygen, it is certainly possible than trace oxygen 
dissolved in 137 could be sufficient to give rise to the observed decomposition over time, even 
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when the product has been stored under an inert atmosphere. Regardless of the exact nature of its 
decomposition, 137 remains resistant to long-term storage; thus, in our own work, we have chosen 
to prepare it (and some other aliphatic aldehydes) only immediately prior to use. 1H NMR (400 
MHz, CDCl3) δ 9.74 (t, J = 1.9 Hz, 1H), 3.66 (s, 3H), 3.16 (s, 3H), 2.45 – 2.35 (m, 4H), 1.67 – 
1.54 (m, 4H), 1.39 – 1.26 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 202.8, 61.2, 43.8, 32.1, 31.8, 
29.1, 29.1, 28.9, 24.5, 22.0. IR (neat): 2931 (C-H stretch), 2721 (aldehyde C-H stretch), 1722 
(aldehyde C=O stretch), 1660 (amide C=O stretch) cm-1. HRMS (ESI): calc’d for C11H21NO3 
[M + H]+ 216.1594, found 216.1595. 
(R)-4-benzyl-3-(4-methylpentanoyl)oxazolidin-2-one (109) 
 
Compound 109 was prepared using a modification of one of many literature procedures100. 
Thus, a flamed-dried, argon-purged, 500-mL round bottom flask equipped with a magnetic stir bar 
and sealed with a rubber septum was charged with 4-methylvaleric acid (11.5 mL, 90.8 mmol, 
1.00 eq) and THF (50 mL) to give a colorless stirred solution. Triethylamine (31.6 mL, 227 mmol, 
2.5 eq) was added and the resulting clear solution was cooled to 0 °C. Pivaloyl chloride (11.17 
mL, 90.8 mmol, 1.00 eq) was added, with the concomitant evolution of a thick white slurry. After 
50 min, (R)-4-benzyl-2-oxazolidinone (16.09 g, 90.8 mmol, 1.00 eq) and lithium chloride (5.77 g, 
136 mmol, 1.50 eq) were added and the reaction mixture allowed to come to r.t. After stirring for 
20 hrs, the reaction mixture was quenched with saturated aqueous NH4Cl, then diluted with H2O 
and stirred to give two clear phases. Layers were separated and the aqueous phase extracted twice 
with diethyl ether. The organics were combined, dried over Na2SO4, decanted, and evaporated 
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onto Celite. The Celite-adsorbed crude material was then added to a silica plug and eluted with 1:1 
hexanes / ethyl acetate to give 109 (22.33 g, 89 %) as a colorless oil that solidified on standing. 
Characterization was in agreement with that previously reported in the literature100. 1H NMR (400 
MHz, CDCl3) δ 7.40 – 7.15 (m, 5H), 4.72 – 4.62 (m, 1H), 4.24 – 4.11 (m, 2H), 3.30 (dd, J = 13.4, 
3.4 Hz, 1H), 3.06 – 2.84 (m, 2H), 2.76 (dd, J = 13.3, 9.6 Hz, 1H), 1.72 – 1.51 (m, 3H), 0.95 (d, J 
= 6.3 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 173.6, 153.4, 135.3, 129.4, 128.9, 127.3, 66.1, 55.1, 




 A flamed-dried 1000-mL round bottom flask equipped with a magnetic stir bar was charged 
with N-acyl oxazolidinone 109 (21.45 g, 77.9 mmol, 1.50 eq), capped with a rubber septum and 
purged with argon. DCM (200 mL) was added to give a colorless stirred solution which was cooled 
to 0 °C. Freshly-prepared101 dibutylboron triflate (19.70 mL, 77.9 mmol, 1.50 eq) was then added 
via syringe, followed by triethylamine (14.47 mL, 104 mmol, 2.00 eq). The resulting pale yellow 
solution was stirred 3.5 hrs at 0 °C, then cooled to -78 °, at which time 104 (11.74 g, 51.9 mmol, 
1.00 eq) was added via cannula as a solution in DCM (150 mL). The flask previously containing 
104 was rinsed with DCM (2 x 75 mL), the rinsings added to the reaction flask and the reaction 
solution allowed to come to room temperature. The reaction solution was then stirred 25 hrs, at 
which time TLC indicated consumption of 104. pH 7 buffer and 20 mL of 30% (w/w) H2O2 were 
added and the mixture stirred overnight, at which time the layers were separated, the aqueous layer 
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extracted with DCM, the organics combined, dried over Na2SO4 and concentrated onto silica. The 
silica-adsorbed crude material was then purified by flash chromatography on silica gel (2 kg) in a 
6000-mL separatory funnel eluting with 3:1 hexanes / ethyl acetate followed by 3:2 hexanes / ethyl 
acetate to give pure 110 (25.63 g, 98%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 
7.26 (m, 3H), 7.21 – 7.16 (m, 2H), 6.73 (d, J = 2.2 Hz, 2H), 6.62 (t, J = 2.3 Hz, 1H), 5.19 – 5.10 
(m, 4H), 4.75 (d, J = 6.1 Hz, 1H), 4.49 – 4.35 (m, 2H), 4.01 (dd, J = 8.9, 2.2 Hz, 1H), 3.77 (t, J = 
8.8, 1H), 3.42 (s, 6H), 3.27 – 3.18 (m, 1H), 2.67 (dd, J = 13.3, 9.9 Hz, 1H), 2.36 (br. s, 1H), 2.02 
– 1.91 (m, 1H), 1.63 – 1.47 (m, 2H), 0.91 (d, J = 6.5 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 
174.8, 158.0, 153.0, 144.1, 135.3, 129.4, 128.9, 127.3, 107.6, 104.4, 94.4, 75.8, 65.9, 56.0, 55.7, 
37.9, 36.8, 26.6, 23.6, 21.9. [α]25D = -79.1° (c 2.13, CHCl3). IR (neat): 3478 (O-H stretch), 2955 
(alkane C-H stretch), 1777 (C=O stretch), 1691 (C=O stretch), 1597 cm-1. HRMS (ESI): calc’d 
for C27H35NNaO8 [M + Na]+ 524.2255, found 524.2268.  
(R)-2-((R)-(3,5-bis(methoxymethoxy)phenyl)(hydroxy)methyl)-4-methylpentanoic acid (111) 
 
 To a 1000-mL round bottom flask containing a magnetically-stirred solution of 110 (25.90 
g, 51.8 mmol, 1.00 eq) at 0 °C was added 30% (w/w) hydrogen peroxide  (31.4 mL, 311 mmol, 
6.00 eq). Lithium hydroxide (64.8 mL of a 2 N aqueous solution, 130 mmol, 2.50 eq) was then 
added over 10 minutes via dropping funnel. The reaction mixture was allowed to come to r.t. and 
stir 5.5 hrs, at which time TLC showed no starting material remaining. The mixture was then 
cooled to 0 °C and Na2SO3 (45 mL of a 1.3 M aqueous solution) was added; the mixture was then 
stirred a further 30 minutes. THF was evaporated under reduced pressure and the remaining 
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aqueous phase extracted with DCM (3x) and Et2O (2x). The aqueous phase was then acidified to 
pH 4 and extracted with DCM (1x) and Et2O (4x). The latter (2nd) set of organic extracts were 
combined, dried over MgSO4, filtered and concentrated under reduced pressure to give 111 
(16.38 g, 92%) as an extremely viscous, colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.71 (d, J = 
2.2 Hz, 2H), 6.65 (t, J = 2.3 Hz, 1H), 5.15 (s, 4H), 4.98 (d, J = 4.6 Hz, 1H), 3.47 (s, 6H), 1.71 (m, 
1H), 1.59 – 1.47 (m, 1H), 1.34 (m, 1H), 0.87 (d, J = 6.5 Hz, 3H), 0.80 (d, J = 6.5 Hz, 3H). 13C 
NMR (101 MHz, CDCl3) δ 180.1, 158.2, 143.8, 107.5, 104.2, 94.4, 73.7, 56.0, 50.3, 35.0, 26.1, 
23.4, 21.3. [α]25D = +27.4° (c 1.0, CHCl3). IR (neat): 3428 (O-H stretch), 2956 (alkane C-H 





 To a 250-mL, argon-purged round bottom flask containing a magnetically-stirred solution 
of 111 (5.82 g, 17.0 mmol, 1.00 eq) in THF (35 mL) were added 2-chloro-4,6-dimethoxy-1,3,5-
triazine (3.28 g, 18.7 mmol, 1.10 eq) and N-methylmorpholine (2.05 mL, 18.7 mmol,  1.10 eq) at 
0 °C; the walls of the reaction vessel were then rinsed with THF (10 mL). After ~2 min, the stirred 
solution became opaque; stirring then continued for 1 hr, at which time N,O-
dimethylhydroxylamine hydrochloride (4.97 g, 51.0 mmol, 3.00 eq) and additional N-
methylmorpholine (5.60 mL, 51.0 mmol, 3.00 eq) were added. After 15 min, the reaction was 
brought to r.t. and allowed to stir 20 hrs, then filtered through a Büchner funnel equipped with a   
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medium-porosity glass frit. The filter cake was washed with Et2O (3x) and the combined filtrate 
washed with water (1x), 1 N HCl (2 x 65 mL), water (2 x 100 mL) and saturated aqueous NaHCO3 
(2 x 55 mL). The organics were then dried over MgSO4, filtered, and concentrated under reduced 
pressure to reveal a pale brown oil. Flash chromatography on silica gel (220 g) eluting with 3:2 
hexanes/ethyl acetate gave the product as a colorless oil (3.82 g, 58%). 1H NMR (400 MHz, 
CDCl3) δ 6.73 (dd, J = 2.3, 0.7 Hz, 2H), 6.62 (t, J = 2.3 Hz, 1H), 5.15 (s, 4H), 4.89 (d, J = 3.5 Hz, 
1H), 3.66 (s, 3H), 3.46 (s, 6H), 3.31 – 3.22 (m, 1H), 3.19 (s, 3H), 1.82 – 1.69 (m, 1H), 1.39 – 1.23 
(m, 2H), 0.80 (d, J = 6.2 Hz, 3H), 0.74 (d, J = 6.2 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 177.0, 
158.1, 144.6, 107.5, 103.6, 94.5, 73.8, 56.0, 45.0, 34.8, 32.0, 26.1, 23.4, 21.8. IR (neat): 3419 (O-
H stretch), 2955 (alkane C-H stretch), 1594 cm-1. HRMS (ESI): calc’d for C19H30NO7 [M - H]- 




 To an argon-purged 250-mL round bottom flask containing a magnetically stirred colorless 
solution of 114 (3.80 g, 9.86 mmol, 1.00 eq) in DCM (90 mL) were added 2,6-lutidine (3.56 mL, 
30.6 mmol, 3.10 eq) and tert-butyldimethylsilyl triflate (3.40 mL, 14.8 mmol, 1.50 eq) at 0 °C. 
The reaction was then allowed to stir 18 hrs, at which time TLC indicated complete consumption 
of starting material. Saturated aqueous NH4Cl and H2O were added and the biphasic mixture 
stirred; layers were then separated and the aqueous layer extracted with DCM (2 x 75 mL). The 
combined organics were washed with water, dried over Na2SO4, decanted and concentrated under 
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reduced pressure. 1H NMR indicated residual 2,6-lutidine – the crude material was thus taken up 
in Et2O (150 mL), washed with 1 N HCl (1 x 100 mL), water (1 x 100 mL), and saturated aqueous 
NaHCO3 (1 x 100 mL). The organics were then dried over MgSO4, filtered and re-concentrated 
under reduced pressure to reveal the product (4.10 g, 83%) as a pale yellow viscous oil. Colorless 
but spectroscopically identical material could be obtained by flash chromatography on silica gel 
eluting with 4:1 hexanes / ethyl acetate. 1H NMR (400 MHz, CDCl3) δ 6.70 (d, J = 2.3 Hz, 2H), 
6.54 (t, J = 2.4 Hz, 1H), 5.11 (s, 4H), 4.69 (d, J = 8.4 Hz, 1H), 3.43 (s, 6H), 3.16 (s, 3H), 3.16 – 
3.08 (m, 1H), 2.97 (s, 3H), 1.81 – 1.58 (m, 3H), 1.50 – 1.35 (s, 1H), 0.89 (s, 9H), 0.88 – 0.83 (m, 
6H), 0.04 (s, 3H), -0.18 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 175.0, 157.7, 146.8, 108.3, 104.0, 
94.4, 76.1, 60.7, 55.8, 49.2, 39.0, 31.7, 26.2, 25.8, 23.9, 22.0, 18.2, -4.6, -5.1. IR (neat): 2954 
(alkane C-H stretch), 1652 (C=O stretch) cm-1. HRMS (ESI): calc’d for C25H46NO7Si [M + H]+ 




 To a flamed-dried, argon-purged 250-mL round bottom flask containing a magnetically-
stirred solution of 126 (4.10 g, 8.20 mmol, 1.00 eq) in THF (125 mL) was added methyllithium 
(15.4 mL of a 1.6 M sol’n in Et2O, 24.6 mmol, 3.00 eq) portionwise at -78 °C. The resulting 
solution was then stirred 3.5 hours, at which time TLC indicated complete consumption of starting 
material. The reaction solution was quenched at -78 °C by the addition of saturated aqueous 
NH4Cl; the resulting mixture was allowed to come to r.t. with stirring. Et2O was then added, the 
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resulting layers separated and the aqueous phase extracted with Et2O (3 x 150 mL). Organics were 
combined, washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure 
to reveal 3.84 g amber oil. CC on silica gel eluting with 4:1 hexanes / ethyl acetate gave 127 (2.99 
g, 80%) as a colorless oil. 1H NMR (300 MHz, CDCl3) δ 6.60 (s, 3H), 5.13 (s, 2H), 4.52 (d, J = 
7.7 Hz, 1H), 3.46 (s, 4H), 2.89 (t, J = 9.1 Hz, 1H), 1.81 (s, 3H), 1.76 – 1.62 (m, 1H), 1.52 – 1.33 
(m, 2H), 0.87 (s, 15H), 0.02 (s, 3H), -0.20 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 175.0, 157.7, 
146.8, 108.3, 104.0, 94.4, 76.1, 60.7, 55.8, 49.2, 39.0, 31.7, 26.2, 25.8, 23.9, 22.0, 18.2, -4.6, -5.1. 
HRMS (DART): calc’d for C24H43O6Si [M + H]+ 455.2823, found 455.2851. 
S-ethyl 2-(triphenyl-λ5-phosphanylidene)ethanethioate (26) 
 
Following the previously described procedure64, a 2-L round-bottom flask containing a 
magnetically-stirred solution of bromoacetic acid (50.0 g, 360 mmol, 1.00 eq) in DCM (700 mL) 
was charged with ethanethiol (34.6 mL, 468 mmol, 1.3 eq) and 4-dimethylaminopyridine (4.40 g, 
36.0 mmol, 0.10 eq) at 0 °C. N,N-dicyclohexylcarbodiimide (77.94 g, 378 mmol, 1.05 eq) was 
then added portionwise, and the addition funnel rinsed with DCM (50 mL). The resulting thick 
white slurry was stirred 20 hrs, at which point the reaction mixture was filtered through Celite® 
and the filter cake washed with DCM (4 x 200 mL). The filtrate was concentrated under reduced 
pressure to give the crude thioester as a tan oil with particulate inclusions. This material was taken 
up in benzene (500 mL) and charged to a 1-L Erlenmeyer flask, to which triphenylphosphine 
(99.15 g, 378 mmol, 1.05 eq) was added. The reaction mixture was allowed to sit for four days 
with periodic agitation, at which point the mixture was filtered to reveal a white solid which was 
washed with toluene (2 x 100 mL) to give the triphenylphosphonium bromide salt as free-flowing 
crystalline powder. This solid was taken up in DCM (500 mL) and charged to a 3-L round-bottom 
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flask containing a 10% w/w solution of Na2CO3 (500 mL). The reaction vessel was then equipped 
with a mechanical stirring apparatus and the biphasic mixture stirred for 6 hrs, evolving a yellow 
color. The layers were separated and the aqueous phase extracted with DCM (3 x 500 mL); the 
combined organics were dried over Na2SO4 and concentrated under reduced pressure to give a 
light yellow solid. Precipitation from DCM with pentane (2:1 pentane / DCM) and filtration, 
followed by repeated concentration and precipitation of the mother liquor as above, afforded 26 
(108 g, 82% over three steps) as a free-flowing, white crystalline powder. 1H NMR (300 MHz, 
CDCl3) δ 7.69 – 7.51 (m, 9H), 7.51 – 7.41 (m, 6H), 3.66 (d, J = 22.5 Hz, 1H), 2.84 (q, J = 7.4 Hz, 
2H), 1.25 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 180.5, 133.0 (d, J = 10.3 Hz), 132.2 
(d, J = 2.9 Hz), 128.9 (d, J = 12.5 Hz), 126.8 (d, J = 90.9 Hz), 46.9 (d, J = 109.7 Hz), 23.1 (d, J = 
2.4 Hz), 16.3. 31P NMR (162 MHz, CDCl3) δ 13.5. IR (neat) 1578, 1336, 1085, 871, 691, 501 
cm-1. HRMS (ESI): calc'd for C22H21OPS [M + H]+ 365.1124, found 365.1122. Characterization 
was in accordance with that previously reported190. 
S-ethyl (E)-5-phenylpent-2-enethioate (53) 
 
The procedure described in the literature191 was adapted as follows: to a 1-L round-bottom 
flask containing a magnetically-stirred solution of hydrocinnamaldehyde (5.56 mL, 42 mmol, 1.0 
eq) in DCM (200 mL) was added 26 (20.00 g, 55 mmol, 1.3 eq). The resulting solution was stirred 
22 hrs at room temperature, at which time TLC showed complete consumption of starting material. 
The reaction mixture was concentrated under reduced pressure and the residue repeatedly extracted 
under sonication with pentane (4 x 100 mL). The combined washings were then purified by flash 
chromatography on silica gel (300 g) eluting with 49:1 pentane / Et2O to give 53 (7.93 g, 86%) as 
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a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.30 (apparent t, J = 7.4 Hz, 2H), 7.24 – 7.15 (m, 
3H), 6.92 (dt, J = 15.5, 6.8 Hz, 1H), 6.12 (dt, J = 15.5, 1.5 Hz, 1H), 2.94 (q, J = 7.4 Hz, 2H), 2.78 
(t, J = 7.6 Hz, 2H), 2.56 – 2.47 (m, 2H), 1.28 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 
190.0, 143.9 140.6, 129.1, 128.5, 128.3, 126.2, 34.3, 33.9, 23.1, 14.8. Characterization agreed with 
that previously reported in the literature191.  
S-ethyl (R)-3-methyl-5-phenylpentanethioate (54) 
 
An argon-purged, 250-mL round-bottom flask equipped with a magnetic stir bar as charged 
with CuBr·Me2S (0.065 g, 0.32 mmol, 0.014 eq) and (R,SP)-Josiphos ethanol adduct (0.247 g, 
0.390 mmol, 0.017 eq), followed by tert-butyl methyl ether (125 mL). The resulting orange 
solution was stirred at r.t. for 30 min, then cooled to -78 °C. To this solution was added 
methylmagnesium bromide (9.1 mL of a 3.0 M solution in Et2O, 27.0 mmol, 1.2 eq); 53 (5.00 g, 
23 mmol, 1.00 eq) was then added as a solution in tert-butyl methyl ether (33 mL) over 1.5 hrs via 
syringe pump. The reaction mixture was allowed to stir for 14 hrs at -78 °C, at which time TLC 
showed complete consumption of starting material. MeOH (8 mL) was added at -78 °C and the 
mixture allowed to warm to room temperature; saturated aqueous NH4Cl was then added and the 
biphasic mixture stirred 30 min. The layers were separated and the aqueous layer extracted with a 
1:1 mixture of DCM / Et2O (3 x 100 mL). The combined organics were dried over MgSO4 and 
concentrated under reduced pressure to give a brown oil. Purification by flash chromatography on 
silica gel (250 g) eluting with 49:1 pentane / Et2O gave 54 (4.49 g, 83%, 93% e.e.) as a colorless 
oil. Enantiomeric excess was determined by reduction to the alcohol followed by HPLC analysis 
on a chiral column using the following conditions: column = Chiralpak® IB, eluent = 97:3 
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hexanes/iso-propanol, flow = 1.0 mL/min; tR = 12.55 min (R), 13.51 min (S). Absolute 
configuration was established by conversion to the known192 aldehyde 55 in the next step. 1H 
NMR (400 MHz, CDCl3): δ  7.31 – 7.25 (m, 3H), 7.21 – 7.15 (m, 3H), 2.88 (q, J = 7.4 Hz, 2H), 
2.72 – 2.54 (m, 3H), 2.41 (dd, J = 14.5, 8.0 Hz, 1H), 2.16 – 2.02 (m, 1H), 1.74 – 1.62 (m, 1H), 
1.57 – 1.46 (m, 1H), 1.25 (t, J = 7.4 Hz, 3H), 1.01 (d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 199.0, 142.3, 128.3, 128.3, 125.7, 51.2, 38.4, 33.2, 30.8, 23.3, 19.5, 14.8. IR (neat): 
3026, 2930, 1685, 1454, 1003, 754, 698 cm-1. [α]25D = +6.5° (c 0.83, CH2Cl2). HRMS (ESI): calc’d 
for C14H21OS [M + H]+ 237.1308, found 237.1310. 
(R)-3-methyl-5-phenylpentanal (55) 
 
A 1-L flame-dried round bottom containing 54 (8.05 g, 34.1 mmol, 1.00 eq) and equipped 
with a magnetic stir bar was capped with a rubber septum, purged with argon and charged with 
DCM (340 mL) to give a colorless, magnetically-stirred solution which was then cooled to -65 °C. 
DIBAL-H (35.8 mL of a 1.0 M solution in hexanes) was added slowly, and the resulting colorless 
solution stirred 50 minutes, at which time TLC showed complete consumption of starting material. 
MeOH (3 mL) was added at -65 °C and the solution stirred 10 min; the solution was then allowed 
to warm to rt. Saturated aqueous Rochelle’s salt was added and the resulting biphasic mixture 
stirred until two clear phases were obtained; layers were then separated and the aqueous phase 
extracted with DCM. The organics were combined, dried over Na2SO4, decanted and concentrated 
under reduced pressure to reveal 55 (6.01 g, 100%) as a colorless oil. Characterization agreed with 
that previously reported192:  [α]25D = +22.8° (c 1.0, CH2Cl2); lit. [α]25D = +22.9°(c 1, CH2Cl2). 1H 
NMR (400 MHz, CDCl3) δ 9.75 (t, J = 2.4 Hz, 1H), 7.31 – 7.26 (m, 3H), 7.21 - 7.15 (m, 3H), 2.73 
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– 2.55 (m, 2H), 2.45 (ddd, J = 16.1, 5.7, 2.0 Hz, 1H), 2.28 (ddd, J = 16.1, 7.9, 2.6 Hz, 1H), 2.18 – 
2.04 (m, 1H), 1.74 – 1.62 (m, 1H), 1.62 – 1.50 (m, 1H), 1.04 (d, J = 6.7 Hz, 3H). 13C NMR (101 
MHz, CDCl3) δ 202.7, 142.1, 128.4, 128.3, 125.8, 51.0, 38.6, 33.3, 27.8, 19.8. 
S-ethyl (R,E)-5-methyl-7-phenylhept-2-enethioate (56) 
 
To a 1-L round bottom flask containing a colorless, magnetically-stirred solution of 55 
(6.01 g, 34.1 mmol, 1.00 eq) in CHCl3 (340 mL) was added 7 (24.84 g, 68.2 mmol, 2.00 eq), giving 
a pale gold solution which was brought to reflux and stirred 12 hrs, at which time 1H NMR of a 
reaction aliquot showed no aldehyde signal. The reaction solution was allowed to cool to r.t., then 
concentrated onto silica (50 g) and purified by flash chromatography on silica gel (400 g) eluting 
with 98:2 pentane / ether to give 56 (6.41 g, 72%) as a colorless oil. The Z-isomer of 56 was also 
isolated as a colorless oil; integration of the corresponding signals in the 1H NMR spectrum of the 
crude reaction mixture indicate a d.r. > 20:1. Other instances of this reaction were observed to 
reach completion in 2 – 5 hrs, with yields averaging 87% after chromatography. 1H NMR (400 
MHz, CDCl3) δ 7.32 – 7.24 (m, 2H), 7.22 – 7.14 (m, 3H), 6.86 (dt, J = 15.2, 7.5 Hz, 1H), 6.10 
(apparent d, J = 15.4 Hz, 1H), 2.94 (q, J = 7.4 Hz, 2H), 2.72 – 2.53 (m, 2H), 2.31 – 2.19 (m, 1H), 
2.13 – 2.01 (m, 1H), 1.76 – 1.60 (m, 2H), 1.57 – 1.41 (m, 1H), 1.28 (d, J = 7.5 Hz, 3H), 0.97 (d, J 
= 6.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 190.0, 143.8, 142.3, 129.9, 128.34, 128.30, 125.7, 
39.5, 38.4, 33.4, 32.2, 23.0, 19.5, 14.8. IR (neat): 3026, 2927, 1668, 1631, 1453 cm-1. [α]25D = 





S-ethyl (3R,5R)-3,5-dimethyl-7-phenylheptanethioate (165) 
 
 To a flame-dried, argon-purged 500-mL round bottom flask were added CuBr•DMS (0.070 
g, 0.341 mmol, 1.4 mol %) and (R,SP)-Josiphos (0.266 g, 0.415 mmol, 1.7 mol %); the flask sealed 
with a rubber septum and tert-butyl methyl ether (100 mL) was added to give an orange solution. 
This solution was stirred 10 min, then cooled to -78 °C and stirred a further 15 min. 
Methylmagnesium bromide (9.8 mL of a 3.0 M solution in Et2O, 29.3 mmol, 1.20 eq) was then 
added dropwise, giving a yellow solution. 56 (6.39 g, 24.4 mmol, 1.00 eq) was then added 
dropwise via syringe pump as a solution in tert-butyl methyl ether (25 mL) over 2 hrs. The resulting 
solution was stirred 16 hrs, at which time TLC showed complete consumption of starting material. 
The reaction was quenched with methanol (~3 mL) at -78 °C to give an opaque yellow-white 
suspension which was stirred 5 min, then allowed to come to r.t. Et2O and saturated aqueous NH4Cl  
were added, the mixture stirred, water added and the layers separated. The aqueous phase was then 
extracted with Et2O (2 x 200 mL), the organics combined, dried over MgSO4, filtered and 
concentrated under reduced pressure to reveal an orange oil (6.80 g). This crude material was 
adsorbed onto silica, loaded onto a column containing silica gel (170 g), and purified by flash 
chromatography eluting with 98:2 pentane/ether to reveal the product as a colorless oil (5.73 g, 
84%). 1H NMR (400 MHz, CDCl3) δ 7.31 – 7.23 (m, 2H), 7.22 – 7.13 (m, 3H), 2.87 (q, J = 7.4 
Hz, 2H), 2.73 – 2.61 (m, 1H), 2.61 – 2.46 (m, 2H), 2.29 (dd, J = 14.4, 8.3 Hz, 1H), 2.21 – 2.06 (m, 
1H), 1.74 – 1.59 (m, 1H), 1.59 – 1.48 (m, 1H), 1.45 – 1.36 (m, 1H), 1.36 – 1.28 (m, 1H), 1.24 (t, 
J = 7.4 Hz, 3H), 1.06 (dt, J = 13.6, 7.3 Hz, 1H), 0.95 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 199.3, 142.9, 128.3, 128.3, 125.6, 51.3, 44.3, 38.4, 33.2, 29.7, 
145 
 
28.6, 23.3, 20.1, 20.0, 14.8. [α]25D = +4.56° (c 1.54, CHCl3). IR (neat): 2928 (alkane C-H stretch), 
1686 (C=O stretch) cm-1. HRMS (ESI): calc’d for C17H27OS [M + H]+ 279.1777, found 279.1777. 
(3R,5R)-3,5-dimethyl-7-phenylheptanal (S1) 
 
 To a 2000-mL, flame-dried, argon-purged round bottom flask containing a magnetically 
stirred, colorless solution of 165 (6.21 g, 22.3 mmol, 1.00 eq) was added DIBAL-H (33.4 mL of a 
1.0 M solution in toluene, 33.4 mmol, 1.50 eq) dropwise over 15 min at -65 °C. The resulting 
colorless solution was stirred an additional 10 min, after which time TLC showed no starting 
material remaining. Methanol (4 mL) was added at -65 °C and the solution stirred until gas 
evolution ceased. The reaction solution was then allowed to warm to r.t. and saturated aqueous 
Rochelle’s salt was added; the resulting mixture was then stirred until two clear phases were 
obtained. Layers were separated and the aqueous phase extracted with DCM (2 x 150 mL). The 
organics were then combined, dried over Na2SO4, decanted and concentrated under reduced 
pressure to reveal the pure product (4.68 g, 96%) as a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 9.74 (s, 1H), 7.31 – 7.25 (m, 2H), 7.21 – 7.14 (m, 3H), 2.68 (ddd, J = 13.6, 10.3, 5.5 Hz, 1H), 
2.55 (ddd, J = 13.7, 10.1, 6.1 Hz, 1H), 2.44 – 2.31 (m, 1H), 2.23 – 2.09 (m, 2H), 1.73 – 1.61 (m, 
1H), 1.60 – 1.48 (m, 1H), 1.47 – 1.37 (m, 1H), 1.37 – 1.23 (m, 1H), 1.11 (dt, J = 13.7, 7.0 Hz, 1H), 
1.00 – 0.89 (m, 6H).  13C NMR (101 MHz, CDCl3) δ 202.9, 142.8, 128.3, 125.6, 50.9, 44.6, 38.5, 
33.2, 29.7, 25.6, 20.5, 19.9. [α]25D = +15.3° (c 1.17, CHCl3). IR (neat): 2914 (alkane C-H stretch), 







 To a 500-mL, flame-dried, argon-purged round bottom flask containing a magnetically 
stirred suspension of freshly-dried methyltriphenylphosphonium bromide (9.17 g, 25.7 mmol, 1.20 
eq, dried by heating at 100 °C under high vacuum for 2 hrs) in THF (105 mL) was added n-
butyllithium (9.4 mL of a 2.5 M solution in hexanes, 23.5 mmol, 1.10 eq) at 0 °C; an orange color 
evolved and most of the solid dissolved. The reaction mixture was brought to r.t. and stirred for 1 
hr, at which time S1 (4.68 g, 21.4 mmol, 1.00 eq) was added as a solution in THF (40 mL + 3 x 10 
mL washes). The resulting cloudy orange reaction suspension was stirred 40 min, at which time 
TLC showed complete consumption of starting material. Saturated aqueous NH4Cl, Et2O and 
water were added and stirred to give a colorless, biphasic mixture. The aqueous phase was 
separated, extracted with Et2O (2 x 200 mL); the organics were then combined, dried over MgSO4, 
filtered and concentrated under reduced pressure to give a colorless oil. Passage of this crude 
material through a plug of SiO2 eluting with pentane gave pure 170 (4.30 g, 93%) as a colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.23 (m, 2H), 7.23 – 7.12 (m, 3H), 5.85 – 5.68 (m, 1H), 
5.05 – 4.91 (m, 2H), 2.66 (ddd, J = 13.6, 10.4, 5.4 Hz, 1H), 2.54 (ddd, J = 13.6, 10.4, 5.8 Hz, 1H), 
2.10 – 2.01 (m, 1H), 1.88 – 1.78 (m, 1H), 1.70 – 1.49 (m, 3H), 1.45 – 1.21 (m, 3H), 1.00 (dd, J = 
13.8, 6.9 Hz, 1H), 0.94 (d, J = 6.5 Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ 143.1, 137.5, 128.3, 128.3, 125.5, 115.6, 44.3, 41.2, 38.7, 33.3, 30.1, 29.8, 20.2, 20.0. [α]25D = 







 A 2-necked, 250-mL round bottom flask was outfitted with a pressure-equalized dropping 
funnel and magnetic stir bar, then sealed with rubber septa. The entire apparatus was then flame 
dried under high vacuum and purged with argon. The round bottom flask was charged with 
BH3•THF (40.4 mL of a 1.0 M solution in THF, 40.4 mmol, 1.10 eq), and 2-methyl-2-butene (9.40 
mL, 88.8 mmol, 2.42 eq) was added via the dropping funnel as a solution in THF (20 mL) over 30 
min at 0 °C. The colorless reaction solution was then stirred 2.5 hrs, at which time 170 (7.94 g, 
36.7 mmol, 1.00 eq) was added as a solution in THF (20 mL + 2 x 5 mL washes). The resulting 
solution was allowed to gradually come to r.t. over 1 hr, then stirred an additional 1 hr. TLC 
indicated complete consumption of starting material. The reaction vessel was cooled to 0 °C and 
aqueous sodium hydroxide (13.93 mL of a 3 M solution, 41.8 mmol, 1.14 eq) was added 
portionwise, with an initial evolution of gas. The reaction mixture evolved a cloudy, opaque 
appearance. The reaction vessel was then equipped with an internal thermometer and 30% aqueous 
hydrogen peroxide (w/w) (13.93 mL) was then added very slowly, keeping the reaction 
temperature below 20 °C. The resulting cloudy mixture was stirred 2 hrs, then water and Et2O 
were added and the resulting layers separated. The pH of the aqueous phase was adjusted to 7.5 
with saturated aqueous NH4Cl, then the aqueous phase was extracted with Et2O (3 x 120 mL) and 
the organics combined, dried over MgSO4, filtered and concentrated under reduced pressure to 
reveal S2 (8.63 g, 100%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.23 (m, 2H), 
7.22 – 7.13 (m, 3H), 3.69 – 3.56 (m, 2H), 2.67 (ddd, J = 13.6, 10.5, 5.4 Hz, 1H), 2.54 (ddd, J = 
13.6, 10.4, 5.9 Hz, 1H), 1.72 – 1.45 (m, 4H), 1.45 – 1.23 (m, 3H), 1.23 – 1.04 (m, 2H), 1.00 (dt, J 
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= 13.9, 7.2 Hz, 1H), 0.93 (d, J = 6.5 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 143.1, 128.3, 128.3, 125.5, 63.4, 44.8, 38.7, 33.3, 32.7, 30.2, 29.9, 29.8, 20.2, 20.1. [α]25D 
= +10.6° (c 1.45, CHCl3). HRMS (ESI): calc’d for C16H30NO [M + NH4]+ 252.2322, found 
252.2317. 
(4S,6R)-4,6-dimethyl-8-phenyloctyl methyl carbonate (171) 
 
To a 500-mL round bottom flask purged with argon, sealed with a rubber septum, and 
containing a magnetically stirred, colorless solution of Y (8.60 g, 36.7 mmol, 1.00 eq), pyridine 
(3.84 mL, 47.7 mmol, 1.30 eq) and 4-dimethylaminopyridine (0.090 g, 0.734 mmol, 2 mol %) in 
DCM (75 mL) was added methyl chloroformate (3.69 mL, 47.7 mmol, 1.30 eq) dropwise over 5 
min. A pale pink color evolved, and the reaction solution was stirred 3 hrs, at which time 1H NMR 
of a reaction aliquot confirms the absence of starting material. Saturated aqueous NH4Cl and water 
were added and the biphasic mixture stirred until two clear, distinct phases were obtained. The 
layers were separated and the aqueous phase extracted with DCM (2 x 120 mL); the organics were 
then combined, dried over Na2SO4, decanted and concentrated under reduced pressure to reveal 
9.85 g colorless oil. This crude material was adsorbed onto SiO2 and loaded onto a column of silica 
gel (300 g). Flash chromatography eluting with 95:5 hexanes / ethyl acetate gave 171 (8.60 g, 
80%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.22 (m, 2H), 7.18 (m, 3H), 4.11 (t, 
J = 6.8, 2H), 3.78 (s, 3H), 2.66 (ddd, J = 13.6, 10.5, 5.4 Hz, 1H), 2.54 (ddd, J = 13.6, 10.4, 5.9 Hz, 
1H), 1.77 – 1.46 (m, 5H), 1.44 – 1.22 (m, 3H), 1.12 (m, 1H), 1.00 (dt, J = 13.9, 7.2 Hz, 1H), 0.93 
(d, J = 6.5 Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 155.9, 143.1, 128.3, 
128.2, 125.5, 68.6, 54.6, 44.8, 38.6, 33.3, 32.6, 29.8, 29.8, 26.1, 20.2, 20.0. [α]25D = +5.6° (c 0.34, 
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CHCl3). IR (neat): 2955 (alkane C-H stretch), 1747 (carbonate C=O stretch) cm-1. HRMS (ESI): 
calc’d for C18H32NO3 [M + NH4]+ 310.2377, found 310.2383. 
(4R,6S)-9-((methoxycarbonyl)oxy)-4,6-dimethylnonanoic acid (172) 
 
 171 (7.00 g, 23.9 mmol) was dissolved in DCM; silica (175 g, 7.3 g/mmol 171) was then 
added and the DCM removed under reduced pressure to give a free-flowing white powder. This 
powder was charged to a 1000-mL round bottom flask equipped with a magnetic stir bar. The flask 
was sealed with a plastic cap and a stainless steel needle was introduced through the cap in such a 
way that the tip of the needle rested at the bottom of the flask below the surface of the silica. A 
second needle of slightly-narrower gauge was introduced through the cap such that its tip was 
positioned in the headspace of the flask; this needle would serve as a point of efflux. A stream of 
ozone in oxygen (OREC ozone generator, high-purity oxygen as input) was introduced into the 
flask through the longer needle and the flask cooled to -78 °C with magnetic stirring. After 
approximately 2 hrs, the silica obtained a pale blue coloration; the flask was uncapped and allowed 
to warm to r.t. The reaction was monitored by TLC on aliquots of the silica extracted with ethyl 
acetate; after three cycles of ozone saturation at -78 °C followed by warming to r.t., TLC indicated 
the complete consumption of starting material. The room-temperature silica was loaded into a glass 
column and eluted with two column volumes of ethyl acetate; the combined ethyl acetate washings 
were then concentrated under reduced pressure to give pure 172 (6.22 g, 100%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 10.38 (br. s, 1H), 4.12 (t, J = 6.7, 2H), 3.78 (s, 3H), 2.45 – 2.25 (m, 
2H), 1.79 – 1.46 (m, 5H), 1.45 – 1.30 (m, 2H), 1.29 – 1.18 (m, 1H), 1.18 – 1.05 (m, 1H), 1.05 – 
0.93 (m, 1H), 0.92 – 0.80 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 179.8, 155.9, 68.5, 54.6, 44.5, 
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32.6, 31.5, 31.2, 29.7, 29.5, 26.1, 19.9, 19.8. [α]25D = +1.6° (c 4.2, CHCl3). HRMS (ESI): calc’d 
for C13H24NaO5+ [M + Na]+ 283.1516, found 283.1523. 
(4S,6R)-9-((R)-4-benzyl-2-oxooxazolidin-3-yl)-4,6-dimethyl-9-oxononyl methyl carbonate (174) 
 
 To a 50-mL flame-dried, argon-purged round bottom flask equipped with a magnetic stir 
bar and capped with a rubber septum was added 172 (0.250 g, 0.96 mmol, 1.00 eq) as a solution 
in THF (1.5 mL, including washes) followed by triethylamine (0.33 mL, 2.40 mmol, 2.50 eq) and 
pivaloyl chloride (0.12 mL, 0.960 mmol, 1.00 eq) at 0 °C. A white precipitant formed and the 
resulting suspension was stirred 1 hr, then (S)-4-benzyl-2-oxazolidinone (0.170 g, 0.96 mmol, 1.00 
eq) and lithium chloride (0.061 g, 1.44 mmol, 1.50 eq). The resulting mixture was stirred 24 hrs, 
then saturated aqueous ammonium chloride was added, the resulting mixture stirred, layers 
separated and the aqueous layer extracted with Et2O. The organics were combined, dried over 
Na2SO4, decanted and concentrated under reduced pressure to reveal a brown oil. This crude 
material was purified by flash chromatography on silica gel (25 g) eluting first with 9:1 
hexanes/ethyl acetate followed by 3:2 hexanes/ethyl acetate gave 174 (0.30 g, 72%) as a colorless 
oil. 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.25 (m, 3H), 7.23 – 7.17 (m, 2H), 4.66 (ddt, J = 10.3, 
6.8, 3.2 Hz, 1H), 4.23 – 4.14 (m, 2H), 4.11 (t, J = 6.8 Hz, 2H), 3.76 (s, 3H), 3.29 (dd, J = 13.3, 3.4 
Hz, 1H), 2.98 (ddd, J = 15.8, 9.9, 5.5 Hz, 1H), 2.87 (ddd, J = 16.4, 9.8, 5.9 Hz, 1H), 2.74 (dd, J = 
13.3, 9.7 Hz, 1H), 1.78 – 1.49 (m, 5H), 1.48 – 1.32 (m, 2H), 1.26 (dt, J = 13.6, 6.9 Hz, 1H), 1.18 
– 1.07 (m, 1H), 1.01 (dt, J = 14.0, 7.2 Hz, 1H), 0.94 – 0.83 (m, 6H). 13C NMR (101 MHz, CDCl3) 
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δ 173.6, 155.9, 153.4, 135.3, 129.4, 128.9, 127.3, 68.5, 66.1, 55.2, 54.6, 44.7, 37.9, 33.2, 32.6, 
30.9, 29.7, 29.6, 26.1, 19.9. [α]25D = +39.5° (c 0.24, CHCl3). IR (neat): 2956 (alkane C-H stretch), 
1779 (C=O stretch), 1745 (C=O stretch), 1698 (C=O stretch) cm-1. HRMS (ESI): calc’d for 
C23H34NO6 [M + H]+ 420.2381, found 420.2383. 
 (4S,6S,8S)-9-((R)-4-benzyl-2-oxooxazolidin-3-yl)-4,6,8-trimethyl-9-oxononyl methyl carbonate 
(175) 
 
 To a 500-mL argon-purged round bottom flask capped with a rubber septum and containing 
a magnetically-stirred colorless solution of 174 (5.00 g, 11.9 mmol, 1.00 eq) in THF (90 mL) was 
added sodium hexamethyldisilazide (14.3 mL of a 1.0 M solution in THF, 14.3 mmol, 1.20 eq) 
dropwise at -78°C. The resulting pale brown solution was stirred 1 hr, at which time methyl iodide 
(1.85 mL, 29.8 mmol, 2.50 eq) was added dropwise. The resulting solution was then stirred 4.5 
hrs, at which time TLC indicated complete consumption of starting material. Saturated aqueous 
NH4Cl, water, Et2O and saturated aqueous Na2S2O3 were added and the mixture allowed to warm 
to r.t. with stirring overnight. The layers were separated and the aqueous phase extracted with Et2O 
(2 x 100 mL); the organics were then combined, dried over Na2SO4, decanted and concentrated 
under reduced pressure to reveal a dark yellow oil. Flash chromatography on silica gel (250 g) 
eluting first with 9:1 hexanes / ethyl acetate followed by 3:1 hexanes / ethyl acetate gave 175 (4.66 
g, 81%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.24 (m, 3H), 7.22 (d, J = 6.7, 
2H), 4.69 (ddt, J = 10.3, 7.4, 3.1 Hz, 1H), 4.25 – 4.15 (m, 2H), 4.13 (t, J = 6.7 Hz, 2H), 3.94 – 3.83 
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(m, 1H), 3.77 (s, 3H), 3.25 (dd, J = 13.4, 3.3 Hz, 1H), 2.77 (dd, J = 13.4, 9.6 Hz, 1H), 1.90 (ddd, 
J = 13.7, 9.3, 4.7 Hz, 1H), 1.80 – 1.67 (m, 1H), 1.67 – 1.52 (m, 2H), 1.52 – 1.41 (m, 1H), 1.41 – 
1.31 (m, 1H), 1.30 – 1.18 (m, 4H), 1.18 – 1.01 (m, 2H), 1.01 – 0.92 (m, 1H), 0.88 (d, J = 6.6 Hz, 
3H), 0.85 (d, J = 6.5 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 177.2, 155.8, 152.9, 68.5, 65.9, 55.1, 
54.5, 45.0, 40.5, 37.7, 35.2, 32.5, 29.6, 28.0, 26.0, 20.4, 19.9, 18.6. [α]25D = +46.1° (c 0.20, CHCl3). 
IR (neat): 2956 (alkane C-H stretch), 1778 (C=O stretch), 1746 (C=O stretch), 1695 (C=O stretch) 
cm-1. HRMS (ESI): calc’d for C24H36NO6 [M + H]+ 434.2537, found 434.2532. 
(2S,4S,6S)-9-((methoxycarbonyl)oxy)-2,4,6-trimethylnonanoic acid (176) 
 
 To a 500-mL round bottom flask containing a magnetically stirred colorless solution of 
175 (4.19 g, 9.67 mmol, 1.00 eq) in THF (100 mL) was added a solution of lithium hydroxide 
monohydrate (0.811 g, 19.3 mmol, 2.00 eq) and 30% (w/w) hydrogen peroxide (7.83 mL, 77.3 
mmol, 8.00 eq) in water (25 mL + 25 mL of washings) at 0 °C. Gas evolution was noted; the walls 
of the flask were then rinsed with an additional 50 mL THF and the resulting cloudy, colorless 
mixture was stirred 45 min, at which time TLC indicated the complete consumption of starting 
material. Na2S2O3 (8.00 eq) dissolved in water was added, followed by saturated aqueous NH4Cl 
as well as solid NH4Cl to give a biphasic mixture of approximately neutral pH. Et2O was added, 
layers were separated and the aqueous phase extracted with ethyl acetate (3 x 300 mL). The 
organics were combined, dried over Na2SO4, decanted and concentrated under reduced pressure 
to reveal a colorless oil. Flash chromatography on silica gel (250 g) eluting with 13:5 hexanes / 
ethyl acetate + 1% (v/v) AcOH gave 176 (2.58 g, 97%) colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 10.61 (s, 1H), 4.12 (t, J = 6.8 Hz, 2H), 3.78 (s, 3H), 2.67 – 2.49 (m, 1H), 1.79 – 1.46 (m, 5H), 
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1.41 – 1.29 (m, 1H), 1.24 – 1.02 (m, 6H), 0.97 (dt, J = 14.0, 7.2 Hz, 1H), 0.89 (d, J = 6.5 Hz, 3H), 
0.85 (d, J = 6.5 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 182.8, 155.9, 68.5, 54.6, 45.0, 40.9, 37.2, 
32.7, 29.6, 28.1, 26.1, 20.3, 19.7, 18.1. [α]25D = +12.9° (c 0.57, CHCl3). IR (neat): 2956 (alkane 
C-H stretch), 1747 (C=O stretch), 1704 (C=O stretch) cm-1. HRMS (ESI): calc’d for C14H27NO5 
[M + H]+ 275.1853, found 275.1858. 
(4S,6S,8S)-9-(methoxy(methyl)amino)-4,6,8-trimethyl-9-oxononyl methyl carbonate (177) 
 
 To an argon-flushed, 500-mL round bottom flask containing a magnetically stirred 
colorless solution of 176 (2.48 g, 9.04 mmol, 1.00 eq) in DCM (20 mL) was added (benzotriazol-
1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (4.94 g, 9.49 mmol, 1.05 eq) and 
diisopropylethylamine (3.85 mL, 22.1 mmol, 2.45 eq). The resulting near-colorless solution was 
stirred 10 min, at which time N,O-dimethylhydroxylamine hydrochloride (1.19 g, 12.2 mmol, 1.35 
eq) was added and the reaction solution stirred an additional 1.5 hrs. At this time, TLC indicated 
complete consumption of starting material. The reaction solution was charged to a separatory 
funnel and rinsed with 1N HCl (1 x 30 mL), water (1 x 30 mL), saturated aqueous NaHCO3 (1 x 
30 mL), dried over Na2SO4, decanted and concentrated under reduced pressure to give a glassy 
solid. This crude material was dissolved in DCM, adsorbed onto SiO2 (35 g); subsequent 
purification by flash chromatography on silica gel (250 g) eluting with 3:1 hexanes / ethyl acetate 
gave 177 (2.24 g, 82%) as a colorless, low-viscosity oil. 1H NMR (400 MHz, CDCl3) δ 4.11 (t, J 
= 6.8 Hz, 2H), 3.77 (s, 3H), 3.70 (s, 3H), 3.18 (s, 3H), 3.01 (s, 1H), 1.79 (ddd, J = 13.9, 9.6, 4.7 
Hz, 1H), 1.74 – 1.66 (m, 1H), 1.66 – 1.50 (m, 2H), 1.50 – 1.40 (m, 1H), 1.40 – 1.29 (m, 1H), 1.24 
– 1.15 (m, 1H), 1.15 – 1.06 (m, 4H), 1.04 – 0.89 (m, 2H), 0.87 (d, J = 4.2 Hz, 3H), 0.85 (d, J = 4.2 
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Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 155.9, 68.6, 61.4, 54.6, 45.2, 41.1, 32.7, 32.6, 29.6, 28.1, 
26.2, 20.6, 19.9, 18.5. [α]25D = +16.1° (c 0.27, CHCl3). IR (neat): 2956 (alkane C-H stretch), 1747 




 To an argon-purged 500-mL round bottom flask equipped with a magnetic stir bar, sealed 
with a rubber septum and containing 177 (2.17 g, 6.84 mmol, 1.00 eq) was added 1% (w/w) K2CO3 
in methanol (60 mL). The resulting colorless solution was stirred 1 hr, at which time 1H NMR of 
a reaction aliquot appeared to indicate the complete consumption of starting material. The reaction 
solution was diluted with Et2O and washed with water. These washings were then back-extracted 
twice with Et2O and the combined organics dried over Na2SO4, decanted and concentrated under 
reduced pressure to reveal a colorless oil with included water. This material was dissolved in DCM, 
re-dried over Na2SO4, decanted and concentrated under reduced pressure to give a colorless oil. 
Despite the apparent lack of starting material in the reaction mixture, flash chromatography on 
silica gel (150 g) gave both starting material (0.52 g) and product (1.22 g, 69%) as colorless oils. 
The recovered starting material was re-subjected to the conditions described above (13 mL 1% 
(w/w) K2CO3 in methanol for 2 hrs); workup without chromatography gave additional pure product 
(0.22 g) which was combined with the previously-obtained material to give 178 (1.46 g, 82%) as 
a colorless oil. 1H NMR (400 MHz, CDCl3) δ 3.70 (s, 3H), 3.68 – 3.56 (m, 2H), 3.18 (s, 3H), 3.02 
(s, 1H), 1.80 (ddd, J = 13.8, 9.6, 4.4 Hz, 1H), 1.67 – 1.40 (m, 4H), 1.40 – 1.29 (m, 2H), 1.26 – 1.16 
(m, 1H), 1.16 – 1.06 (m, 4H), 1.06 – 0.90 (m, 2H), 0.87 (d, J = 4.1 Hz, 3H), 0.86 (d, J = 4.1 Hz, 
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3H). 13C NMR (101 MHz, CDCl3) δ 63.4, 61.5, 45.3, 41.3, 32.7, 32.5, 32.4, 30.0, 29.8, 28.3, 20.5, 
20.1, 18.5. [α]25D = +28.5° (c 0.22, CHCl3). IR (neat): 2931 (alkane C-H stretch), 1643 (C=O 
stretch) cm-1. HRMS (ESI): calc’d for C14H30NO3 [M + H]+ 260.2220, found 260.2193. 
methoxymethyl 3,5-bis(methoxymethoxy)benzoate (102) 
 
 To a 500-mL, flame-dried three neck round bottom flask equipped with a magnetic stir bar 
and pressure-equalized dropping funnel was added 3,5-dihydroxybenzoic acid (10.63 g, 69.0 
mmol, 1.00 eq); the flask was then sealed with rubber septa and purged with argon. DCM (80 mL) 
was added, followed by Hünig’s base (72.11 mL, 414 mmol, 6.00 eq). The resulting off-white 
suspension was then cooled to 0 °C with stirring and methoxymethyl chloride (25.00 g, 311 mmol, 
4.5 eq) was added dropwise (dropping funnel) over 1.5 hrs with some evolution of white gas. The 
resulting opaque, dark brown solution was allowed to come to r.t. and stirred 23 hrs, at which time 
TLC appeared to show complete consumption of starting material. Saturated aqueous NaHCO3 
was added and the biphasic mixture stirred until color had lightened considerably. Layers were 
then separated and the aqueous phase extracted with DCM (2 x 150 mL). Organics were combined 
and back-extracted with aqueous KOH (1 N, 2 x 250 mL), washed with brine, and dried over 
Na2SO4, then decanted and concentrated under reduced pressure to reveal the product as a brown 
oil (17.84 g) which was used directly in the next step without further purification. Pure 102 could 
be obtained as a colorless oil by purification by flash chromatography on silica gel eluting with 
3:1 hexanes / ethyl acetate. 1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 2.3 Hz, 2H), 6.95 (t, J = 
2.3 Hz, 1H), 5.47 (s, 2H), 5.20 (s, 4H), 3.54 (s, 2H), 3.49 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 
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165.5, 158.1, 131.9, 110.9, 109.9, 94.5, 91.1, 57.8, 56.1. IR (neat): 2956 (C-H stretch), 1723 (C=O 




A flame-dried 1000-mL round bottom flask equipped with a magnetic stir bar, purged with 
argon and containing crude 102 (14.53 g, 50.8 mmol, 1.00 eq) was sealed with a rubber septum 
and charged with DCM (100 mL) to give a pale yellow stirred solution. The reaction vessel was 
cooled to -78 °C and DIBAL-H (100 mL of a 1.0 M solution in hexanes, 100 mmol, 1.97 eq) was 
added over 15 minutes via cannula. The yellow reaction solution was stirred an additional 5 
minutes, at which time TLC showed complete consumption of starting material. Excess MeOH 
was added at -78 °C; once gas evolution had ceased, the reaction mixture was allowed to warm 
somewhat and saturated aqueous Rochelle’s salt was added. The biphasic mixture was allowed to 
warm to r.t. and stirred overnight, at which time layers were separated. The aqueous phase was 
extracted with diethyl ether (3 x 150 mL); organics were combined, dried over Na2SO4, decanted 
and concentrated under reduced pressure to reveal the crude product (12.04 g) as a viscous, yellow 
oil which was used directly in the next step without further purification. Pure 103 could be obtained 
as a colorless oil after purification by flash chromatography on silica gel eluting with 98:2 
DCM/MeOH. Of note, when a 1.0 M solution of DIBAL-H in THF was used in place of DIBAL-
H in hexanes in this reaction, the reaction failed to progress even after warming to r.t., and the 
starting material was recovered unchanged. 1H NMR (400 MHz, CDCl3) δ 6.72 (d, J = 2.3 Hz, 
2H), 6.66 (t, J = 2.3 Hz, 1H), 5.16 (s, 4H), 4.64 (s, 2H), 3.48 (s, 6H), 1.68 (s, 1H). 13C NMR (101 
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MHz, CDCl3) δ 158.4, 143.5, 107.9, 104.0, 94.4, 65.1, 56.0. IR (neat): 3401 (br, O-H stretch), 




 To a 1000-mL round bottom flask containing a magnetically-stirred solution of crude 103 
(12.04 g) in DCM (200 mL) was added activated manganese dioxide (88.33 g, 1.02 mol). The 
walls of the flask were rinsed with DCM (2 x 25 mL) and the black suspension cooled with an ice 
bath until the reaction was no longer exothermic. The reaction was then brought to r.t. and stirred 
21 hrs, at which time TLC showed complete consumption of starting material. The reaction 
mixture was filtered through Celite and the filter cake thoroughly washed with DCM and the 
combined filtrates concentrated under reduced pressure to reveal 9.40 g yellow oil. Flash 
chromatography on silica gel (330 g) eluting with 85:15 hexanes/ethyl acetate gave 104 (9.16 g, 
59% over three steps) as a colorless oil that solidified on standing at -30 °C over a period of months. 
1H NMR (400 MHz, CDCl3) δ 9.91 (s, 1H), 7.21 (d, J = 2.3 Hz, 2H), 6.98 (t, J = 2.3 Hz, 1H), 5.21 
(s, 4H), 3.49 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 191.6, 158.7, 138.5, 111.1, 110.4, 94.5, 56.2. 
IR (neat): 2904 (C-H stretch), 2827 (aldehyde C-H stretch), 1700 (C=O stretch), 1593 cm-1. 







 To a 500-mL round bottom flask containing freshly-prepared149 (R)-1-(4-benzyl-2-
thioxothiazolidin-3-yl)-4-methylpentan-1-one (3.43 g, 11.2 mmol, 1.00 eq) was added 
MgBr2•Et2O (0.434 g, 1.68 mmol, 15 mol %). The flask was equipped with a magnetic stir bar, 
sealed with a rubber septum and purged with argon. Ethyl acetate (10 mL) was then added, 
followed by 104 (2.53 g, 11.2 mmol, 1.00 eq) as a solution in ethyl acetate (5 mL + 3 mL 
washings). Triethylamine (3.12 mL, 22.4 mmol, 2.00 eq) and trimethylsilyl chloride (2.13 mL, 
16.8 mmol, 1.50 eq) were then added to give a pale yellow opaque suspension. The reaction 
mixture was stirred 43 hrs, at which time TLC indicated complete consumption of starting 
material. The reaction mixture was filtered through a plug of silica gel, eluting with Et2O. The 
filtrate was then concentrated under reduced pressure into a 500-mL round bottom flask to give 
the crude trimethylsilyl ether as a viscous, yellow oil. This material was dried under high vacuum 
overnight; the flask was then charged with a magnetic stir bar, sealed with a rubber septum and 
purged with argon. DCM (100 mL) was added to give a yellow solution, then trifluoroacetic acid 
(1.72 mL, 22.4 mmol, 2.00 eq) was added dropwise over 5 min. The resulting solution was stirred 
1.5 hrs; saturated aqueous NaHCO3 was then added and the resulting biphasic mixture stirred until 
gas evolution had ceased. The layers were separated and the aqueous phase extracted with DCM 
(2 x 100 mL); the organics were then combined, dried over Na2SO4, decanted, and concentrated 
under reduced pressure onto SiO2 (25 g). This silica-adsorbed material was then loaded onto a 
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silica gel (250 g) column and purified by flash chromatography eluting with 9:1 hexanes / ethyl 
acetate followed by 7:3 hexanes / ethyl acetate to give S3 (5.31 g, 89%) as a light yellow 
amorphous solid after azeotropic drying with heptane and drying on high vacuum. 1H NMR (400 
MHz, CDCl3) δ 7.35 – 7.28 (m, 2H), 7.28 – 7.18 (m, 3H), 6.65 (d, J = 2.2 Hz, 2H), 6.56 (t, J = 2.3 
Hz, 1H), 5.22 – 5.14 (m, 3H), 5.06 (d, J = 6.8 Hz, 2H), 4.86 (dt, J = 8.3, 4.1 Hz, 1H), 4.80 (td, J = 
6.7, 3.3 Hz, 1H), 3.34 (s, 6H), 3.27 (d, J = 9.1 Hz, 1H), 3.10 (dd, J = 13.2, 3.8 Hz, 1H), 2.89 (dd, 
J = 13.2, 10.7 Hz, 1H), 2.70 (dd, J = 11.3, 6.8 Hz, 1H), 2.61 (d, J = 11.3 Hz, 1H), 1.96 – 1.83 (m, 
1H), 1.79 (t, J = 7.1 Hz, 2H), 1.00 (d, J = 6.5 Hz, 3H), 0.96 (d, J = 6.5 Hz, 3H). 13C NMR (101 
MHz, CDCl3) δ 202.0, 177.1, 158.3, 145.5, 136.4, 129.4, 128.8, 127.2, 106.0, 103.9, 94.3, 74.2, 
68.8, 56.0, 48.1, 37.8, 36.5, 31.9, 25.7, 23.7, 22.2. [α]25D = -200° (c 0.24, CHCl3). IR (neat): 3491 
(O-H stretch), 2952 (alkane C-H stretch), 1667 (C=O stretch) cm-1. HRMS (ESI): calc’d for 




 A 500-mL flame-dried round bottom flask charged with X (5.31 g, 9.95 mmol, 1.00 eq) 
was equipped with a magnetic stir bar, sealed with a rubber septum and purged with argon. DCM 
(80 mL) was added to give a yellow solution, then 2,6-lutidine (2.32 mL, 19.9 mmol, 2.00 eq) was 
added at 0 °C, followed by tert-butyldimethylsilyl triflate (3.43 mL, 14.9 mmol, 1.50 eq) dropwise. 
The cooling bath was then removed and the yellow reaction solution allowed to warm towards 
ambient temperature over 20 min, at which time TLC indicated the complete consumption of 
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starting material. Saturated aqueous NaHCO3 and water were added and the biphasic mixture 
stirred; the layers were then separated and the aqueous phase extracted with Et2O (2 x 100 mL). 
The combined organics were then rinsed with 1 N HCl (1 x 200 mL), water (1 x 200 mL), saturated 
aqueous NaHCO3 (1 x 200 mL) and dried over Na2SO4. The organics were then decanted and 
concentrated under reduced pressure to reveal a viscous yellow oil that contained residual 2,6-
lutidine. This crude material was then redissolved in Et2O (200 mL), re-washed with 1 N HCl (2 
x 100 mL), rinsed with water (1 x 150 mL) and saturated aqueous NaHCO3 (1 x 150 mL), then 
dried over MgSO4. Filtration and concentration under reduced pressure followed by stirring under 
high vacuum overnight gave the crude TBS ether as a viscous yellow oil. This material was then 
charged to a flame-dried 500-mL round bottom flask equipped with a magnetic stir bar; the flask 
was sealed with a rubber septum and purged with argon. DCM (100 mL) was added to give a 
stirred rich yellow solution. DIBAL-H (19.5 mL of a 1.0 M solution in hexanes, 19.5 mmol, 2.00 
eq) was then added dropwise at -78 °C over 30 min to give a near-colorless solution. This solution 
was then immediately quenched with saturated aqueous Rochelle’s salt at -78 °C; the resulting 
heterogeneous mixture was then allowed to warm to r.t. with stirring and stirred an additional 2 
hrs to give two clear phases. The layers were separated and the aqueous phase extracted with DCM 
(2 x 100 mL). The organics were combined, dried over Na2SO4, decanted and concentrated under 
reduced pressure to give a yellow oil. Flash chromatography on silica gel (250 g) eluting with 9:1 
hexanes / ethyl acetate gave 185 (3.18 g, 73%) as a colorless oil. Characterization agreed with that 
previously reported21. 1H NMR (400 MHz, CDCl3) δ 9.70 (d, J = 3.8 Hz, 1H), 6.65 (d, J = 2.3 Hz, 
2H), 6.63 (d, J = 2.2 Hz, 1H), 5.14 (s, 4H), 4.73 (d, J = 6.7 Hz, 1H), 3.46 (s, 6H), 2.69 – 2.58 (m, 
1H), 1.62 – 1.51 (m, 1H), 1.46 (dt, J = 13.5, 6.5 Hz, 1H), 1.04 (ddd, J = 13.6, 8.7, 4.7 Hz, 1H), 
0.85 (s, 9H), 0.83 (d, J = 6.5 Hz, 3H), 0.78 (d, J = 6.5 Hz, 3H), 0.01 (s, 3H), -0.20 (s, 3H). 13C 
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NMR (101 MHz, CDCl3) δ 204.3, 158.1, 145.0, 108.1, 104.1, 94.5, 75.8, 58.1, 55.9, 35.1, 25.7, 




 To a 500-mL flame-dried, argon-purged round bottom flask containing a colorless, 
magnetically stirred solution of dimethyl methylphosphonate (2.39 mL, 22.0 mmol, 3.05 eq) in 
THF (35 mL) was added n-BuLi (8.64 mL of a 2.5 M solution in hexanes, 21.6 mmol, 3.00 eq) 
dropwise over 8 min at -78 °C; approximately halfway through this addition the reaction solution 
became opaque as a fine white suspension appeared to form. This suspension was stirred 1.5 hrs, 
at which time 185 (3.18 g, 7.22 mmol, 1.00 eq) was added dropwise over 25 min as a solution in 
THF (20 mL + 25 mL washings). The reaction mixture was then stirred an additional 10 min, at 
which time TLC showed complete consumption of 25. The reaction was quenched via the addition 
of saturated aqueous NH4Cl and Et2O at -78 °C; the biphasic mixture was stirred as it was allowed 
to come to r.t. gradually. Water and additional Et2O were added to obtain two clear phases; the 
layers were then separated and the aqueous phase extracted with Et2O (2 x 150 mL). The organics 
were then combined, dried over Na2SO4, filtered and concentrated under reduced pressure to reveal 
the crude β-hydroxyphosphonate as a yellow oil. 1H NMR indicated an inconsequential 1:1 
mixture of diastereomers at C13. This crude material was then charged to a 2000-mL round bottom 
flask equipped with a magnetic stir bar; the flask was charged with DCM (65 mL) to give a pale 
yellow solution. Dess-Martin periodinane (4.60 g, 10.8 mmol, 1.50 eq) was then added to the 
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reaction flask against a stream of argon; the reaction vessel was capped with a rubber septum and 
the opaque white reaction suspension stirred 30 min, at which time TLC indicated complete 
consumption of starting material. The reaction was quenched with saturated aqueous NaHCO3 and 
saturated aqueous Na2S2O3 and the resulting the biphasic mixture stirred. Water and solid Na2S2O3 
were then added portionwise with shaking until two clear phases were obtained. Layers were then 
separated and the aqueous phase extracted twice with Et2O. The organics were combined, rinsed 
with water (1x) and brine (1x), then dried over Na2SO4, decanted and concentrated under reduced 
pressure to reveal a milky, off-white oil. This crude material was then purified by flash 
chromatography on silica gel (250 g) eluting with ethyl acetate to give 186 (3.65 g, 90%) as a 
colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.65 (d, J = 2.2 Hz, 2H), 6.62 (t, J = 2.2 Hz, 1H), 5.15 
(s, 4H), 4.50 (d, J = 8.5 Hz, 1H), 3.79 (dd, J = 11.2, 9.4 Hz, 6H), 3.46 (s, 6H), 3.35 (dd, J = 20.9, 
15.1 Hz, 1H), 3.21 – 3.05 (m, 2H), 1.65 – 1.54 (m, 1H), 1.34 – 1.21 (m, 1H), 0.81 (s, 9H), 0.77 (d, 
J = 6.6 Hz, 3H), 0.70 (d, J = 6.5 Hz, 3H), -0.05 (s, 3H), -0.25 (s, 3H). 13C NMR (101 MHz, CDCl3) 
δ 205.1, 158.0, 145.1, 108.5, 104.3, 94.4, 78.5, 58.7, 55.9, 52.8 (d, J = 6.4 Hz), 52.7 (d, J = 6.3 
Hz), 43.6 (d, J = 133 Hz), 37.7, 25.7, 25.4, 23.5, 21.6, 18.0, -4.8, -5.3. [α]25D = -79.5° (c 0.38, 
CDCl3). IR (neat): 2954 (alkane C-H stretch), 1712 (C=O stretch) cm-1. HRMS (ESI): calc’d for 







 To a 500-mL flame-dried, argon-purged round bottom flask containing a magnetically 
stirred colorless solution of 177 (0.620 g, 2.39 mmol, 1.00 eq) in DCM (24 mL) was added Dess-
Martin periodinane (1.52 g, 3.59 mmol, 1.50 eq). The flask was sealed with a rubber septum and 
the reaction mixture stirred; most of the solid dissolved to give a slightly cloudy, colorless mixture 
which was stirred 18 min, at which time TLC showed no starting material. Ethanol (0.07 mL, 1.20 
mmol, 0.50 eq) was added to quench any excess periodinane, and the resulting mixture was stirred 
an additional 30 min. All volatiles were then evaporated under reduced pressure to leave a white 
residue which was sonicated with 1:1 hexanes / ethyl acetate. The resulting suspension was then 
passed through a plug of silica gel, eluting with 1:1 hexanes / ethyl acetate. The combined eluent 
was concentrated under reduced pressure into a 100-mL round bottom flask to reveal the crude 
aldehyde as a colorless oil. This flask was then charged with a magnetic stir bar and THF (12 mL) 
to give a colorless stirred solution. Barium hydroxide octahydrate (0.603 g, 1.91 mmol, 0.80 eq) 
which had been pre-treated at 120 °C for 2 hrs was added at room temperature. The reaction flask 
was sealed with a rubber septum and a wide-bore stainless steel needle inserted through the septum 
such that the needle reached the bottom of the flask. A vigorous stream of argon was bubbled 
through the white reaction suspension, vented by way of a second needle piercing the rubber 
septum which in turn was exhausted through a mineral oil bubbler. The reaction was thus stirred 
25 min, at which time 186 (1.34 g, 2.39 mmol, 1.00 eq) was added as a solution in THF (12 mL), 
followed by water (0.3 mL). The opaque white reaction mixture was stirred 1.5 hrs, during which 
time the reaction mixture obtained a gel-like consistency and TLC indicated complete 
consumption of the aldehyde starting material. The reaction mixture was partitioned between 
saturated aqueous NaHCO3 and Et2O; the aqueous phase was then diluted with water, the layers 
separated, and the aqueous phase extracted with additional Et2O (3 x 25 mL). The organics were 
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then combined, rinsed with brine, dried over MgSO4, filtered and concentrated under reduced 
pressure to reveal 1.51 g pale yellow oil. Flash chromatography on silica gel eluting with 1:1 
hexanes/ethyl acetate gave a viscous, colorless oil. Azeotropic drying with DCM followed by 
heptane gave 187 (1.17 g, 70% over two steps) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 
6.89 (dt, J = 15.6, 6.9 Hz, 1H), 6.67 (d, J = 2.3 Hz, 2H), 6.62 (t, J = 2.2 Hz, 1H), 6.28 (d, J = 15.6 
Hz, 1H), 5.15 (s, 4H), 4.58 (d, J = 9.2 Hz, 1H), 3.71 (s, 3H), 3.47 (s, 6H), 3.19 (s, 3H), 3.18 – 3.10 
(m, 1H), 3.02 (s, 1H), 2.35 – 2.11 (m, 2H), 1.80 (ddd, J = 13.8, 9.4, 4.7 Hz, 1H), 1.66 – 1.41 (m, 
4H), 1.35 – 1.17 (m, 3H), 1.11 (d, J = 6.9 Hz, 3H), 1.07 – 0.93 (m, 2H), 0.90 (d, J = 3.0 Hz, 3H), 
0.88 (d, J = 2.9 Hz, 3H), 0.75 (s, 9H), 0.72 (app. d, J = 6.6 Hz, 4H), 0.69 (d, J = 6.6 Hz, 3H), -0.11 
(s, 3H), -0.31 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 203.7, 157.9, 147.5, 145.8, 131.9, 108.7, 
104.0, 94.5, 78.4 61.4, 55.9, 55.6, 45.1, 41.1, 38.4, 35.3, 32.6, 30.1, 29.7, 28.1, 25.7, 25.6, 23.7, 
21.5, 20.5, 19.9, 18.5, 18.0, -4.8, -5.5. [α]25D = -40.2° (c 0.84, CHCl3). IR (neat): 2926 (alkane C-






A flame-dried 2-dram vial equipped with a magnetic stir bar was charged with copper(I) 
chloride (6.8 mgs, 0.0687 mmol, 12 mol %) and (S,RP)-Josiphos ethanol adduct (0.132 g, 0.173 
mmol, 36 mol %), sealed with a rubber septum, and purged with argon. To this vial was then added 
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dry, degassed toluene (1 mL) to give a dark orange, homogenous solution (henceforth “Solution 
A”). Solution A was stirred 30 min, then sodium tert-butoxide (0.05 mL of a 2.0 M solution in 
degassed THF, 0.0864 mmol, 18 mol %) was added. Meanwhile, a flame-dried 25-mL round 
bottom flask was charged with 187 (0.400 g, 0.576 mmol, 1.00 eq), bis(pinacolato)diboron (0.249 
g, 0.979 mmol, 1.70 eq) and a magnetic stir bar, then sealed with a rubber septum and purged with 
argon. Dry, degassed toluene (3 mL) was then added to this flask, yielding a colorless, homogenous 
solution. To this solution was then added 0.83 mL of Solution A (a volume such that the reaction 
vessel contained 10 mol % CuCl and 30 mol % (S,R)-Josiphos), yielding a bright orange 
homogenous reaction solution which was stirred 19 hrs, at which time 1H NMR of an aliquot 
indicated complete consumption of starting material. The reaction was quenched by the addition 
of saturated aqueous NH4Cl and water. The layers were then separated and the aqueous phase 
extracted with EtOAc (2 x 10 mL). The organics were combined, dried over Na2SO4, decanted and 
concentrated under reduced pressure to give a viscous orange oil. This crude material was then 
purified by flash chromatography on silica gel (50 g) eluting with 4:1 hexanes/ethyl acetate to give 
the boronate ester as a pale yellow oil; 1H NMR analysis showed a 3:1 mixture of C-11 epimers 
which were carried on to the next step without further purification. 
The mixed boronate ester isomers were charged to a 20-mL glass vial equipped with a 
magnetic stir bar, and THF (3 mL) was added to give a colorless solution. Sodium perborate 
tetrahydrate (0.412 g, 2.68 mmol, 5.00 eq) was added, followed by water (3 mL). The resulting 
brown mixture was stirred 13 hrs, at which time the reaction mixture was partitioned between 
water and EtOAc to obtain two phases. The layers were separated and the aqueous phase extracted 
with Et2O (3 x 7 mL). The organics were then combined, dried over Na2SO4, decanted and 
concentrated under reduced pressure to reveal a yellow oil. This crude material was then purified 
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by flash chromatography on silica (50 g) gel eluting with 4:1 hexanes / ethyl acetate to give 
recovered starting material (0.113 g) and pure 188 (0.077 g) as colorless oils; additional product 
contaminated with 11-epi-188 was also isolated as a colorless oil. The recovered starting material 
was then oxidized as follows: to a colorless, magnetically stirred solution of recovered starting 
material in THF (5 mL) was added a freshly-prepared homogenous solution of sodium perborate 
tetrahydrate (0.105 g, 0.687 mmol, 5.00 eq) in water (5 mL). The resulting opaque colorless 
mixture was then stirred 15 hrs, at which time TLC indicated complete consumption of starting 
material. The reaction was then worked up in a manner directly analogous to that described above, 
giving a colorless oil which was then combined with the impure product obtained above to give a 
colorless oil (0.250 g). A second round of flash chromatography on silica (25 g) gel again eluting 
with 4:1 hexanes / ethyl acetate yielded further pure product (0.027 g), which was combined with 
that obtained above, giving pure 188 (0.094 g, 23% over two steps) as a colorless oil. 1H NMR 
(400 MHz, CDCl3) δ 6.70 – 6.62 (m, 3H), 5.18 (s, 4H), 4.61 (d, J = 9.0 Hz, 1H), 4.09 – 3.98 (m, 
1H), 3.73 (s, 3H), 3.49 (s, 6H), 3.40 (s, 1H), 3.21 (s, 3H), 3.04 (s, 1H), 2.96 (ddd, J = 10.5, 8.9, 
3.7 Hz, 1H), 2.75 – 2.68 (m, 2H), 1.82 (ddd, J = 13.7, 9.1, 4.9 Hz, 1H), 1.65 – 1.44 (m, 5H), 1.44 
– 1.32 (m, 2H), 1.32 – 1.19 (m, 3H), 1.14 (d, J = 6.8 Hz, 3H), 1.09 – 0.94 (m, 2H), 0.91 (d, J = 7.4 
Hz, 3H), 0.89 (d, J = 7.4 Hz, 3H), 0.83 (s, 9H), 0.78 (d, J = 6.6 Hz, 3H), 0.76 (d, J = 6.5 Hz, 
3H), -0.02 (s, 3H), -0.24 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 216.2, 158.0, 145.1, 108.6, 104.2, 
94.4, 78.1, 67.7, 61.4, 58.8, 55.9, 51.9, 45.3, 41.1, 38.2, 33.8, 32.6, 32.4, 29.8, 28.1, 25.8, 25.8, 
23.7, 21.5, 20.7, 20.0, 18.4, 18.0, -4.8, -5.2. [α]25D = -13.2 ° (c 1.1, CHCl3). IR (neat): 3447 (alcohol 
O-H stretch), 1701 (ketone C=O stretch), 1663 (amide C=O stretch) cm-1. HRMS (ESI): calc’d 








 To a 20-mL glass scintillation vial containing 188 (0.093 g, 0.131 mol, 1.00 eq) and 
equipped with a magnetic stir bar was added anhydrous THF (1.5 mL) to give a colorless solution. 
The vial was blown out with argon, capped with a rubber septum and cooled to -30 °C. BH3•DMS 
(27 μL, 0.287 mmol, 2.20 eq) was then added via syringe through the rubber septum and the 
resulting solution stirred 14 hrs, at which time TLC indicated complete consumption of starting 
material. Saturated aqueous NaHCO3 (0.75 mL) and 30% (w/w) H2O2 (0.70 mL) were added 
sequentially, with gas evolution observed upon the initial addition of base. The resulting mixture 
was stirred 15 min, then Et2O and water were added and the biphasic mixture sonicated to give 
two clear phases. The layers were separated and the aqueous phase extracted with Et2O (2 x 10 
mL); the organics were then combined, dried over Na2SO4, decanted and concentrated under 
reduced pressure to reveal the product (0.090 g, 96%) as a colorless oil was used in the subsequent 
step without further purification. 1H NMR showed a 3:1 mixture of 198 and 13-epi-198; epimers 
were separated in the subsequent step. 1H NMR (400 MHz, CDCl3) Major (syn) isomer: δ 6.66 (d, 
J = 2.3 Hz, 2H), 6.61 – 6.57 (m, 1H), 5.14 (s, 4H), 4.63 (d, J = 5.6 Hz, 1H), 3.97 (dd, J = 9.5, 5.1 
Hz, 1H), 3.75 (br s, 1H), 3.70 (s, 3H), 3.46 (s, 6H), 3.18 (s, 3H), 3.01 (br s, 1H), 1.83 – 1.71 (m, 
4H), 1.59 – 1.14 (m, 12H), 1.10 (d, J = 6.7 Hz, 3H), 1.07 – 0.95 (m, 1H), 0.90 (s, 9H), 0.89 – 0.82 
(m, 9H), 0.75 (d, J = 6.5 Hz, 3H), 0.04 (s, 3H), -0.20 (s, 3H). Minor (anti) isomer: δ 6.74 – 6.52 
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(m, 3H), 5.14 (s, 4H), 4.82 (d, J = 3.5 Hz, 1H), 4.24 (d, J = 10.3 Hz, 1H), 3.76 (br s, 1H), 3.69 (s, 
3H), 3.47 (s, 6H), 3.17 (s, 3H), 3.00 (br s, 1H), 1.85 – 1.10 (m, 16H), 1.09 (d, J = 6.7 Hz, 3H), 
1.00 (m, 2H), 0.92 (s, 9H), 0.91 – 0.82 (m, 9H), 0.80 (d, J = 6.5 Hz, 3H), 0.08 (s, 3H), -0.17 (s, 
3H). 13C NMR (101 MHz, CDCl3) Major (syn) isomer: δ 157.9, 146.5, 108.3, 103.6, 94.4, 74.6, 
73.6, 61.4, 55.9, 49.5, 45.2, 41.2, 39.7, 36.1, 35.3, 32.7, 32.2, 29.9, 28.2, 25.8, 23.0, 22.3, 20.7, 
20.0, 18.4, 18.1, -4.5, -5.2. Minor (anti) isomer: δ 158.0, 145.9, 107.9, 103.7, 94.5, 78.0, 69.3, 
67.3, 61.4, 56.0, 55.9, 47.7, 45.1, 41.2, 40.4, 34.5, 34.3, 32.7, 29.8, 28.2, 25.9, 25.7, 23.4, 22.0, 






 To a 20-mL glass scintillation vial equipped with a magnetic stir bar and containing 198 
and 13-epi-198 (0.051 g, 0.0714 mmol, 1.00 eq, 3:1 ratio of epimers) was added dry acetone 
(2 mL) to give a colorless solution. Sodium sulfate (0.101 g, 0.714 mmol, 10.0 eq) was added, 
followed by p-TsOH (1.2 mgs, delivered as 0.1 mL of a freshly-prepared solution of 12 mgs p-
TsOH in 1 mL dry acetone, 0.00714 mmol, 10 mol %) to give a colorless suspension. This reaction 
mixture was then stirred 1 hr, at which time TLC indicated complete consumption of starting 
material. The reaction was quenched with saturated aqueous NaHCO3 (12 drops) to obtain a near-
neutral mixture which was then partitioned between EtOAc (7 mL) and water (5 mL). The resulting 
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layers were separated and the aqueous phase extracted with EtOAc (3 x 10 mL). The organics were 
then combined, dried over Na2SO4, decanted and concentrated under reduced pressure to reveal a 
colorless oil (0.051 g, 94%). This crude residue was then dissolved in anhydrous DCM (3.5 mL) 
and transferred to a 20-mL glass scintillation vial containing a magnetic stir bar. The vial was 
blown out with argon, capped with a rubber septum and cooled to 0 °C, at which time p-TsOH 
(0.6 mgs, delivered as 0.1 mL of a freshly-prepared solution of 5.8 mgs p-TsOH in 1 mL dry DCM, 
0.00338 mmol, 5 mol %) was added. This colorless solution was then stirred 4 hr 15 min, at which 
time the solution was quenched with Et3N (5 drops) and concentrated under reduced pressure to 
give 200 together with 13-epi-198 as a pale yellow oil. This crude material was then dissolved in 
DCM and loaded directly onto a silica gel (2.5 g) plug, which was eluted with several plug volumes 
of 7:3 hexanes / ethyl acetate, giving pure 200 (0.036 g, 67%) as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 6.66 (d, J = 2.3 Hz, 2H), 6.58 (t, J = 2.2 Hz, 1H), 5.18 – 5.09 (m, 4H), 4.73 (d, J 
= 5.5 Hz, 1H), 3.96 – 3.83 (m, 1H), 3.70 (apparent s, 4H), 3.46 (s, 6H), 3.18 (s, 3H), 3.01 (s, 1H), 
1.89 – 1.82 (m, 1H), 1.78 (ddd, J = 13.7, 9.0, 4.9 Hz, 1H), 1.59 – 1.42 (m, 5H), 1.38 (s, 3H), 1.34 
(s, 3H), 1.34 – 1.15 (m, 5H), 1.10 (apparent d, J = 6.8 Hz, 5H), 1.01 (ddd, J = 13.6, 8.4, 5.2 Hz, 
1H), 0.98 – 0.89 (m, 1H), 0.88 (s, 9H), 0.87 – 0.82 (m, 6H), 0.81 (d, J = 6.5 Hz, 3H), 0.77 (d, J = 
6.5 Hz, 3H), 0.01 (s, 3H), -0.21 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 157.6, 146.3, 108.7, 103.3, 
98.1, 94.5, 74.7, 69.2, 69.0, 61.4, 55.9, 48.4, 45.1, 41.1, 34.9, 34.0, 33.6, 32.6, 32.5, 31.9, 30.2, 
28.1, 26.1, 25.8, 23.2, 22.5, 20.7, 20.0, 19.8, 18.4, 18.1, -4.7, -5.1. [α]25D = -12.8° (c 0.95, CHCl3). 
IR (neat): 2952 (alkane C-H stretch), 1669 (C=O stretch) cm-1. HRMS (ESI): calc’d for 




Baulamycin A (1) 
 
 A 2-dram vial equipped with a magnetic stir bar and containing 200 (29.9 mgs, 0.0396 
mmol, 1.00 eq) was sealed with a rubber septum, purged with argon and charged with Et2O (2 mL) 
to give a colorless solution. Ethyl magnesium bromide (0.13 mL of a 3.0 M solution in diethyl 
ether, 0.396 mmol, 10.0 eq) was added dropwise at room temperature, and the resulting solution 
was stirred 19 hrs, at which time the reaction mixture was cooled to 0 °C and saturated aqueous 
NH4Cl was added dropwise until gas evolution ceased. Water and additional diethyl ether were 
added and the resulting biphasic mixture stirred until two clear phases were obtained. The layers 
were then separated and the aqueous phase extracted with diethyl ether (3 x 10 mL). The organics 
were combined, dried over Na2SO4, decanted and concentrated under reduced pressure to reveal 
the ethyl ketone (23.1 mg) as a colorless oil. A portion of this material was then deprotected as 
follows: a 20-mL glass vial equipped with a magnetic stir bar crude was charged with crude ethyl 
ketone (20.4 mg, 0.0282 mmol, 1.00 eq) followed by THF (1 mL) and methanol (1 mL) to give a 
colorless solution. 2 N HCl (1 mL) was then added dropwise to give an opaque white mixture 
which clarified upon stirring. The reaction solution was stirred 36 hrs, then quenched by the slow, 
portionwise addition of solid NaHCO3 until gas evolution ceased and the pH of the reaction 
approached neutrality. EtOAc and water were added to give two clear phases, which were then 
separated. The aqueous phase was then extracted with EtOAc (4 x 10 mL). The organics were 
combined, dried over Na2SO4, decanted and concentrated under reduced pressure to reveal a 
colorless oil. This crude residue was dissolved in EtOAc and purified by PTLC eluting with 1:1 
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heptane / ethyl acetate to reveal baulamycin A (8.9 mgs, 51% over two steps) as a colorless oil. 
Characterization matched that previously reported in the literature in all respects. 1H NMR (400 
MHz, MeOD) δ 6.33 (d, J = 2.2 Hz, 2H), 6.15 (t, J = 2.2 Hz, 1H), 4.47 (d, J = 6.8 Hz, 1H), 4.00 
(dt, J = 10.0, 3.4 Hz, 1H), 3.74 – 3.64 (m, 1H), 2.75 (dqd, J = 9.1, 6.9, 5.0 Hz, 1H), 2.64 – 2.242 
(m, 2H), 1.88 (m, 1H), 1.78 (m, 1H), 1.72 (m, 1H), 1.61 – 1.46 (m, 2H), 1.46 – 1.27 (m, 5H), 1.27 
– 1.13 (m, 4H), 1.06 (d, J = 6.9 Hz, 3H), 1.02 (t, J = 7.3 Hz, 3H), 0.99 – 0.90 (m, 2H), 0.89 (d, J 
= 6.5 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H), 0.83 (d, J = 6.6 Hz, 3H), 0.77 (d, J = 6.5 Hz, 3H). 13C 
NMR (101 MHz, MeOD) δ 218.6, 159.3, 148.3, 106.3, 102.2, 76.9, 73.7, 72.9, 48.8, 46.6, 45.0, 
42.0, 41.0, 37.6, 35.7, 35.4, 33.4, 31.2, 29.5, 26.9, 23.6, 22.8, 20.9, 20.6, 18.2, 8.1. [α]25D = -15.3° 
(c 0.65, CH3OH). HRMS (ESI): calc’d for C28H49O6 [M + H]+ 481.3524, found 481.3529. 
Baulamycin B (2) 
 
 To a 2-dram vial containing a colorless solution of 200 (4 mgs, 0.0053 mmol, 1.00 eq) in 
anhydrous THF (0.35 mL) was added methyllithium (0.01 mL of a 1.6 M solution in Et2O, 0.0159 
mmol, 3.00 eq) at -78 °C. The resulting solution was then stirred 2.75 h, at which time TLC showed 
complete consumption of starting material. The reaction solution was quenched by the addition of 
saturated aqueous NH4Cl and water at -78 °C; the resulting mixture was then extracted with Et2O 
(4 x 4 mL). The organics were combined, dried over Na2SO4, decanted and concentrated under 
reduced pressure to reveal a colorless residue. This crude material was then charged to a 2-dram 
vial equipped with a magnetic stir bar, and THF (0.5 mL) was added to give a colorless solution. 
Water (10 μL, 0.564 mmol, 100 eq) was then added, followed by 3 M HCl in methanol (0.5 mL). 
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The vial was then sealed and the reaction solution stirred 14 hours, at which time TLC showed 
complete consumption of starting material. Solid NaHCO3 (0.126 g) was added portionwise slowly 
to quench the reaction, giving an opaque colloidal suspension. This suspension was sparged with 
argon for 15 minutes, then evaporated under reduced pressure at 32 °C to give a solid white residue. 
This crude material, which was assumed to be primarily NaCl, was dissolved in water (1.5 mL); 
this aqueous solution was then extracted with ethyl acetate (3 x 1.5 mL). The combined organics 
were then dried over Na2SO4, decanted and concentrated once again under reduced pressure to 
reveal a colorless resuide (2.8 mg). This crude material was purified by PTLC eluting with 13:7 
ethyl acetate / hexanes, providing a 1:1 mixture of baulamycin B and 3-epi-baulamycin B as a 
colorless oil (1.3 mg, 50% combined yield of diastereomers). 1H NMR (400 MHz, MeOD) 
Baulamycin B: δ 6.32 (d, J = 2.2 Hz, 2H),  6.14 (t, J = 2.2 Hz, 1H), 4.47 (d, J = 6.8 Hz, 1H), 4.00 
(d, J = 10.0 Hz, 1H), 3.74 – 3.64 (m, 1H), 2.76 – 2.62 (m, 1H), 2.15 (s, 3H), 1.92 – 1.85 (m, 1H), 
1.82 – 1.68 (m, 2H), 1.65 – 1.14 (m, 11H), 1.08 (d, J = 7.0 Hz, 3H), 0.91 – 0.85 (m, 6H), 0.83 (d, 
J = 6.5 Hz, 3H), 0.77 (d, J = 6.5 Hz, 3H). 3-epi-Baulamycin B: δ 6.32 (d, J = 2.2 Hz, 2H),  6.14 (t, 
J = 2.2 Hz, 1H), 4.47 (d, J = 6.8 Hz, 1H), 4.00 (d, J = 10.0 Hz, 1H), 3.74 – 3.64 (m, 1H), 2.76 – 
2.62 (m, 1H), 2.16 (s, 3H), 1.92 – 1.85 (m, 1H), 1.82 – 1.68 (m, 2H), 1.65 – 1.14 (m, 11H), 1.06 
(d, J = 6.9 Hz, 3H), 0.91 – 0.85 (m, 6H), 0.83 (d, J = 6.5 Hz, 3H), 0.77 (d, J = 6.5 Hz, 3H).  13C 
NMR (101 MHz, MeOD) Baulamycin B: δ 216.1, 159.4, 148.3, 106.3, 102.3, 76.9, 73.7, 72.9, 
46.6, 46.0, 41.8, 41.0, 37.6, 35.7, 33.3, 31.2, 29.4, 28.2, 26.9, 23.6, 22.8, 20.8, 20.6, 20.4, 17.8. 
3-epi-Baulamycin B: δ 216.0, 159.4, 148.3, 106.3, 102.3, 76.9, 73.7, 72.9, 46.7, 46.0, 41.2, 41.0, 
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Appendix I – Spectra of Novel Compounds 
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